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Introduction and scope of the thesis 
1.1 Steroid receptors and steroid hormone action 
There is good evidence that the concentration of nuclear 
steroid-receptor complexes shows a direct relationship with 
the effect of steroids on cells. Anderson et al. (l) showed 
that uterotrophic responses correlated well with nuclear 
oestradiol receptor levels. Correlations between concentra-
tions of nuclear receptors and cell specific effects have 
also been observed for glucocorticoids in eukaryotic cells 
(2), oestrogens in chicken liver {3,4) and for oestradiol 
and progesterone in chick oviduct (5-10). 
In the search for effects of steroid hormones on cellular 
metabolism it has been observed that oestradiol can affect 
several important parameters that may influence gene expres-
sion, such as synthesis of histone and non-histone proteins 
in uterus {ll-14), the rate of peptide elongation of uterine 
ribosomes (15) and the rate of methylation of ribosomal and 
tRNA's (16,17) 
The involvement of RNA synthesis during the early effects 
of steroids has also been well established for several tis-
sues. Within 0.5-4 h after administration of oestradiol to 
mature or ovariectomized rats, uterine nuclear RNA-polymerase 
activity is stimulated (18,19,20), predominantly at nucleolar 
sites (21,22). The oestrogen induced stimulation of RNA syn-
thesis could be prevented if puromycine or cycloheximide was 
administered prior to injection of the hormone {18,23), in-
dicating the necessity of a continuous protein synthesis for 
the expression of the oestrogen effect. In fact, a group of 
proteins, including one acidic protein, called IP {induced 
protein) , is formed in response to oestrogen administration 
(24,25,26). The synthesis of this protein, which appears 
within 15 min after oestradiol injection, can be blocked by 
actinomycin D (27 1 28) and cordycepin (29) .However, the biolo-
gical significance of this IP 1 which recently has been puri-
fied and characterized as a polypeptide of molecular weight 
45,000 (30), and its possible relation to the stimulation of 
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nucleolar RNA-polymerase remains to be elucidated. 
In more recent studies the effect of steroid hormones on 
template activity of nuclear chromatin of target tissues has 
nucleolar (I) and been investigated. 
nucleoplasmic (II) 
It was found that both 
RNA-polymerase were stimulated but at 
different times after oestradiol administration (31,32,33, 
34) • 
More detailed studies concerning the possible role of 
hormone-receptor comple~es were carried out by O'Malley and 
coworkers for the effects of progesterone and oestradiol in 
the chick oviduct (35,36). They could demonstrate that the 
accumulation of steroid-receptor complexes in nuclei or on 
the chromatin caused an increase in the number of initiation 
sites for RNA-polymerase molecules prior to the increase in 
ovalbumin synthesis, which is the cell's response to hormone 
administration (10,37,38). 
Based on the kind of information described above, it is 
now generally believed, that effects of steroid hormones in 
target cells are mediated through the binding of steroids to 
specific receptor molecules and the subsequent interaction 
of steroid-receptor complexes with the chromatin. The quan-
tity of nuclear receptor molecules appears to be important 
for the magnitude of a cell's response. The interaction 
between the steroid-receptor complexes and the genome causes 
activation or derepression of transcription or post-trans-
criptional regulation of RNA synthesis. The products of mRNA 
and rRNA dictate the synthesis of specific proteins, which 
ultimately determine the morphogenetic and physiological 
responses to the hormone. 
1.2 Scope of this thesis 
It has been shown previously by Brinkmann et al. (39), 
that the interstitial compartment of the rat testis contains 
a limited number of specific oestradiol receptor sites with 
a high affinity for oestrogens (Ka for oestradiol is 
10 10M- 1 ). This receptor, which in the presence of oestradiol 
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will be translocated into the nuclear fraction (40), shows 
a steroid specificity comparable to that of the uterine 
receptor for oestradiol (41). 
The physiological significance of the uptake of oestra-
diol and its subsequent binding to the oestradiol receptor 
in the testis, is not yet understood. In studies of de Jong 
et al. (42,43) it was found that oestradiol concentrations 
in rat testis interstitial tissue (0.5-lxl0- 9M) are higher 
than those in seminiferous tubules. 
Actions of oestradiol in the testis on DNA, RNA and pro-
tein synthesis have been reported for Balb/c mice (44). It 
has also been suggested that after long-term treatment with 
oestrogens, the observed decrease of testosterone levels in 
rat plasma and testicular tissue would occur without inter-
ference of the LH secretion (45,46,47). Other studies (48), 
however, indicated that the observed oestradiol effect could 
be fully explained through a feedback action of administered 
oestrogens on pituitary LH secretion. The lack of a distinct 
and well-defined effect of oestradiol in the testis made it 
important to investigate whether oestradiol and oestradiol 
binding sites in both the cytoplasmic and nuclear compart-
ments of the testicular tissue would show the same behaviour 
as in an established oestradiol target tissue. In some of our 
studies therefore the nuclear translocation of the oestradiol 
receptor in uterine tissue was used for comparison, because 
this tissue contains an oestradiol receptor which is known 
to be related to the effects of oestradiol on the uterus. 
The results of experiments on the regulation of the 
cytoplasmic oestradiol receptor and the nuclear oestradiol 
receptor are discussed in chapter 6 and appendix papers I 
and II. Also in chapter 6 and appendix paper III the processes 
of translocation and nuclear binding of oestradiol-receptor 
complexes in testicular and uterine tissue are compared. 
It is now well accepted that steroid hormones exert their 
actions in target tissues via the binding of steroid-receptor 
complexes to chromatin constituents in the nuclear fraction. 
There is hardly any information, however, about the nature 
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and the localization of the so-called 'acceptor sites' on 
the chromatin, which bind the steroid-receptor complexes. 
we have studied this aspect of steroid hormone action in 
uterine nuclei and preliminary results are discussed in 
chapter 5. 
Ccpillcry 
Transcription Tran•lction 
I l:-om·RNA' '~ t: Phy'''''''''' -,-- rt" S(terojd) - Induced proteins Effects >---- R-S ---+ R-S - f'-' R-S ~- r-RNA c c act ""'--. Receptor 
Figure Interaction of steroid hormones with a 
target cell 
14 
Summary of the literature on steroid interactions with 
target cells 
2.1 Interaction of steroid hormones with target cells 
It is generally accepted that receptors play an important 
role in the expression of steroid hormone effects.in target 
tissues (35,49-53) and binding of steroids to specific 
receptors appears to be related to and precedes the physio-
logical effects of steroids. However, the precise sequence 
of events which occur between the entry of the steroid in 
the cell and the expression of the hormone effect is still 
unknown. Present knowledge about the fate of steroid hor-
mones in a target cell can be summarized as depicted in 
Fig. 1. The steroid hormone enters a cell, binds to specific 
receptor proteins located in the cytoplasm, followed by 
translocation of the hormone-receptor complex into the 
nucleus where a presumed specific interaction of the complex 
with chromatin constituents ultimately leads to specific 
changes in the cell metabolism ascribed to that specific 
steroid hormone. 
A brief summary about the following aspects, as indicated 
in Fig. 1 will be given in the following paragraphs: 
a) entry of steroid hormones into the target cell. 
b) nature of cytoplasmic receptors and the inter-
action of steroids with the receptor. 
c) steroid induced changes of the cytoplasmic 
receptor. 
d) translocation of the steroid-receptor complex 
from the cytoplasm into the nucleus. 
e) interaction of steroid-receptor complexes with 
nuclear components. 
f) dissociation of steroids from receptor and/or 
acceptor sites. 
g) regulation of the amount of steroid hormone 
receptors. 
h) receptors and actions of steroid hormones. 
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This discussion will mainly concern receptors for oestrogens 
and progestins. 
2.2 Entry of steroid hormones into a target cell 
Steroid hormones outside target cells are generally bound 
to (plasma) proteins which, in comparison to the intracellu-
lar receptor proteins, show a moderate binding specificity 
and a rather low affinity for steroid hormones (Kassociation 
=10 5-10 BM- 1 ). For example serum albumin, the most abundant 
protein constituent of plasma, binds oestradiol, progeste-
rone, testosterone and oestrone with a Ka in the order of 
5 6 10 -10 {54) .Although the more specific steroid binding 
globulins {CBG, SBG, DBG, PBG, EBG). are present in smaller 
amounts, they still will strongly bind the larger part of 
steroids in the blood because of their higher affinity (Ka= 
10 7 -10 9M- 1 ) even if total blood steroid levels are low{SS-59)_. 
The biological function of the plasma steroid binding 
proteins is not clear. They may protect steroids from degra-
dation in the liver, but there is no strong evidence that 
blood proteins can indeed act as a reservoir from which 
steroids can be fed gradually to target organs. In fact, 
there are some indications that the biological activity of 
steroids is probably related to the unbound fraction of 
steroids in plasma (60,61), which is only a small percentage 
of the total amount. 
Before the free steroid can interact with receptor pro-
teins inside the cell, it has to pass the cell membrane. It 
has been generally assumed that the cell membrane provides 
little or no barrier to the diffusion of steroids into cells, 
because of their lipophilic properties. It has been shown by 
Jensen and Jacobson (62) that oestradiol and oestrone are 
taken up rapidly by most tissues of the rat, suggesting a 
simple but rapid diffusion process. A protein mediated pro-
cess was proposed for the entry of oestradiol in uterine 
cells by Milgram et al. (63), who found that the rate of 
entry of oestradiol was reaching a maximum in the range of 
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physiological hormone concentrations and that it could be 
inhibited by SH-blocking agents. This saturable protein is 
probably not the oestrogen receptor since the uptake of 
diethylstilboestrol, which also binds to the receptor, could 
not be blocked significantly. However using N-ethylmaleirnide 
as a SH-blocking agent Peck et al (641 found no support for 
a saturable transport mechanism for oestradiol in uterine 
tissue.Sirnilar results obtained with thymus cells indicated 
that the membrane of thymus cells is also freely permeable 
for corticoids. It can be concluded therefore that steroids 
can enter the cell by simple diffusion and there is little 
evidence to support facilitated transport mechanisms for 
steroid hormones. 
2.3 Nature of the cytoplasmic receptor and the interaction of the steroid 
with the receptor 
After entering a cell steroid hormones can be bound to 
many proteins. In most cases this binding is 'nonspecific', 
but the binding of the steroid to the receptor is the excep-
tion. This steroid receptor interaction is characterized by 
a high affinity (Ka=2xl0 10-lxl0 9M- 1 ), a limited number of 
receptor molecules per cell {3000-40,000 receptors/cell) 
and ~ompetition with small amounts of compounds which are 
chemically similar to the specifically bound hormones. Little 
is known about the physicochemical nature of the strong 
interaction between the steroid and the receptor molecule. 
It has been suggested that the bulkiness and the flatness of 
the steroid plays a more important role in receptor binding 
than the detailed electronic structure of the steroid nucleus 
(65). This would imply that the site of interaction is loca-
ted inside the receptor molecule rather than on the surface 
of the protein. A localization of the steroid binding sites 
inside the receptor proteins could also be responsible for 
the very high affinity constant for receptor binding of 
steroids, the extremely slow rates of association and dis-
sociation of steroids at low temperatures, the acceleration 
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of rates of exchange of unbound steroids with bound steroids 
' by freezing and thawing and the inability of ethanol (30%) 
and detergents {Triton-X-100 or deoxycholate) to dissociate 
steroids from receptors at low temperatures (66). It has 
also been suggested {67) that the binding sites could be 
located in a hydrophobic pocket in the receptor protein and 
that it is necessary for the receptor to 'envelop 1 the 
steroid molecule. 
Treatment of steroid hormone receptors with proteolytic 
enzymes generally destroys the steroid binding capacity. 
Other enzymes like DNAse and RNAse do not effect the binding 
properties indicating that nucleic acids do not play a sig-
nificant role in the interaction between receptors and 
steroids. 
The state of receptor molecules under physiological con-
ditions is still unknown. On sucrose gradients sedimentation 
values between 3S and 125 have been observed depending on 
the protein concentration and the ionic strength of the 
medium (68). In hypotonic media receptors mostly appear as 
an 85 sedimenting entity. Increasing salt concentrations 
reduce the size of the molecule to a 45 sedimenting mole-
cule at 0.4 M KCl. In 0.15 M KCl (isotonic media) receptor 
molecules with sedimentation values of 45 or 65 have been 
observed (69,70,71). After homogenization of uterine tissue 
without adding buffer only a 65 form of the oestradiol re-
ceptor could be detected in the cytosol (72). These obser-
vations indicate, but do not prove, the possibility that 
the 65 form is the predominant receptor form in the target 
cell cytoplasm. During the past years several attempts have 
been made to estimate the molecular weight of steroid hor-
mone receptor molecules as they are present in the cell. 
For the uterine oestradiol receptor with a sedimentation 
value of 4S, Notides and Nielsen estimated a molecular 
weight of about 80,000 (73). Puca et al. consider the 8.65 
sedimenting molecule of the oestradiol receptor to be a 
dimer of the 5.35 form, which may have a molecular weight 
of about 118,000 (74,75). 
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The progesterone receptor in chick oviduct is probably 
considerably larger than the uterine oestradiol receptor. 
The 8S form is thought to be a tetramer of the 4S form, 
which has a molecular weight of 90,000 (76). More recent 
studies showed that the 6S form of the progesterone recep-
tor, probably the native form, consisted of two 4.2S sub-
units, with molecular weights of 110,000 and 117,000 res-
pectively. The subunits differ in binding characteristics 
as will be discussed later (77). 
It can be concluded that steroid receptors are proteins 
and show a very specific high affinity interaction with 
their respective ligand. The nature of the interaction 
between the steroid and the receptor molecule is not yet 
understood. Steroid hormone receptors in cell fractions have 
thusfar been detected only after binding of a radioactive 
steroid. Therefore these studies may not give reliable in-
formation about the receptor as it exists in the cytoplasm 
of a cell prior to the interaction with the steroid. 
2.4 Steroid induced changes in the cytoplasmic receptor 
Steroid-receptor complexes are found predominantly in the 
nuclear fraction, while free receptors remain in the cyto-
plasm. The nature of the changes in the structure of the 
receptor protein during or after binding of the steroid is 
still unknown. It has been shown (78,79,80) that free oestra-
diol receptors are more susceptible to changes in temperature 
than the oestrogen-receptor complex. Other studies (81,82,83) 
have shown that the presence of the steroid is essential for 
induction of specific changes in the structure of the recep-
tor protein at a temperature of 20°C or higher, although 
opposite results have also been reported (83). After inter-
action of the steroid with its receptor site in vivo or in 
vitro a change in the sedimentation value of the complex has 
been observed: the 45 form of the uterine oestradiol receptor 
is converted to aSS form (84). This change in receptor con-
formation probably occurs in the cytoplasmic compartment of 
the cell, because no oestradiol binding proteins with a se-
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dimentation value of 58 can be observed if nuclei are incu-
bated with oestradiol in the absence of cytoplasm (82,85). 
Also, if uterine nuclei are incubated with isolated oestra-
diol-receptor complexes at 25°C or at 0°C with cytosol which 
has been preincubated at 25°C, a considerable accumulation 
of nuclear receptor can be observed {85). The 4S--+ 5S recep-
tor transformation takes place only slowly in the cold, pro-
ceeds rapidly at 25°C to 37°C and is accelerated with in-
creasing pH over 
EDTA, Ca2+, Mg2+ 
the range 6.5-8.5. The presence of salt, 
2+ 
and Mn retards the tran_sformation{S2). 
A somewhat different view has been presented by Puca and 
coworkers {75,86), who believe that oestradiol binds to a 
5.3S cytosol receptor and that this complex is cleaved by a 
proteolytic factor (the •receptor transforming factor') to 
a 4.58 complex which is retained by the nuclei. 
On basis of these results it could be proposed that the 
cytoplasmic receptor binds the steroid, thereby transforming 
the steroid-receptor complex to a 5S form which then trans-
locates into the nucleus. Some data, however, do not support 
this. 8iiteri et al. (87) reported the presence of 4S oestra-
diol binding macromolecules in carefully washed nuclei, and 
they suggested that the 4S form- could have been converted 
into a 5S form inside the nucleus. In addition observations 
of Yamamoto (88) indicate that the presence of DNA could in-
crease the conversion rate of the 4S form into the 58 form. 
Some yet unknown steps may therefore be involved in the 
transformation of cytoplasmic receptor molecules and the sub-
sequent transfer of the complexes into the nucleus. 
In contrast to the transformation theory of steroid recep-
tors, it has been suggested by Notides and Nielsen (73), that 
the 48 and 5S sedimenting entities are chemically different 
molecules. They suggested that the 48 protein, with a mol. 
weight of 80,000 forms a complex with a second cytoplasmic 
protein, thus creating the 5S receptor molecule with a mol. 
weight of 130,000. This view is supported by studies of 
Yamamoto (88) which indicated in addition, that the unknown 
factor was present in both nontarget and target cells. 
In summary,therefore,it can be concluded that steroid hormo-
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nes interact with and bind to receptor proteins, in vivo as 
well as in vitro, but almost nothing is known about the 
nature of the free receptor in vivo, the exact subcellular 
localization of the receptor transformation process and the 
mechanisms which ultimately result in a receptor protein 
suitable for the nuclear translocation. Future studies with 
purified receptors (89,90,91) might provide the information 
necessary for a better understanding of the processes of 
steroid receptor interaction and receptor transformation. 
2.5 The translocation of the steroid-receptor complex into the nucleus 
Early observations from Jensen {92,93) indicated that 
after incubation of uterine tissue in vitro with radioactive 
oestradiol the major part of the hormone was located in the 
nuclear fraction. Subsequently Jensen and Gorski (92,94,95, 
96) found that the nuclear accumulation of uterine hormone-
receptor complexes was accompanied by a concomitant decrease 
of the steroid bound in the cytoplasmic cell fraction. Simi-
lar observations were made using in vivo studies (97,98). 
The pLocess of translocation in uterus is not under the con-
trol of protein synthesis and RNA synthesis (95) and cannot 
be influenced by inhibitors which either affect the energy 
utilization of a cell (95) or interfere with rnicrotubules 
or rnicrofilaments, such as cytochalasin or vinblastin (99). 
However recent observations on chick liver indicate that a 
polypeptide with a high turnover might be involved in the 
interaction of steroid receptor molecules with the acceptor 
site (100). This could be one of the subunits of the recep-
tor itself or a polypeptide involved in binding the hormone-
receptor complex to the chromatin. Addition of SH-blocking 
agents (iodoacetarnide or p-chloromercuribenzoate) gave a 
considerable inhibition of the process, probably via an in-
teraction of the agents with SH-groups on the receptor sur-
face (83,95). 
In contrast to the results obtained for chicken liver it 
has been reported that the rate of translocation of uterine 
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receptor molecules was directly proportional to the concen-
tration of the oestrogen-receptor complex in the cytoplasm 
at the start of the experiment (101). Therefore it can be 
assumed that translocation in uterus occurs without any in-
terference of other cellular functions and appears to be 
the consequence of the inherent properties of the receptor 
as modulated by the binding of the steroid. The movement of 
the steroid-receptor complexes might take place via a simple 
diffusion process. For oocyte cytoplasm it has been shown 
that various materials could be transported from the cyto-
plasm into the nuclei, via the nuclear pores (102,103), and 
that proteins with a molecular weight of about 70,000 enter 
nuclei only at a very slow rate. It remains to be proven 
whether receptor proteins with. _even larger molecular weights 
(80,000-130,000) can simply diffuse through the nuclear po-
res of a cell. From the calculation of the axial ratio of 
the receptor proteins (ratio 7-14) it was concluded that re-
ceptors are rod shaped (84,90,104) and this might be in fa-
vour of the transport of receptors into the nuclei. 
Only after interaction of the receptor with its steroid 
hormone the hormone-receptor complex can translocate into 
the nucleus. Free receptor molecules are located in the cy-
toplasm. There are two possible explanations for this pheno-
menon: 1) the free receptor is bound to some cytoplasmic 
constituents and 2) free receptor molecules cannot pass the 
nuclear membrane. The observations of Little et al. (105), 
Robel et al. (106) and Hirsch et al. (107) are in favour of 
the first explanation. These groups did observe microsomal 
and lysosomal forms of oestradiol and androgen receptors 
respectively. Observations on the glucocorticoid recep-
tor are in favour of the second explanation. Munck et al. 
(67) and Bell and Munck (108) showed that prewarmed (25°C) 
cytosol receptor could translocate into nuclei at a tempera-
ture of 3°C. This observation could reflect that in the pre-
sence of steroid at elevated temperatures an inactive form 
of the steroid receptor is transformed into an active form, 
which can pass the nuclear membrane. In all translocation 
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studies of steroid-receptor complexes very little attention 
has been paid to a possible role of the nuclear chromatin, 
the substance which ultimately binds the complexes. It has 
been observed, however, that progesterone treatment (3 days) 
of ovariectomized rabbits did increase the number of nuclear 
acceptor sites and the binding affinity for the retention of 
oestradiol-receptor complexes in uterine tissue (1-09). 
From the summarized studies it is evident that the trans-
location of steroid receptor molecules is preceded by a still 
unknown change in the steroid-receptor complex itself. Stu-
dies presented in the literature make it very likely that 
this change is mainly due to the interaction of a second pro-
tein with the steroid-receptor complex (73,88,110). Binding 
of the transformed steroid-receptor complexes to high affi-
nity nuclear acceptor sites will result in a shift of the 
equilibrium, which is supposed to exist between the number 
of binding sites in the cytoplasmic and nuclear fraction, 
towards the nuclei. 
2.6 Interaction of steroid receptors with nuclear components 
A 'translocation model, for steroid-receptor complexes has 
been derived from earlier studies about the lac-operon in 
E.coli. In this prokaryote, it was observed that the repres-
sor of the lac-operon, an allosteric protein, binds to speci-
fic DNA regions and that this binding can be modulated by 
small molecular weight substances. After the initial observa-
tion that steroid-receptor complexes could be translocated 
into the nuclear fraction (92,94) an intensive search was 
started for a so-called nuclear acceptor, a component which 
had to account for both the accumulation of receptor in the 
nucleus and the nuclear response to the hormone. 
Several studies have shown, that steroid receptors could 
associate with crude chromatin (111-116), as well as with 
DNA (either from eukaryotes or prokaryotes) (88, 117-120), 
specific acidic (116,121) or basic proteins (122,123,124), 
ribonucleoprotein particles (125,126) and the nuclear mem-
brane (127). Recently it was shown by MUller et al. (128) 
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that the oestradiol receptor in quail oviduct could associa-
te with RNA-polymerase I 1 a finding which is consistent with 
the stimulation of RNA-polymerase activities observed in 
uterus after oestradiol administration. Thus RNA-polymerase 
may be another nuclear site of oestrogen receptor action and 
binding. 
Steroid-receptor complexes bound to target cell nuclei 
are commonly demonstrated using extraction of nuclei with 
high salt, a method which releases part of the nuclear bound 
receptors. With in vitro cell-free studies it has been pos-
sible to demonstrate a saturable, tissue specific interaction 
between receptor-hormone complexes and nuclei (115,129,130 1 
131). However in these studies variations in the ionic 
strength of the incubation medium caused an overestimation of 
the concentration of specific acceptor sites (132). Recent 
studies have raised questions concerning the use of a cell-
free system as a model for translocation studies (133,134, 
135), because it was demonstrated that nuclear binding could 
be inhibited by a cytoplasmic factor, different from the re-
ceptor. In addition nuclei preloaded with hormone-receptor 
complexes and nuclei without receptors showed the same kine-
tics for uptake of steroid-receptor complexes. Williams and 
Gorski (101) observed that a fixed percentage of the total 
number of receptors that bound oestradiol, were translocated 
into the nucleus at any oestradiol concentration and they 
concluded that an equilibrium exists between the oestrogen 
receptors in the cytoplasm and in the nuclei. This observa-
tion supports the view that the translocation is independent 
on high affinity binding sites in the nucleus. Based on 
these and other experiments (88,120) Yamamoto and Alberts 
have proposed that in the nucleus a very large number of low 
affinity binding sites in combination with only a very few 
high affinity binding sites are responsible for known hor-
mone effects. In their studies they found that the oestrogen-
receptor complex binds to DNA with a low affinity (K =l0 4M-1 ) 
a 
but due to the larger number of these binding sites, high 
affinity binding sites might be masked (136). This model of 
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Yamamoto and Alberts is similar to the model explaining the 
control of the lac-operon in prokaryotes (137), which invol-
ves regulatory proteins interacting with nonspecific binding 
sites on the DNA but which in addition have a very high 
affinity for some specific regions of the DNA. Thus an equi-
librium develops between binding to a large number of non-
specific low affinity sites and to the limited number of 
specific higher affinity sites. In this respect the oestro-
gen receptor can be thought of as being in an equilibrium 
between three sites: 
cytoplasm~ DNA (low affinity) ~ DNA (high affinity) 
Results obtained for a variety of tissues are in favour 
of this model. Alberga et al. (138) have presented evidence 
that uterine nuclei contain an oestradiol binding protein 
with a very high affinity (K =10 14M- 1 ). In addition Anderson 
a 
et al. (139) have suggested that the continuing presence of 
oestrogen-receptor complexes in the nuclei of uterus is 
required for the responses to oestrogen. It was concluded 
that particularly the late responses are dependent on a pool 
of oestrogen that shows delayed disappearance from the tar-
get cell and which is defined as the nuclear fraction which 
resists extraction from nuclei with 0.4 M KCl {140). The de-
monstration of similar non-KCl extractable nuclear receptors 
in other tissues (31,141-144) might indicate that this par-
ticular type of nuclear receptor is indeed important in the 
mechanism of action of steroid hormones. 
The interaction of a steroid hormone-receptor complex 
with possible nuclear acceptor sites has been most extensi-
vely studied by O'Malley et al. for the progesterone recep-
tor in the chick oviduct. The progesterone-receptor complex 
binds to chromatin isolated from the oviduct to a greater 
extent than to chromatin isolated from nontarget tissues 
(116). With chromatin reconstituted from dehistonized chro-
matin and nonhistone proteins, it was shown that the binding 
specificity resides in the acidic protein fraction. Thus if 
nonhistone proteins from a nontarget tissue such as spleen, 
were used, binding of the progesterone-receptor complex did 
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not occur (116). Fractionation of the acidic proteins reveal-
ed one group of the nonhistone proteins, called AP 3 , as the 
most effective in the observed binding on the chromatin. In 
addition they could demonstrate that steroid-receptor complex 
accumulation in nuclei or on the chromatin did increase the 
number of initiation sites for RNA-polymerase molecules prior 
to the increase in ovalbumin synthesis which is the cell 
response to hormone administration (10,37,38,145). Only the 
complete set_of subunits of the progesterone receptor (sub-
unit A and B) could increase the number of initiation sites, 
whereas the B subunit, which binds to chromatin but not to 
DNA (146), did not have this effect. The A subunit, which 
only binds to DNA (146), could only enhance the number of 
initiation sites on the chromatin if present in a tenfold 
higher concentration than needed for the intact 6S dimer 
(147). On basis of their studies the following model was 
proposed: The 6S cytoplasmic steroid-receptor complex enters 
the nucleus and binds to chromatin acceptor sites with mode-
rate affinity through the presence of the B subunit. As a 
result of this association the A subunit is released and 
searches along the adjacent genome for specific effector 
sites with a high affinity constant for the subunit. The 
ultimate binding of this A subunit to such an effector site 
would then promote a destabilization of the DNA duplex and 
create new binding sites for RNA-polymerase molecules and 
initiation sites for RNA synthesis (35,36). Most of the des-
cribed studies were carried out in vitro with isolated chro-
matin and purified E-coli RNA-polymerase. Therefore the 
question remains whether endogenous RNA-polymerase molecules 
act on similar initiation sites as has been observed for the 
prokaryotic enzyme and whether the initiation sites used in 
vitro are identical to the actual sites in vivo. 
In conclusion it appears, that interaction of steroid-
receptor complexes with still poorly defined constituents of 
the chromatin leads to an activation of specific genes. 
About the steps between the initial interaction of the hor-
mone-receptor complex with the chromatin and the transcrip-
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tion of specific gene sequences only speculations can be 
made (148). It seems very likely that as a result of the 
interaction of steroid-receptor complexes with the chromatin 
ultimately new initiation sites for the transcription machi-
nery are created. 
2.7 Dissociation of steroids from receptor sites and intracellular recycling 
of receptors 
One of the main questions, still unanswered, concerns the 
disappearance of the steroid-receptor complex from the nu-
cleus. It was shown after in vivo administration of radio-
active oestradiol that larger doses of the hormone dis-
appeared more rapidly from uterine tissue than low doses. 
This difference in release could be explained through the 
presence of larger amounts of nonspecific low affinity bin-
ding sites at high doses of oestrogen (149). In other studies 
it was shown that,after injection of oestradiol,receptor sites 
could not immediately reassociate with oestradiol in vitro after 
releasing the ligand. Only 16 h after the injection of the hor-
mone the amount of cytosol receptor had returned to control 
levels and this process of replenishment could be inhibited by 
cycloheximide and actinomycin D, indicating that probably 
both RNA and protein synthesis were required (98). There are 
also indications that nuclear RNP-particles may be involved 
in steroid receptor recycling in target cells and that such 
a recycling may be functionally related to gene expression 
(150). RNA sequences, transcribed after the entry of steroid-
receptor complexes in the nucleus might combine with the 
steroid-receptor complexes to form RNP-particles. After the 
maturation, RNP-particles leave the nucleus and may alter the 
protein synthesizing capacity in the target cell cytoplasm. 
For glucocorticoid receptors in cultured thymus cells a 
correlation between ATP levels and the magnitude of specific 
cortisol binding has been observed (151). It has been sug-
gested that ATP is necessary for the activation of the recep-
tor for binding of the steroid (108). In other studies it has 
been shown that the release of glucocorticoid receptor from 
fibroblast nuclei and its generation to an active form was 
regulated by an energy dependent step (152,153). For the pro-
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gesterone receptor and the androgen receptor a specific 
interaction with mononucleotides has been observed (154,155), 
indicating again that other factors in addition to the steroid 
are involved in the mechanism of action of steroid hormones. 
F~om these studies it is clear that more investigations 
are required to solve the remaining questions concerning 
the dissociation of the steroid-receptor complexes in the 
nucleus and the fate of the free receptor. A steroid recep-
tor antibody technique could be very useful in this respect. 
2.8 Regulation of the amount of steroid hormone receptors 
Several studies have reported on the regulation of cyto-
plasmic and nuclear steroid receptor concentrations. In the 
rat uterus, a tissue in which most cells appear to be a tar-
get for oestrogens, oestradiol receptors have been detected 
immediately after birth of the animal (156,157,158). Are-
ceptor for oestradiol could already be demonstrated in the 
MUllerian duct cells (159,160). In the immature animal the 
receptor concentration in the cytoplasm first rises to a 
maximum of 20,000-60,000 sites/cell at the age of about 
10 days, declining subsequently to a level of 15,000-20,000 
sites/cell at 20-22 days. After puberty the values vary be-
tween a minimum just after oestrus (2000 sites/cell) and a 
maximum at pro-oestrus (20,000 sites/cell) (98,161,162,163) 
In pregnancy the maximum cytosol receptor concentrations 
coincide with the implantation of embryos and reaches 
40,000 sites/cell in the endometrium {163). In studies con-
cerning the measurement of cytoplasmic receptor levels it is 
uncertain whether the data obtained are a true reflection of 
the total available or of the number of non-occupied receptor 
sites. 
The nuclear levels of the oestrogen receptor as measured 
by an 3H-oestradiol exchange assay (164) vary also during 
the oestrus cycle, closely following the variation in oes-
trogen secretion (165,166). The maximum at pro-oestrus was 
about 5000 sites/cell, the minimum value at metoestrus 
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900 sites/cell. The total available number of receptor sites, 
measured after administration of a saturating dose of oestra-
diol, was similar for rats either in metoestrus or in pro-
oestrus. This indicates that the cyclic fluctuation in nu-
clear receptor sites during the oestrus cycle reflects the 
change in the distribution of oestradiol receptors between 
the cytoplasm and the nuclei. From these results and the ob-
servation that cytoplasmic receptor levels decrease after 
castration (161,167), it is clear that oestrogens do influence 
the receptor concentration. However, it is not known whether 
or not the development of receptor from birth to puberty is 
influenced by oestrogen production. 
Administration of oestradiol to immature rats (20-23 days) 
caused a 50% increase of the initial receptor content in 
uteri 24 h after injection of the animal (98). The process of 
replenishment of cytoplasmic receptor molecules, which 
occurred between 4 and 24 h after oestradiol administration 
was inhibited by cycloheximide, indicating the involvement of 
protein synthesis (98,144,168). However in other studies part 
of the replenishment process could not be inhibited by cyclo-
heximide {92,144). Also in some studies it was observed that 
the decrease in cytosol receptor after administration of 
oestradiol in vivo could not be accounted for by the complexes 
measured in the nuclei (92,169). Only 50% of the cytoplasmic 
receptor molecules could be recovered in the nuclear frac-
tion. A process of receptor inactivation was postulated to 
explain this phenomenon. For uterus it has been demonstrated 
that progesterone could influence the cytoplasmic and nuclear 
oestradiol receptor levels (170), an effect which may be im-
portant in the regulation of oestradiol receptor sites in 
female rats (171). Observations that hypophysectomy did not 
affect the receptor levels in the uterus indicate that pitui-
tary hormones are not necessary for the maintenance of cyto-
plasmic receptor levels (168). 
The highest amount of the progesterone receptor in the 
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Methods used for studying steroid receptor interactions 
3.1 Measurement of specific steroid binding sites 
If intact tissue or isolated cell fractions containing 
oestradiol receptors are incubated with tracer amounts of 
radioactive oestradiol (range l0-10-lo- 8M), the steroid 
' becomes bound by both nonspecific binding sites of low affi-
nity (Ka=l0 6-Io 8M-l) and specific binding sites of high 
affinity (K =10 9-lOlOM-l). 
a 
One can distinguish between steroid bound to nonspecific 
sites and specific binding sites, by taking advantage of the 
fact, that, in addition to their differences in affinity, 
the specific binding sites are present only in very limited 
amounts. Thus if samples are incubated either with radio-
active oestradiol or with radioac·tive oestradiol in the pre-
sence of a 100-200 fold excess of non-radioactive oestradiol, 
the difference between the bound radioactivity recovered in 
each sample represents the amount of specifically bound 
oestradiol. This procedure can only be used if the nonspeci-
fic binding component behaves as a linear function of the 
steroid concentration with the employed concentration range. 
All commonly used methods for measuring steroid binding 
sites are based on the separation of macromolecular bound 
steroid and free steroid at temperatures between 0-4°C. At 
these temperatures no appreciable dissociation of steroid 
occurs from the formed steroid-receptor complexes. The num-
ber of specific binding sites can be measured as described 
above. In this thesis four different methods have been used: 
1. Sephadex gel chromatography 
2. Sucrose density gradient centrifugation 
3. Agar-gel electrophoresis 
4. Hydroxylapatite column chromatography 
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3.2 Sephadex gel chromatography 
This method originally developed by Williams and Gorski 
{180) has been used in the present studies only for cyto-
sols. Small portions of cytosol (50 ]ll) after incubation 
with radioactive steroid were layered on Sephadex G-25 
columns {8x0.5 em). Macromolecular bound steroid (recovered 
in the void volume) and free steroid were separated by elu-
ting the column with buffer as illustrated in Figure 1. The 
shaded area indicates the number of specific oestradiol bin-
ding sites which was obtained as described under 3.1. 
m\ effluent 
Figure 1 
labelled 
Sephadex gel chromatography 
with 3H-oestradiol. 
of testicular cytosol 
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excess non-radioactive oestradiol. 
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Figure 2 Gradient centrifugation of 3H-oestradiol-receptor 
complexes present in cytosol (Fig. zA) and nuclear extract 
(Fig. 2B). 
. - • incubation with 3H-oestradiol 
0 - o incubation with 3H-oestradiol plus a 200-fold excess 
non-radioactive oestradiol. 
The arrows indicate the positions of bovine serum albumin 
(4.35) and alcohol dehydrogenase (7.65). 
3.3 Sucrose density gradient centrifugation 
This method first introduced by Toft and Gorski {181) was 
used in the present studies for the measurement of both cy-
tosol receptors and nuclear receptors which were extracted 
from nuclei with 0.4M KCl. An aliquot of 200 ~1 of incubated 
cytosol was layered on a linear 5-20% (w/v) sucrose gradient 
and was centrifuged for 16 h at 150,000 gav to achieve sepa-
ration of macromolecular bound steroid (8S) and free steroid 
(Fig. 2A). Nuclear receptors, extracted with 0.4M KCl, were 
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separated on linear 5-20% (w/v) sucrose gradients, containing 
0.4M KCl. Gradients were centrifuged for 18 h at 260,000 g , 
av 
which gave a clear separation of macromolecular bound steroid 
(58) and free steroid (Fig. 2B). The shaded areas represent 
the amount of specifically bound oestradiol measured as des-
cribed under 3.1. 
3.4 Agar-gel electrophoresis 
This method was introduced by Wagner (182) and was used 
in the present studies only for the measurement of cytoplas-
mic receptor sites. A 50 ul aliquot of incubated cytosol 
was layered on an agar plate kept at o0 c. After electropho-
resis for 90 min at 130 rnA per plate a good separation could 
be obtained between bound oestradiol and free oestradiol, 
which moves to the cathode as a result of electroendosmosis 
(Fig. 3). The shaded area of Figure 4 represents the amount 
of specifically bound oestradiol. 
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Figure 3 Agar-gel electrophoresis of testicular cytosol 
labelled with 3H-oestradiol. 
. - • cytosol incubated with 3H-oestradiol 
o - o cytosol incubated with 3H-oestradiol plus a 200-fold 
excess non-radioactive oestradiol 
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3.5 Hydroxylapatite column chromatography 
This method introduced by Gschwendt (183) for measurement 
of the amount of nuclear steroid-receptor complexes is based on 
hydroxylapatite column chromatography in the presence of SM 
urea and 2M KCl. Nuclei, nuclear extracts or subnuclear 
fractions in urea and KCl are applied to a hydroxylapatite 
column (1.4x6.0 em) in the presence of l mM phosphate buffer 
(pH=6.8). Under these conditions nonhistone proteins and 
nucleic acids bind preferentially to the column, whereas 
histone proteins are not retained at all. Using a stepwise 
elution system with 20 rnM, 200 mM and 500 mM phosphate buffer 
respectively, containing urea and KCl, two nonhistone protein 
80 
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'I~ 40 + 
" X 20 ~ 
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ml effluent 
Figure 4 Hydroxylapatite column chromatography of uterine 
nuclei, containing 3H-oestradiol-receptor complexes, after 
solubilization in 5M urea/2M KCl. 
The column was eluted with phosphate buffers of increasing 
ionic strength containing SM urea/2M KCl. 
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fractions and a fraction containing DNA can be obtained as 
described by McGillivray (184). The elution pattern in Figure 4 
was obtained from uterine nuclei, loaded with 3H-oestradiol. 
This technique was used for the present investigations 
concerning the localization of subnuclear oestradiol-
receptor complexes in uterus. 
3.6 Determination of nuclear receptor sites in the presence of endogenous 
steroids 
In tissues, which contain rather high amounts of steroids, 
either from endogenous production or through exogenous ad-
ministration, a certain fraction of the receptor population 
moves into the nuclear fraction. For a quantitative measure-
ment of the number of nuclear receptor sites it is necessary 
to use a method that can distinguish between the total avai-
lable amount of receptor sites and the number of receptor 
sites occupied by steroid. In the exchange assay, developed 
by Anderson et al. (164) isolated nuclei are incubated with 
radioactive oestradiol at elevated temperatures in order to 
achieve an exchange of non-radioactive oestradiol for radio-
active oestradiol. After removal of excess free steroid by 
charcoal treatment, the amount of radioactive &eroid bound 
to receptor sites was measured directly or after extraction 
of nuclei with 0.4M KCl. 
Introduction and discussion of experimental work 
4.1 Introduction 
Receptors for steroid hormones in target cells play an 
important role in the mechanism of action of steroid hor-
mones (49-53), but it is not (yet) clear whether the reverse 
is also true, i.e. whether the presence of a steroid recep-
tor does reflect that a tissue can be considered as a target 
tissue for the steroid. 
The interstitial tissue is a steroid producing tissue 
which is influenced by luteinizing hormone (LH) and secretes 
testosterone into the blood stream (43). Processes involved 
in spermatogenesis are located in the other tissue compart-
ment of the testis, the seminiferous tubules. Spermatogenesis 
requires both testosterone and follicle stimulating hormone 
(FSH) (185,186). Recent experiments have shown that Sertoli 
cells in the seminiferous tubules may be considered as tar-
get cells for FSH (187,188) and that these cells can produce 
oestradiol from testosterone under the influence of FSH 
(189). Considering these results one might speculate about a 
mutual interaction between the two testicular compartments. 
Oestradiol produced in the Sertoli cell might influence the 
metabolism of steroids in the Leydig cell via the hormone 
receptor interaction and the subsequent translocation of the 
oestradiol-receptor complexes into the nuclei. The Leydig 
cell in turn might influence the Sertoli cell via changes 
in the testosterone production. If oestradiol affects the 
Leydig cell via receptor steroid interactions, changes in 
the amount and in the subcellular distribution of the recep-
tor might provide useful information concerning the function 
of oestradiol and its receptor. Therefore we have attempted 
to investigate the regulation of the number of cytoplasmic 
receptor sites for oestradiol as a reflection of the total 
available number of receptor sites. Changes in the number 
of total available receptor sites might be directly correla-
ted with the number of receptor sites which can ultimately 
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be bound in the nuclear fraction. It is most likely that the 
ultimate effect of steroid hormones will occur via an inter-
action of hormone-receptor complexes and the chromatin. For 
other tissues it has been shown that hormone effects are 
directly related to the number of oestradiol-receptor com-
plexes found in the nucleus {1-10) and prolonged effects of 
steroid hormone effects appear to be dependent on the reten-
tion of steroid-receptor complexes in the nuclear fraction. 
This process could be correlated with the depletion and re-
plenishment of cytoplasmic receptor sites (98,143,168). 
Steroidogenesis in testicular Leydig cells is dependent 
on the presence of LH. Until now it is not known whether 
other Leydig cell parameters, which are not directly invol-
ved in the steroidogenesis, are also under the control of 
gonadotrophins. Therefore it was decided to investigate the 
effect of hypophysectomy on testicular oestradiol receptor 
concentrations. During the development of an organism a 
variety of biochemical changes occurs in different cell 
types; these changes ultimately result in the formation of 
fully differenti~ted cells. For some steroid hormone recep-
tors it has been shown that they are present in their target 
cells immediately after birth of the animal or even in the 
foetus (159,160,190,191). However most of such data have 
been expressed in a qualitative way. One might speculate 
about the ontogeny of steroid hormone receptors. It is not 
clear whether these receptors are synthesized during the 
very early stages of the embryonic development or whether 
they are induced in the foetus or in the immature animal by 
some unknown factor. If the receptors are induced only at 
later stages during development, one might suppose that 
changes either in the number of receptor molecules or in the 
binding properties of the protein are related to steroid hor-
mone effects, which are only needed at certain stages of 
development. 
We have attempted to study the following aspects of the 
regulation of cytoplasmic receptor sites in testicular tissue: 
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1) Effect of in vivo administration of oestradiol on the 
depletion and replenishment of cytoplasmic receptor sites. 
2) Effect of hypophysectomy on cytoplasmic receptor levels. 
3) Ontogeny of cytoplasmic receptor sites. 
4.2 Effects of oestradiol, hypophysectomy and age on cytoplasmic receptor 
levels 
The results in appendix paper I show that in both mature 
{3 months old) and immature (23 days old) rats administration 
of oestradiol resulted in a rapid depletion (within 1 h) of 
cytoplasmic receptor sites. However 5 h after the hormone 
administration control levels were restored and remained 
constant for at least an additional period of 20 h. 
In mature rats, 10-15 days after hypophysectomy, no dra-
matic effects could be observed on cytoplasmic receptor 
levels, suggesting that neither steroid hormones nor gona-
dotrophins, which both disappear from testicular tissue as 
a result of hypophysectomy (42,192), are important in main-
taining cytoplasmic receptor levels. 
In studies concerning the ontogeny of cytoplasmic recep-
tor sites for oestradiol, a plasma protein in the testicular 
cytosol preparations, which binds oestradiol with a rather 
high affinity (Ka=lOBM-l) and which is called a-foetoprotein, 
interfered with accurate measurements of cytoplasmic recep-
tors. Therefore in the testicular tissue of rats younger than 
14 days of age cytoplasmic receptor sites could not be detec-
ted. It was shown for rats from 4 days of age onwards, 
however, that receptors accumulated in the nuclear fraction, 
after incubation of whole testicular tissue with oestradiol. 
These results on the regulation of the oestradiol receptor 
in testicular tissue showed that oestradiol translocates 
cytoplasmic receptor sites very effectively, but the hormone 
itself was not important in maintaining a constant level of 
total receptor sites. But if hormones exert their effects 
via a hormone-receptor complex in the nuclei, information on 
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the regulation of nuclear receptor complexes appears to be 
essential. Results on this aspect of receptor regulation 
are described for both in vivo and in vitro studies in 
appendix papers II and III respectively. 
4.3 Effects of oestradiol, hypophysectomy and choriogonadotropin on 
nuclear receptor sites 
For a quantitative measurement of nuclear receptor sites 
in intact rats it was necessary to use a method that can 
distinguish between free receptor sites and receptor sites 
that have been occupied in vivo with endogenous hormone. 
Therefore a 3H-oestradiol exchange method was developed for 
testicular tissue of immature rats. Using this method it was 
possible to obtain quantitative information on the number of 
oestradiol receptor sites in the KCl extractable nuclear 
fraction. In appendix paper II it has been demonstrated that 
hypophysectomy of immature rats did result in a considerable 
decrease of both the total number of receptor sites and the 
number of receptor sites occupied in vivo with endogenous 
oestradiol. In intact rats 20% of the total number of avai-
lable receptor sites was present in the nuclear fraction, 
suggesting that the presence of this small but significant 
amount may be important in maintaining some unknown Leydig 
cell function. 
In immature rats treated with human choriogonadotropin 
for 5 days it was observed that the number of available 
receptor sites per testis increased threefold, while 73% of 
this amount was present in its nuclear form. 
4.4 Kinetics of in vitro binding of oestradiol in subcellular fractions of 
testicular and uterine tissue 
Like other tissues the testicular tissue contains two 
types of nuclear receptor sites 1 which differ in their ex-
tractibility with 0.4M KCl. For uterine tissue it has been 
described that the number of nuclear receptor sites, which 
resist KCl extraction 1 shows a good correlation with the 
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tissue's response to oestradiOl (140). With the 3H-oestradiol 
exchange method described in appendix paper II only the class 
of receptor sites which can be extracted from nuclei with KCl 
could be measured quantitatively. Therefore it was decided to 
use an in vitro system in order to study the translocation 
and the subsequent binding of oestradiol-receptor complexes 
in the KCl extractable and in the non-KCl extractable nuclear 
fraction in testicular and uterine tissue under similar expe-
rimental conditions. In appendix paper III the following as-
pects have been investigated: 
1) Mechanism and rate of translocation of cytoplasmic recep-
tor molecules into the nuclear fractions of testis and 
uterus. 
2) The nature of the nuclear acceptor sites in the testicu-
lar tissue. 
3) The effect of energy deprivation (following addition of 
KCN) on the subnuclear distribution of oestradiol recep-
tor sites in testicular and uterine tissue. 
The latter aspect concerning the role of energy in the 
subnuclear distribution of receptor sites was studied because 
it has been reported that cellular ATP might be involved in 
the action of g1ucocorticoids, progesterone and dihydrotes-
tosterone (151,153,154,155). 
The results obtained on the comparison between receptors 
in testis and uterus in appendix paper III showed that the 
interaction of oestradiol-receptor complexes with nuclear 
acceptor sites in testicular and uterine nuclei followed 
different kinetics. In both tissues the number of binding 
sites in the KCl extractable and non-KCl extractable frac-
tion of the nuclei showed an increase observed during the 
first 30 min of incubation. Thereafter the concentration of 
oestradiol receptor sites in the nuclear extract of uterine 
tissue showed a decrease, but reached a steady state level 
(SO% of the maximum value) 60 min after the start of the 
incubation. During this same period no changes could be 
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observed for the number of oestradiol receptor sites in the 
KCl extract of testicular nuclei. The difference between 
both tissues in the time dependent uptake of binding sites 
in the non-KCl extractable nuclear fraction was even more 
striking. In uterine tissue the concentration of binding 
sites decreased to levels 50% of the maximum value and this 
level was maintained for at least an additional period of 
60 min. In testicular nUclei a similar decrease was observed, 
but 60 min after the start of the incubation almost all 
binding sites had dissapeared from the non-KCl extractable 
fraction. This suggests that a difference exists between the 
dissociation rates of the steroid-receptor complexes from the 
acceptor sites in testicular and uterine nuclei. 
The effect of energy deprivation, as a result of the 
addition of KCN, on the number of binding sites was similar 
for testicular and uterine tissue. A significant increase 
was observed for the number of binding sites in the non-KCl 
extractable nuclear fractions, whereas the number of KCl 
extractable nuclear receptor sites remained unaffected. 
For testicular tissue some attempts have been made to 
solubilize the non-KCl extractable receptor sites. However, 
of all the methods used only mild trypsin treatment could 
release a limited number of receptor sites in a soluble form. 
After trypsin treatment the additional receptor sites had a 
sedimentation value of 4S on sucrose gradients, instead of a 
sedimentation value of 55. Attempts with DNAse and deoxycho-
late were unsuccessful: only an increase in the amount of 
unbound oestradiol could be obtained. 
4.5 Conclusions 
In summary it can be concluded that the distribution 
of testicular oestradiol receptor molecules between the 
cytoplasmic and the nuclear fractions is influenced by the 
oestradiol concentration in testicular tissue. After being 
translocated into the nucleus,oestradiol-receptor complexes 
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are bound by at least two different types of chromatin 
acceptor sites which differ in affinity for the oestradiol-
receptor complex as determined by KCl extraction. In con-
trast to the oestradiol receptor in uterus testicular recep-
tors are retained by the high affinity acceptor sites inside 
the nucleus only for short periods. This might reflect that, 
although both tissues contain oestradiol receptors in compa-
rable amounts, different mechanisms are involved in the bin-
ding of oestradiol-receptor complexes to and the subse-
quent release from the acceptor sites inside the nucleus. 
The experiments described thusfar were performed in order 
to obtain more information about the regulation and subcel-
lular localization of testicular oestradiol-receptor com-
plexes. It appeared that the kinetics of the interaction of 
the oestradiol-receptor complex with nuclear constituents 
from testis and uterus were different. However these results 
do not permit definitive conclusions concerning the mole-
cular mechanisms underlying these differences. This would 
require more information about the nature of the interaction 
between the oestradiol-receptor complexes and the chromatin. 
In this respect results of experiments on the interaction of 
the oestradiol-receptor complex and uterine chromatin are 
presented in chapter s. Uterine tissue was chosen for this 
purpose because in this tissue a possible interaction of 
steroid-receptor complexes with a specific nuclear fraction 
i.e. DNA or chromatin proteins, might be correlated with 
the tissue response to oestradiol. A comparison of these 
mechanisms in a well-known responsive tissue, like the uterus 
and in a tissue with a less defined response like testis, 
might indicate whether the presence of steroid receptors 
defines a tissue as a 'hormone target tissue 1 , even if dis-
tinct actions of the steroids are not (yet) known. 
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Distribution of oestradiol-receptor complexes in subnuclear 
fractions of uterine tissue after administration of oestradiol 
in vivo and in vitro 
5.1 Introduction 
An important step in the response of a tissue to a 
steroid hormone is the interaction of the steroid with its 
receptor in the cytosol of the target tissue. The cornolex 
formed between hormone and receptor migrates into the 
nucleus and binds to acceptor sites on the chromatin and 
this binding ultimately causes a response of the tissue to 
the hormone via changes in RNA and protein synthesis (193-
196) . 
The location of the oestradiol binding protein or the 
newly synthesized RNA in chromatin is not known. The present 
study was started in an attempt to obtain information on the 
subnuclear localization of the steroid-receptor complex. 
There is considerable morphological (197,198,199) and 
physical (200,201) evidence that chromatin consists of a 
biological 'active' form (euchromatin) and a transcrip-
tionally repressed form (heterochromatin). In the literature 
some methods have appeared on the fractionation of chromatin 
in an active and an inactive form (202-207), but these 
methods have the disadvantage that the chromatin is fraction-
ated after its isolation from purified cell nuclei. During 
the isolation procedure RNA-polymerase molecules and other 
chromatin proteins {histones and nonhistones) might be re-
leased or become inactivated. In addition it seems very 
likely that cleavage of the chromatin, by DNAse digestion or 
by shearing of the chromatin, produces either artificial 
initiation sites or damaged template DNA in the fragments. 
Tata and Baker (208) and Chesterton et al. (209) have des-
cribed a method for fractionation of isolated eukaryotic 
nuclei in 8 different subnuclear fractions in a single step. 
In this method, introduced by Frenster et al. (210) the 
nuclei are gently sonicated in an isotonic buffer and sepa-
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rated in nuclear sap, euchromatin, heterochromatin, nucleoli 
and nuclear membranes by virtue of their different sedimen-
tation rates in a discontinuous sucrose gradient. Individual 
fractions are considerably enriched in either one type of 
the chromatin, one type of the RNA-polymerases or enriched 
in poly A-rich Hn-RNA (211,212). 
In the present study it was tried to apply this method 
to the subnuclear distribution of oestradiol receptors in 
nuclei, isolated from uterus after treatment of either 
ovariectomized rats or isolated uterine tissue with oestra-
diol. 
5.2 Materials and methods 
Animal and tissue treatment 
Mature female rats of the Wistar strain, ovariectomized 
for 3-5 days, were used. Two different methods were used 
for the preparation of nuclear 3H-oestradiol-receptor com-
plexes: 
1) Isolated uterine tissue was incubated for 30 min at 37°C 
in KRBG-buffer (pH 7.4) either with 10-8M radioactive 
oestradiol or with 10-8M radioactive oestradiol plus a 
1000-fold excess of non-radioactive oestradiol. There-
after the tissue was rinsed with buffer and nuclei were 
isolated. 
2) Rats were injected subcutaneously with 5 vg of oestradiol 
and 60 min later uterine nuclei were isolated. 
The nuclear suspensions thus obtained were incubated for 
60 min at 20°c with 10-BM 3H-oestradiol in order to obtain 
complete exchange between receptor bound oestradiol and 
added 3H-oestradiol(J64). 
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Preparation of nuclei 
Uterine tissue (approximately 1 g) was homogenized in an 
Ultraturrax homogenizer for three periods of 10 sec with 
intermittant cooling periods of 10 sec in 3 ml of 10 rnM 
Tris-HCl buffer, pH 7.4, containing 0.32M sucrose, 2.5 mM 
KCl, 2.5 mM MgCl 2 and 25% glycerol (TKMSG-buffer). The homo-
genate,·after dilution with TKMSG-buffer (1:1) and after 
filtration through two layers of 500 ~ gauze, was centrifu-
ged for 10 min at 600 g. After washing the crude nuclear 
pellet with TKMSG-buffer, containing 0.1% Triton X-100, the 
nuclei were collected for 10 min at 600 g. After washing with 
TKMSG-buffer, the nuclear suspension was resuspended and 
washed three times with 50 mM Tris-HCl, pH 7.5, containing 
12.5 mM NaCl, 12.5 mM KCl, 5 mM MgC1 2 (TKMNa-buffer). The 
ultimate nuclear suspension was resuspended with gentle ho-
mogenization (2-3 strokes in an hand-operated all-glass ~otte~­
Elvehjern homogenizer) in 2.5 ml TKMNa-buffer. The nuclei 
thus obtained appeared intact by phase contrast microscopy 
and had a protein/DNA ratio in the range of 1.7-1.9. The 
whole procedure is summarized in Figure 1. 
UTERUS 
I 
Homogenize in TKMSG 
I 
Filtration (500 ~ gauze) 
I 
10 min at 600 g 
I 
Wash in TKMSG- 0.1% Triton X-100 
I 
10 min at 600 g 
I 
Wash in TKMSG 
I 
wash 3x in TKMNa 
10 mini at 600 g 
I 
Suspend in TKMNa 
Figure 1 Flow sheet summarizing the procedure for isolation 
of uterine nuclei 
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Fractionation of nuclei 
Uterine nuclei suspended in 2.5 rnl TKMNa-buffer were 
placed in a 15 ml round-bottom tube and were exposed to 
15 sec sonication at 20 kHz and a probe amplitude of 
70 microns using an MSE sonicator with the microtip placed 
3-5 mm below the surface. This treatment was sufficient for 
the Qisruption of 90-95% of the nuclei as was checked by 
phase contrast microscopy. The lysed nuclei were centrifuged 
at 7000 g for 30 min and the supernatant (nuclear sap) sepa-
rated from the pellet. The residual pellet was resuspended 
in 2.5 ml TKMNa-buffer, containing either 90 mM Na citrate 
and 90 mM K citrate or 90 roM Na chloride and 90 mM K 
chloride, followed by homogenization with 5-6 strokes in an 
all-glass hand-operated homogenizer. The suspension thus 
Supernatant 
(nucleoplasm) 
NUCLEI 
I 
Sonicate at 20 kHz for 15 sec 
I 
30 min at 7000 g 
Pellet (chromatin, membranes, 
I nucleoli) 
suspend in 2.5 ml TKMNa-buffer 
I 
Layer on discontinuous sucrose 
gradient in TKMNa-buffer 
I 
110 min at 94,000 g 
I 
Collect fractions 
Figure 2 Flow sheet summarizing the procedure for sub-
nuclear fractionation of uterine nuclei 
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obtained was layered on a discontinuous sucrose gradient in 
TKMNa-buffer containing either 90 mM each of Na and K citrate 
or 90 roM each of Na and K chloride, in a Beckman SW27 17 ml 
tube as follows: 2.5 ml 2.0M sucrose, 2.5 ml l.72M sucrose, 
3.0 ml 1.37M sucrose, 3.0 ml l.l7M sucrose and 2.5 ml 0.55M 
sucrose. The samples were centrifuged at 94,000 g for 
110 min at 2°C and the fractions were removed carefully with 
a Pasteur pipette bent at right angles at the tip. A summary 
of the fractionation procedure is given in Figure 2. 
Figure 3 illustrates the numbering of the fractions obtained 
after the fractionation is described. 
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Figure 3 The distribution of subnuclear fractions isolated 
from nuclei of uterine tissue with discontinuous sucrose 
density gradient centrifugation 
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Labelling of RNA in vitro 
One uterus, stripped of adhering fat and mesentery, was 
incubated in 2.0 ml of Krebs Ringer bicarbonate buffer, 
pH 7.4, containing 0.2% glucose and 50 ~Ci/rnl s- 3H-uridine 
(sp. act. 20 Ci/rnmol). Incubation was carried out for 
30 min at 37°C in an atmosphere of 95% o 2 : 5% co 2 . Nuclei 
were prepared from uterine tissue and fractionated by the 
described procedure in buffers containing K and Na chloride. 
Nucleic acids in each subnuclear fraction were precipitated 
with O.SM HC10 4 at 0°C and were washed three times with 
O.SM HC10 4 . RNA in the pellet was dissolved in 1M KOH at 
37°C for 60 min and samples, taken after the addition of 
HClo 4 to precipitate the DNA, were used for the measurement 
of incorporated radioactivity and RNA 
was treated with HClo 4 at 70°C for 15 
content. The pellet 
min 
DNA and samples were taken to measure the 
to hydrolyse the 
DNA content (see 
under Measurement of DNA, RNA and protein). 
Measurement of specific binding of 3 H-oestradiol 
Different methods were used for the estimation of 3H-
oestradiol binding by receptor proteins: 
1) After the isolation of the·subnuclear fractions samples 
were taken for the measurement of total radioactivity 
present in each fraction. Specific 'binding' in each 
fraction was determined as previously described by sub-
tracting the nonspecific binding (obtained after incu-
bation of tissue in the presence of excess non-radioactive 
oestradiol) from the total binding of 3H-oestradiol 
(144). Binding was expressed as dprn/~g DNA present in 
each fraction. 
2) In some experiments samples of various subnuclear frac-
tions were run on a linear sucrose density gradient 
(5-20%) in the presence or in the absence of high salt 
concentrations as described previously (144,213). 
3) Binding of 3H-oestradiol by receptor molecules was also 
demonstrated by hydroxylapatite cOlumn chromatography. 
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The method used was essentially the procedure described 
by Gschwendt (183), originally developed by McGillivray 
et al. (184). Hydroxylapatite was washed three times in 
5M urea/2M KCl in 1 mM potassiumphosphate buffer pH 6.8 
by suspension and decantation. Columns were then packed 
(1x6 em), equilibrated and run at 4°C. Subnuclear frac-
tions containing chromatin were diluted with 5M urea/2M 
KCl in phosphate buffer (1:1), applied to the column and 
eluted with 1 mM, 20 mM, 200 mM and 500 mM potassium-
phosphate pH 6.8 in 5M urea/2M KCl. The flow rate was 
maintained at 30 ml/h and 3 ml fractions were collected. 
In later experiments the columns were prepared in 
1 mM potassiumphosphate pH 6.8 containing 0.4M KCl. Sub-
nuclear fractions diluted (1:1) with 0.8M KCl were applied 
to the column and were eluted with 1 mM, 20 mM, 200 mM 
and 500 mM potassiumphosphate buffer pH 6.8 respectively, 
containing 0.4M KCl. 
Measurement of DNA, RNA and protein 
After accurately measuring the volume of each subnuclear 
fraction the fractions were diluted 2-3 fold with water. 
HCl0 4 was added at 0°C to a final concentration of 0.5M and 
the samples were washed three times with 0.5M HC104 . The 
pellets were dissolved in lM KOH at 37°C for 60 min. DNA and 
protein were precipitated after the addition of HClo 4 at 
0°C for 30 min. The supernatant containing the products of 
RNA hydrolysis was used for RNA estimation. The pellet was 
treated with HCl0 4 at 70°C for 15 min to hydrolyze the DNA. 
The residual pellet, containing protein, was dissolved in lM 
KOH at 70°C for 60 min. DNA in the fractions was measured 
using the method of Giles and Myer (214), RNA was measured 
according to Fleck and Munro (215) and the protein content 
of each fraction was measured by the method of Lowry et al. 
(216). In some experiments the amounts of DNA in the subnu-
clear fractions were very small (less than 10 ~g/fraction) 
and in those cases the fluorescence method of Robertson and 
Tait was used (217). 
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5.3 Results 
Isolation and chemical characterization of subnuclear fractions 
In initial experiments it was tried to establish the con-
ditions for fractionation of uterine nuclei. With light 
microscopy as a parameter it could be observed that sonica-
tion for a period of 15 sec was sufficient to disrupt about 
90-95% of the uterine nuclei. The pattern of bands obtained 
after the final ultracentrifugation step in TKMNa-buffer 
containing K{Na) citrate was similar to that observed for 
liver nuclei by Tata and Baker (208). After the collection 
of the various fractions the recoveries of protein, RNA and 
DNA were measured. Generally approximately 45-50% of the 
total nuclear DNA was recovered in the pellet fraction. The 
pellet also contained about 40-50% of the total amount of 
protein recovered. The very small amount of DNA (in the 
order of 1% of the total amount) and the relatively large 
amount of protein in the 7000 g supernatant of the nuclear 
sonicate were considered to reflect the nucleoplasm in this 
fraction (Table I). 
The results in Table I are representative for the data 
obtained as percentages of each constituent and as RNA/DNA 
and protein/DNA ratios. From these data it is evident that 
the individual fractions differ considerably in composition. 
However these data cannot be used for the determination of 
the functional properties of the constituents present in 
each fraction. Tata and Baker (208,211) showed that sub-
nuclear fractions isolated from rat liver contained different 
types of chromatin, different types of RNA-polymerase and 
differed also in the rate of labelling of RNA in vivo. They 
concluded that the top fractions of the sucrose gradient 
(fraction 1 and 2) contained the euchromatin, whereas the 
pellet and fraction 6 contained the heterochromatin. A mix-
ture of both types of chromatin was located in fractions 3, 
4 and 5. 
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Table I Chemical composition of subnuclear fractions of 
uterine tissue, isolated as given in the flow 
sheet in Figure 2. 
After collection of the different fractions, DNA, 
RNA and protein were measured in each fraction. 
Results are given in vg of each component/fraction. 
NP represents the nucleoplasmic fraction. 
Fraction protein DNA RNA RNA/DNA protein/DNA % DNA 
Intact nuclei 
NP 
1 
2 
3 
4 
5 
6 
Pellet 
696 
478 
496 
15 0 
152 
260 
132 
1860 
12 
53 2 
48 4 
20 
16 
32 
20 
83 2 
53 
50 
88 
28 
22 
34 
22 
82 
0.20 
4.41 
0. 09 
0.18 
l. 40 
l. 37 
l. 06 
l. 10 
0.10 
l. 89 
58.0 9 
0.90 
l. 02 
7. 50 
9.50 
8.13 
6.60 
2. 24 
Distribution of RNA labelled in vitro in the subnuclear fractions 
1 
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The presence or absence of rapidly labelled RNA can be 
used to determine the distribution of the different types of 
chromatin over the isolated subnucl~'·ar fractions. Therefore 
uterine tissue was incubated in the presence of 3H-uridine 
and subnuclear fractions were isolated in TKMNa-buffer con-
taining K(Na) chloride. The results presented in Table II 
show that RNA with the highest specific activity (dpm 3H/ 
vg RNA) was recovered in fractions 1, 5 and in the nucleo-
plasm, indicating that rapidly labelled RNA is predominantly 
located in these fractions. The ratio of incorporated 3 H-
uridine per vg DNA can be used as a marker for the number 
of RNA chains which have been synthesized per unit DNA. 
Table II shows that the top layers of the fractionation gra-
dient contain DNA which is probably representative for active 
chromatin in vivo. The high ratio of radioactive RNA/vg DNA 
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Table II Distribution of 3H-labelled RNA in subnuclear 
fractions of uterus after incubation of the tis-
sue for 30 min at 37°C in the presence of s- 3H-
uridine. After isolation of subnuclear fractions 
acid precipitable radioactivity, DNA and RNA were 
measured in each fraction. 
Fraction dpm/"g RNA dpm/"g DNA 
Intact nuclei 543 520 
NP 360 14,147 
1 637 5,984 
2 209 8,156 
3 101 3,881 
4 120 866 
5 30 3 362 
6 256 268 
Pellet 209 242 
as observed for the nucleoplasmic fraction might be the 
result of the release of rapidly labelled RNA into the 
nucleoplasmic fraction of uterine nuclei after its synthesis 
on the chromatin. 
Distribution of 3 H-oestradiol in subnuclear fractions of uterine tissue 
With a nuclear 3H-oestradiol exchange procedure (144,164) 
it was tried to demonstrate specific binding of oestradiol 
in subnuclear uterine fractions isolated in TKMNa-buffer 
containing K(Na)citrate. In this exchange assay uterine nu-
clei obtained from rats after injection of large amounts of 
oestradiol and from (Control) rats not treated with the hor-
mone were incubated with equal amounts of 3H-oestradiol. 
From the data presented in Table III it appears that a rela-
tive enrichment of specifically bound 3H-oestradiol (ex-
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Table III Localization of specific oestradiol-receptor 
complexes in subnuclear fractions of uterine 
tissue. Nuclei obtained from oestradiol treated 
rats and from control rats were incubated with 
3H-oestradiol for 60 min at 20°C. After isolation 
of subnuclear fractions samples were taken for 
the measurement of radioactivity and the diffe-
rence between the values obtained in dpm/vg DNA 
was taken as a measure for the specific binding 
of 3H-oestradiol. 
Fraction Oestradiol treated Control Specific 
Intact nuclei 1,793 1,186 607 
NP 129,050 42,444 89,213 
1 954 279 675 
2 967 494 472 
3 8,801 3,567 5,235 
4 2,679 4,074 
5 6,380 3,122 3,258 
6 4,775 3,040' 1,735 
Pellet 2,160 1,512 672 
pressed as dpm/~g DNA) occurred in fractions 3, 5 and 6 and 
also in the nucleoplasm. 
These data suggest that these subnuclear fractions might 
contain the so-called 'nuclear acceptor sites' for oestradiol-
receptor complexes. In a control experiment sonic disruption 
of nuclei was performed in the presence of an amount of 3H-
oestradiol (either in the absence or in the presence of ex-
cess non-radioactive oestradiol) comparable with the amount 
used in the 3H-oestradiol exchange procedure. From the dif-
ference in the total 'binding' and 
ding' in this experiment, it could 
oestradiol was not retained in the 
during the sonication procedure at 
the non-specific 'bin-
be concluded that 3H-
various nuclear fractions 
0 
a temperature of 0 c. 
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This argues against the possibility that the distrribution of 
3H-oestradiol in the subnuclear fractions (Table III) is the 
result of the interaction of free 3H-oestradiol with the 
chromatin during the sonic dLsruption of the nuclei. Never-
theless it remains uncertain whether the obtained ratios 
(dprn 3H/Jlg DNA) are a true re·flection of the presence of 
oestradiol-receptor complexes in the individual fractions. 
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Figure 4 Distribution of 3H-oestradiol in KCl extracts of 
subnuclear uterine fractions. 
Subnuclear fractions isolated from nuclei, loaded with 3 H-
oestradiol, were diluted with TKMNa-buffer and centrifuged 
for 60 min at 240,000 g. The pellets thus obtained were 
extracted with 0.4M KCl and samples were layered on 5-20% 
sucrose density gradients. 
After centrifugation for 18 h at 240,000 g, fractions were 
collected and assayed for radioactivity. 
•- • Subnuclear fraction 
o - o Subnuclear fraction 2 
A- .A Subnuclear fraction 3 
The arrow indicates the position of bovine serum albumin 
(4,3S). 
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In an attempt to demonstrate the binding of oestradiol to 
macromolecules, subnuclear fractions, after dilution with 
TKMNa-buffer, were centrifuged for 60 min at 240,000 g. The 
pellets thus obtained were extracted with 0.4M KCl for 
60 min at Q°C and the KCl extracts were used for analysis 
on high salt sucrose gradients. The distribution of 3H-
oestradiol in these extracts is shown for subnuclear frac-
tions 1,2 and 3 in Figure 4. A comparabl~ heterogeneous 
distribution of radioactivity was also obtained for the 
other subnuclear fractions including the pellet, and this 
observation made the sucrose density gradient centrifugation 
technique less suitable for the detection of nuclear recep-
tor sites. Moreover it cannot be excluded that receptor 
sites were lost during the centrifugation step in diluted 
buffer. Another disadvantage is that KCl extraction is sui-
table only for the detection of KCl extractable receptor 
sites. Considering this, together with the low capacity and 
the low resolving power of sucrose gradients, it was tried 
to concentrate the various subnuclear fractions. All methods 
used, including dialysis and concentration by hollow fibers 
resulted, however, in considerable losses (about 50%) of both 
radioactivity and protein and no binding could be observed in 
the resulting preparations. 
Demonstration of nuclear oestradiol receptor sites in uterine nuclei by 
hydroxylapatite column chromatography in the presence of urea and KCI 
It has been demonstrated by Gschwendt (183) for the oes-
tradiol receptor in nuclei from chicken liver that chroma-
tography on hydroxylapatite columns for separation of chro-
matin proteins as originally developed by McGillivray (184), 
could be used for the measurement of nuclear oestradiol 
receptors. This method is based on retention of proteins by 
the column and the subsequent release by increasing phosphate 
concentrations. It has also been demonstrated by Gschwend·t:, 
that the method could distinguish between KCl extractable 
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Figure 5 Hydroxylapatite column chromatography of uterine 
nuclei, loaded with 3 H-oestradiol. 
Nuclei, solubilized in 1 mM phosphate buffer pH 6.8 con-
taining SM urea/2M KCl, were applied to the column. The 
column was eluted with phosphate buffers of increasing 
ionic strength containing SM urea/2M KCl. In peak I histone 
proteins were eluted and non-histone proteins were eluted lll 
peak II and III. The fractions eluted at 500 mM phosphate 
( IV ) contained DNA. 
and non-KCl extractable oestradiol receptors on basis of 
their difference in retention on the column. In addition 
this technique can be used for the analysis of large volumes 
of buffer containing high sucrose concentrations. 
In initial experiments, we could demonstrate receptor 
bound oestradiol in isolated nuclei (Figure 5, peak II and 
III), but not in subnuclear fractions. In control experi-
ments it could be shown, that 
1) ureurn, which is used to dissociate the chromatin in its 
constituents, disrupted the binding of oestradiol with 
its receptor 
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2) citrate, which is present in the fractionation gradient, 
extracted considerable amounts of oestradiol-receptor 
complexes from isolated nuclei and also interfered with 
the elution of oestradiol-receptor complexes from the 
hydroxylapatite column. 
On basis of these observations it was decided to omit 
ureum from the elution buffer and to substitute citrate ions 
for chloride ions in the fractionation gradient. Subnuclear 
fractions, after addition of O.BM KCl (1:1), were applied to 
columns prepared in 1 mM phosphate buffer containing 0.4M 
KCl. Fractions were collected after elution with 20 mM, 
200 rnM and 500 rnM phosphate buffer, respectively, containing 
0.4M KCl. This alternative method appeared to be reliable, 
because in the order of 80% of the number of receptor sites 
present in a KCl extract of uterine nuclei could be recover-
ed in fraction II and III after elution of a hydroxylapatite 
column. 
Demonstration of nuclear oestradiol receptor sites in subnuclear fractions of 
uterine nuclei by hydroxylapatite column chromatography 
Subnuclear fractions were isolated in TKMNa-buffer con-
taining KCl and NaCl after incubation of uterine tissue for 
60 min at 37°C in the presence of 10-BM 3H-oest·radiol. The 
isolated subnuclear fractions were diluted (1:1) with 0.8M 
KCl and chromatographed on hydroxylapatite columns. Table IV 
gives a summary of the results. It was possible to demon-
strate binding of 3H-oestradiol in subnuclear fractions 1,2 
and 3, in the nucleoplasm (NP) but not in fractions 4,5 and 
6. In order to obtain information about the presence of 
receptor sites in the pellet fraction of the fractionation 
gradient it was tried to solubilize receptor sites by adding 
0.4M KCl for 60 min at 0°C. In a further attempt to demon-
strate receptor sites in the pellet fraction the residual 
(non-KCl extractable) fraction was sonicated for 15 sec in 
buffer containing 0.4M KCl. The KCl extracts thus obtained 
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Table IV Separation of oestradiol receptor sites in diffe-
rent subnuclear fractions by hydroxylapatite 
column chromatography. Data for the amounts eluted 
in the 3 peaks after chromatography (see figure 5) 
are given as percentages of the amount of receptor 
sites which was recovered from the column. 
Frdclion Elution peak 
II III + IV 
Nuclear extract in 0.4M KCl 87 13 
NP 77 23 
1 69 31 
2 56 44 
3 42 58 
Pellet extract in 0.4M KCl 53 47 
Pellet after sonication in 0.4M KCl 26 74 
were used as such for analysis of receptor sites on hydro-
xylapatite columns and the results are also presented in 
Table IV. 
Some striking differences can be observed for the amounts 
of oestradiol receptor sites recovered in the different 
hydroxylapatite column fractions. In the nucleoplasm as well 
as in subnuclear fraction 1 most of the binding sites were 
recovered trom the column in elution peak II (70-80%). This 
distribution of bound 3H-oestradiol on the column is similar 
to that observed for a KCl extract prepared from intact 
uterine nuclei. In contrast in subnuclear fractions 2 and 3 
in the order of 50% of the number of binding sites was reco-
vered from the column in elution peak II. The relative 
increase of radioactive oestradiol in elution peak II (as 
well as in an additional peak IV, which is eluted at 500 mM 
phosphate buffer) is even more striking for the pellet of 
the fractionation gradient. In the KCl extractable fraction 
of this pellet 50% of the number of binding sites was still 
recovered in elution peak II, whereas from the non-KCl ex-
tractable fraction, applied to the hydroxylapatite column 
after sonication in 0.4M KCl, only 20-35% was eluted in this 
peak. A similar treatment, including KCl extraction of nuclei 
and sonication of the nuclear residual pellet in 0.4M KCl, 
also resulted in the recovery of non-KCl extractable receptor 
sites predominantly in elution peaks III and IV. 
In summary therefore it can be concluded that non-KCl 
extractable receptor sites appear to sediment in the heavier 
sucrose gradient fractions and in the pellet of the fraction-
ation gradient. KCl extractable receptors were recovered 
predominantly in the nucleoplasm and in the lighter sucrose 
gradient fractions. 
Recovery of oestradiol-receptor complexes in subnuclear fractions of uterus 
Considering the quantitative distribution of oestradiol-
receptor complexes over the various subnuclear fractions it 
appears that in the order of 40% of receptor sites was re-
covered in the top layers of the fractionation gradient 
(30%) and in the nucleoplasm (10%). The remaining 60% was 
found in the pellet fraction obtained during the isolation 
of the subnuclear fractions. From the total amount of nuclear 
receptor sites present in uterine nuclei before sonication 
and fractionation, approximately 40% could be recovered. This 
loss of nuclear receptor sites was not caused by the sonica-
tion procedure because after KCl extraction of sonically dis-
rupted nuclei more than 80% of the number of receptor sites 
present in intact nuclei was recovered as measured by sucrose 
gradient centrifugation. During the fractionation of uterine 
nuclei, the sonicated nuclei are considerably diluted during 
the centrifugation through the discontinuous gradient. 
This step, which might induce a considerable dissociation of 
oestradiol-receptor complexes could explain, at least in 
part, the low recovery of nuclear receptor sites. 
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Nature of oestradiol-receptor complexes in uterine 
subnuclear fractions. 
A sample of subnuclear fraction 1 was layered on a linear 
5-20% sucrose density gradient prepared in TKMNa-buffer 
(Fig. 6 A). A sample of the nucleoplasmic fraction was layered 
on a linear 5-20% sucrose density gradient, prepared in 10 mM 
Tris-HCl buffer containing 0, 4M KCl (Fig. 6 B). 
After centrifugation for 18 h at 240,000 g fractions were 
collected and assayed for radioactivity ( •- •) and DNA 
(E260) ( o- o ). 
The arrow indicates the position of bovine serum albumin 
(4.3S). 
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Nature of oestradiol-receptor complexes in subnuclear fractions 
An attempt was made to obtain further information about 
the state of the oestradiol-receptor complexes in the nu-
cleoplasmic fraction and in subnuclear fraction number 1. A 
sample of the nucleoplasm was layered on a sucrose density 
gradient prepared in 0.4M KCl in buffer. After centrifuga-
tion and collection of the individual fractions, the amount 
of radioactivity was determined in each fraction. Figure 6B 
shows that oestradiol bound to macromolecules in the nucleo-
plasm sediments heterogeneously in the 3-8S region of the 
gradient. A sample of subnuclear fraction 1 was layered on a 
sucrose gradient prepared in TKMNa-buffer in the absence of 
KCl. Figure 6A shows that subnuclear fraction 1, in addition 
to oestradiol bound to macromolecules, also contains a 
heterogeneous fraction of DNA, which was determined by mea-
suring E260 in each fraction. This might reflect a possible 
interaction between the two components, i.e. the oestradiol-
receptor complex and the DNA, in vivo. 
5.4 Discussion 
Chromatin in vivo appears to occur in two forms, hetero-
chromatin, which is inactive in transcription and euchroma-
tin, which includes genes participating in transcription 
(199). In vitro chromatin can be separated in fractions which 
have different template activities in incubations with added 
exogenous RNA-polymerase and different amounts of nascent 
RNA after labelling in vivo or in vitro (206,209,210,211, 
218,219,220,221). Also differences in histone and nonhistone 
protein content could be observed (221,222,223,224). Although 
the molecular composition of these chromatin fractions is not 
known, they may be separated from each other as a consequence 
of their differences in: 
-hydrodynamic properties, which are reflected in shearing or 
sonication and sedimentation through glycerol or sucrose 
gradients {208, 209,210,219,221). 
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-electrostatic properties after sonication, as reflected 
during separation by ECHTAM-cellulose column chromatography 
(223). 
-behaviour during DNAse digestion of chromatin (203,225}. 
In some of these methods chromatin was isolated from 
nuclei and fractionated by either of the treatments as des-
cribed above in order to obtain chromatin fractions. A major 
disadvantage of this procedure is the fact that isolated 
chromatin may be different from chromatin in vivo with res-
pect to the location of histones and nonhistones on the 
chromatin (226). It is also possible that as a result of 
the isolation and fractionation methods the bulk of RNA-
polymerase would be released from its template or become 
inactivated. Furthermore most procedures used for prepara-
tion of chromatin and RNA-polymerases could destroy the 
nuclear envelope, while, at the same time, methods used for 
isolating nuclear membranes would not allow a meaningful 
study of the role of nuclear structures in the regulation of 
transcription of DNA. 
In order to correlate a possible interaction of oestra-
diol-receptor complexes with their acceptor sites and the 
ultimate effect of oestradiol inside the nucleus i.e. changes 
in RNA-polymerase activity and synthesis of new mRNA species, 
it was tried to disrupt isolated uterine nuclei by sonication 
and prepare subnuclear fractions on sucrose gradients. 
This relatively mild method which was originally introdu-
ced by Frenster et al. (210} was applied successfully by 
Chesterton (209} and Tata and Baker (208) to liver nuclei. 
However this sonication method had thusfar not been used to 
study the subnuclear localization of steroid-receptor com-
plexes. 
From the present results it appears that administration 
of oestradiol in vivo resulted in a relative enrichment of 
oestradiol (expressed as dpm/~g DNA) in the subnuclear frac-
tions of uterus designed fractions 3,5 and 6 and also in the 
nucleoplasm (Table III). Although it could be demonstrated 
by a 3H-oestradiol exchange procedure that this relative 
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enrichment was specific and not due to the sonication proce-
dure at 0°C, it was tried to elucidate the nature of the 
oestradiol present in each fraction. Sucrose density gradient 
centrifugation appeared to be less suitable for the analysis 
of oestradiol-receptor complexes in each fraction. Hydroxyl-
apatite column chromatography was expected to be more 
suitable for the localization of receptor bound oestradiol, 
because it had previously been used by Gschwendt (183) for 
separation of the oestradiol receptor population in chicken 
liver in KCl extractable and non-KCl extractable receptor 
sites due to the differences in interaction with the exchange 
resin. In this procedure the isolated chromatin was first 
dissociated in histones, nonhistones and DNA by adding SM 
urea and 2M KCl. 
In the present study it was observed that, in contrast to 
the oestradiol receptor in chicken liver, steroids are dis-
sociated from the uterine receptor in the presence of urea. 
In addition it became apparent, that citrate ions in the 
buffe~, which are used for the isolation of subnuclear frac-
tions according to the method of Tata and Baker (208), 
interfered with both the interaction of oestradiol receptor 
molecules with the hydroxylapatite column and the interac-
tion of receptor molecules with DNA in intact nuclei. There-
fore, in later experiments urea was omitted and chloride ions 
rather than citrate ions were used in the subnuclear fractio-
nation procedure and in the chromatography of the isolated 
subnuclear fractions. 
Oestradiol receptors present in the individual subnuclear 
fractions of uterus could be eluted from the hydroxylapatite 
column at different ionic strengths. KCl extractable recep-
tor sites (eluted predominantly at 20 rnM phosphate) were 
found in the upper region of the fractionation gradient and 
in the nucleoplasm, whereas non-KCl extractable receptor 
sites (eluted at 200 rnM and 500 mM phosphate) were measured 
in the pellet fraction. These results indicate that a sepa-
ration of receptor molecules with different affinities for 
the chromatin could be achieved. The results might reflect 
that low affinity acceptor sites were recovered in the light 
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sucrose fractions and in the nucleoplasm, whereas high affi-
nity acceptor sites were found in the pellet fraction. It 
has been suggested by others (140), that receptor molecules 
which interact with high affinity acceptor sites could be 
important for the response of the uterus to oestradiol. The 
present observation that these complexes are mainly located 
in the pellet fraction of the fractionation gradient suggests 
that this nuclear fraction might be important in the regula-
tion of the activity of steroid hormones. 
For the progesterone receptor in chick oviduct it has also 
been demonstrated that steroid receptor molecules were loca-
ted in a heavy sucrose gradient fraction, containing the 
heterochromatin {2061. In contrast to these results it has 
been demonstrated that, using a different technique for 
fractionation, progesterone receptors (218) and oestradiol 
receptors (227,228) were located in the lighter chromatin 
(euchromatin) fraction. 
The recovery of receptor sites after the fractionation 
procedure of uterine nuclei was far from complete (in the 
order of 40%). A possible explanation may be found in the 
dilution of the nuclear sonicate during the separation of 
the subnuclear fractions on the sucrose gradient, which 
might result in a considerable dissociation of oestradiol-
receptor complexes. This explanation is sustained by the 
observation that a considerable amount of the 3H-oestradiol, 
which is present in the individual subnuclear fractions, is 
not bound to macromolecules, whereas in intact uterine 
nuclei unbound oestradiol was almost absent. In addition it 
was found that the binding sites were almost equally dis-
tributed between the upper two gradient fractions, including 
the nucleoplasm, and the pellet fraction of the gradient. 
No conclusive data were obtained concerning the possible 
interaction of oestradiol receptor molecules and DNA present 
in the subnuclear fractions. On low salt sucrose density 
gradients oestradiol-receptor complexes, present in frac-
tion 1, were shown to sediment heterogeneously in a region 
where small-size DNA species were also located (Figure 6A). 
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From the detailed studies of Yamamoto (120) it appears that 
such an interaction, if present, could represent a low 
affinity interaction without 
Tata 
physiological meaning. 
and Baker (208,211) and It has been shown by 
Chesterton et al. (209) that sonication and sucrose gradient 
centrifugation of rat liver nuclei could achieve separation 
of euchromatin and heterochromatin fractions. This has been 
supported by results of transcription on DNA stretches in 
vitro, the localization of nascent RNA molecules and the 
precipitation of heterochromatin in the presence of 5 mM 
MgC1 2 . Due to the presence of Mg
2
+ ions in the fractionation 
buffer this simple method could not be applied to the isola-
ted uterine subnuclear fractions. In the present study it 
could be demonstrated that rapidly labelled RNA, after in 
vitro incubation of uterus, was predominantly located in 
the upper layers of the fractionation gradient (Table II), 
suggesting that euchromatin is p~esent in these fractions. 
It cannot be excluded, however, that as a result of the 
isolation and fractionation of nuclei RNA chains become de-
tached from their respective templates and interact with 
other DNA stretches. Nevertheless a random redistribution 
of labelled RNA can be excluded on basis of the results 
presented in Table II. 
From the results presented in this chapter it is evident 
that the localization of oestradiol-receptor complexes in 
subnuclear fractions of uterus requires still further inves-
tigations. In this respect the influence of the different 
fractionation techniques on the subnuclear localization of 
steroid receptor molecules creates a challenging problem. 
Another difficulty is caused by the different ionic condi-
tions which are required for the isolation of the 'physio-
logical' form of those components which are supposed to be 
obligatory for the ultimate effect of steroid hormones, i.e. 
steroid hormone receptor associated with chromatin, RNA-
polymerases and chromatin. Furthermore the question remains 
whether the isolated chromatin fractions are really repre-
sentative for regions which are active and inactive in 
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transcription in vivo. In two studies (229,230) it has been 
reported that chromatin could be separated in euchromatin and 
heterochromatin, which differed in protein composition as well 
in their activity in transcription with RNA-polymerase in 
vitro. However DNA-DNA reassociation experiments performed 
with radioactive eDNA, obtained after transcription of RNA 
molecules with reverse transcriptase, did not provide any 
evidence for an unequal distribution of the RNA genes over 
both chromatin fractions. However the usefulness of endoge-
nous genomes as probes for the structure of chromatin has 
been demonstrated in these studies. Perhaps the use of such 
experiments will assist in future attempts to relate in 
vitro definitions of fractionated chromatin to activities 
in vivo. 
In conclusion the results in this chapter indicate that: 
1. Oestradiol-receptor complexes with different affinities 
for the chromatin were present in subnuclear fractions 
isolated from uterine tissue. 
2. Oestradiol-receptor complexes were located in both the 
light and heavy chromatin fractions, which might be 
representative for euchromatin and heterochromatin res-
pectively. 
3. Oestradiol-receptor complexes loosely bound to the chro-
matin were located in the light chromatin fractions, 
whereas tightly bound oestradiol-receptor complexes were 
located predominantly in the heavy chromatin fractions. 
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General discussion and conclusions 
The work presented in the previous chapters concerning 
the regulation of the concentration and the subcellular 
localization of steroid receptors in target cells was 
started because almost nothing is known about the mechanisms 
regulating the amount and localization of steroid receptors. 
These receptors, which are supposed to be obligatory for 
steroid hormone effects, are located in the cytoplasmic 
fraction of a target cell, but are translocated into the 
nucleus after having formed a steroid-receptor complex with 
their specific steroid. Therefore c·hanges in the number of 
cytoplasmic receptor sites might have a direct effect on 
the number of receptor sites, which can be translocated and 
this could ultimately result in changes of physiological 
effects i.e. the response of a tissue to the hormone. 
6.1 Regulation of cytoplasmic and nuclear receptor sites for oestradiol in 
testicular tissue 
It was attempted to investigate possible control mecha-
nisms which might be important in controlling the number of 
oestradiol receptor sites in cytoplasmic and nuclear frac-
tions of Leydig cells from rat testis. 
Effect of oestradiol 
From the results in appendix paper I it appears that 
oestradiol administration results in a maximal depletion of 
the oestradiol receptor from the cytoplasmic fraction iso-
lated from both mature and immature rat testis within 1 h. 
For mature rats it has also been demonstrated that this de-
pletion is accompanied by a rapid increase and a subsequent 
decrease of plasma oestradiol levels, suggesting that oes-
tradiol from the rat plasma penetrates into the Leydig cell 
and induces a shift in the subcellular distribution of 
receptor molecules towards the nucleus. Replenishment 
of cytoplasmic receptor sites was shown to occur between 3 
and 5 h after the administration of oestradiol. 
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For uterine and hypothalamic tissue it has been demon-
strated that the replenishment of receptor sites involves 
both synthesis of new receptor molecules and recycling of 
receptors from the nucleus to the cytoplasm (98,143,168). 
These two processes resulted in a restoration of the cyto-
plasmic receptor levels to values similar to control levels 
between 11 and 15 h after the hormone administration. 
The results obtained in the present studies for testicu-
lar tissue appeared different from those described for 
uterine and hypothalamic tissue. From the data obtained 3 
and 5 h after the administration of oestradiol it is evident 
that the replenishment of cytoplasmic receptor sites in 
testis occurs at a faster rate. Similar differences in the 
rate of restoration of cytoplasmic receptor levels for oes-
tradiol have been observed between pituitary tissue of male 
and female rats (231). It has also been observed that the 
replenishment of receptors in the pituitary of neonatally 
androgenized female rats follows the same pattern as was 
observed for the pituitary of either normal or androgenized 
male rats (231). Considering these results, it is tempting 
to speculate about a sex related difference between the 
replenishment of receptor molecules in male and female rats 
which might be caused by an interaction of androgens with 
the process. This might result either in differences in the 
de novo synthesis of receptor sites or in differences in 
the rate of transfer of nuclear receptor sites into the 
cytoplasm. The finding that the nuclear retention of oestra-
diol receptor sites in testis is relatively short when com-
pared to that of the uterus (appendix paper III) is in favour 
of the latter possibility. 
Effect of hypophysectomy 
In order to study the influence of oestradiol on the 
amount of receptor sites for oestradiol, the number of cyto-
plasmic receptor sites in interstitial tissue from mature 
rat testis and the number of total available receptor sites 
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in immature rat testis were measured at different times after 
hypophysectomy. In appendix paper I it was shown that no 
changes in the oestradiol receptor concentration (expressed 
as fmol/mg interstitial cytosol protein) could be observed 
in adult rats between 1 and 10 days after hypophysectomy. 
During this period the weight of the testis does not change 
considerably. In studies of de Jong (42) it was shown that 
hypophysectomy for periods of 6-12 days drastically decreased 
the testicular oestradiol concentrations. 
The observation that oestradiol receptor levels remain 
unaffected, while oestradiol concentrations decrease leads 
to the conclusion that oestradiol itself is not necessary 
for the maintainance of a constant number of cytoplasmic 
receptor sites per Leydig cell. It can, however, not be ex-
cluded that small but significant amounts of oestradiol 
produced extratesticularly play a role in maintaining con-
stant receptor levels. 
From studies performed with immature rats 5 days after 
hypophysectomy (Table 2, appendix paper II) it became clear 
that the total number of oestradiol receptor sites per testis 
was influenced by a factor which is under the control of the 
pituitary-hypothalamic system. This factor might be oestra-
diol, LH or some other steroid or trophic hormone. Because 
no data are available concerning the number of Leydig cells 
in testes of hypophysectomized immature rats it remains un-
certain whether the observed changes reflect also a change 
in the number of receptor sites per Leydig cell. 
Effect of choriogonadotropin 
The decrease in the total availablE number of receptor 
sites per immature rat testis after hypophysectomy might be 
the result of a decrease in the number of Leydig cells. This 
view is supported by the observation that LH administration 
to hypophysectomized rats could prevent or even reverse the 
atrophy of the interstitial tissue (232). This view also 
fits the data obtained after injection of immature rats 
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with HCG, presented in appendix paper II. Administration of 
HCG to immature rats has a stimulatory effect on the number 
of Leydig cells per testis (233) . It appears from this ob-
servation and the data presented in appendix paper II that 
HCG can stimulate the number of mitosis in Leydig cells 
which results in an increase of the number of Leydig cells 
also containing oestradiol receptors. Possibly as a result of 
the increase in production of oestradiol after HCG administra-
tion, as was shown for mature rats (42), the fraction of the 
,receptor population which could be recovered from the 
nuclear fraction was increased. This suggests that the distri-
bution of oestradiol receptor molecules over the cytoplasmic 
and the nuclear compartment of the Leydig cell is under the 
control of testicular oestradiol concentrations. The number 
of available receptor sites may also be influenced by the 
hormonal environment. Further studies are needed to eluci-
date whether LH and oestradiol are the only two hormones 
involved in the regulation of receptor sites for oestradiol 
and whether this regulation has any physiological signifi-
cance in the development of the rat testis. 
Om~e~ 
In order to investigate the ontogeny of the oestradiol 
receptor in the testis, testicular tissue from immature rats 
was used. As a result of the presence of a second oestradiol 
binding protein (called a-foetoprotein) it was only possible 
to perform accurate quantitative measurements of cytoplasmic 
receptors in testicular tissue of rats older than 14 days. A 
rather constant amount of receptor sites (9 fmoljmg cytosol 
protein) appeared to be present in the cytoplasm of rats be-
tween 14 and 35 days of age. In mature rat testis an amount of 
approximately 18 fmol/mg cytosol protein has been measured. 
The increase in the receptor amount which appears from these 
data is in agreement with the results of Pahnke et al. (234). 
They observed a steep increase in the number of Leydig cells 
per testis between 30 and 60 days of age concomitant with a 
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parallel increase in testis weight. 
A nuclear form of the oestradiol receptor could be demon-
strated in testicular tissue of 4 days old rats, because 
contaminations originating from the plasma or the cytoplasm 
were effectively removed during the isolation of nuclei. 
Because no accurate data are available about the change of 
the number of Leydig cells during early development of the 
testis it is difficult to interpret these data per Leydig 
cell. Moreover, quantitative data would only be reliable if 
a method had been used, which estimates the number of recep-
tor sites indepently from the amounts of endogenous oestra-
diol present in the testis from rats of different ages. Such 
a method has been developed for testicular tissue of immature 
rats and is described in appendix paper II. 
Data on the amount of a-foetoprotein in the plasma of 
immature male rats are presented in appendix paper I. The 
change in the number of binding sites in plasma with age was 
compared with the amount measured in female rat plasma (235). 
It appears from the data in Table 1 of appendix paper I that 
the amount of a-foetoprotein in plasma of male rats is about 
100 times lower, but the disappearance of the plasma protein 
occurs with a half life of about 5.5 days, which is in good 
agreement with the half life of 4 days observed in plasma of 
female rats. 
Demonstration of occupied nuclear receptor sites 
With the exchange method described in appendix paper II 
it could be shown that in nuclei isolated from intact imma-
ture rats (25 days of age), a considerable fraction of the 
total receptor population was present in the nuclear frac-
tion isolated from Leydig cells. This observation suggests 
that sufficient oestradiol is present in the interstitial 
tissue compartment in order to keep the oestradiol-receptor 
complexes in the nuclear fraction. Nothing is known however 
about the origin of the oestradiol. It could have been pro-
duced from intratesticular as well as from peripheral 
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sources. Also nothing is known about its physiological 
role. If one assumes that under the influence of endogenous 
oestradiol also a significant fraction of the non-KCl 
extractable fraction of receptors is located inside the 
nucleus it is tempting to relate some Leydig cell function 
with it, because this fraction of receptors was shown to 
correlate with an oestradiol effect in the uterus (140). 
6.2 Characterization and retention of nuclear receptor complexes 
In appendix paper III studies concerning the nuclear 
translocation and nuclear binding of oestradiol receptor 
sites in testis and uterus are presented. This comparative 
study was performed in order to relate these processes in a 
cell with a poorly defined response, like the immature Leydig 
cell (236), with those in a cell, with a well-known response, 
the uterine cell. 
Characterization of nuclear receptor sites in testis and uterus 
From the results presented in appendix paper II it became 
apparent that certain differences concerning the retention 
of nuclear oestradiol-receptor complexes did exist between 
testicular and uterine tissue. In both tissues oestradiol 
is retained by two different nuclear receptor sites which 
could be distinguished according to their differences in 
extraction from nuclei with 0.4M KCl. 
In order to obtain further information about the charac-
teristics of the non-KCl extractable oestradiol receptor in 
testicular tissue, it was tried to solubilize the oestra-
diol-receptor complexes with either DNAse, trypsin or deoxy-
cholate. All three different treatments did not result in 
a considerable release of oestradiol-receptor complexes. 
Only treatment with trypsin gave some information about the 
interaction of receptor complexes with the chromatin. From 
the altered sedimentation value of the complex after trypsin 
treatment, 4S instead of SS, it was concluded that the enzyme 
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cuts off one part of the receptor protein containing the 
chromatin interaction site, while leaving the oestradiol 
binding site intact. In this respect the testicular oestra-
diol receptor does not differ from the oestradiol receptors 
found in liver and uterus (142,237). 
The results presented in appendix paper II show that 
incubation of testicular nuclei, loaded with oestradiol-
receptor complexes, for 60 min at 20°C in the presence of 
3H-oestradiol was sufficient for a complete exchange of the 
radioactive steroid with the non-radioactive steroid. It was 
also demonstrated that only 40% of the total receptor popu-
lation (the fraction recovered in the KCl extract of the 
nuclei) could be measured by this method. In this respect 
two differences between testicular and uterine nuclei were 
observed. The oestradiol receptor in uterine nuclei can be 
readily extracted with 0.4M KCl (60 to 80% has been reco-
vered in the extractable fraction) and in the exchange pro-
cedure routinely used for uterine nuclei by others (143, 
164), a shift of receptor sites from the extractable frac-
tion into the so-called nuclear residual fraction was obser-
ved. Whether this change is merely artificial or has any 
physiological significance is not clear. 
Effect of energy and the release of nuclear bound receptor sites 
It is generally accepted that nuclear oestradiol-receptor 
complexes, after being bound by the chromatin, can return 
into the cytoplasm via a recycling process (143,168). This 
suggests that after the interaction with the chromatin, 
enzymes must be involved in the release of nuclear receptor 
complexes. From the data in Figure 3 and Figure 4 in appen-
dix paper III it can be concluded that different mechanisms 
might be involved in the retention of hormone-receptor com-
plexes in nuclei of testicular and uterine tissue which 
could be related to differences in enzyme activities, neces-
sary for the detachment of receptor sites. 
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From the studies performed with KCN it seems very likely 
that a continuous supply of energy is also important for the 
release of receptor complexes from the nuclei. In the non-
KCl extractable fraction of both uterus and testis, addition 
of KCN drastically increased the number of oestradiol bin-
ding sites. This might be due to inhibitory action of KCN, 
mediated via ATP, on those enzymes which probably are neces-
sary for the release of receptor sites associated tightly 
with the chromatin. In the literature other data are avail-
able which are in favour of this explanation concerning the 
release of chromatin bound steroid-receptor complexes. In 
studies performed on erythrocyte chromatin it has been 
demonstrated that the presence of Mg 2+-ions resulted in a 
complete contraction of the chromatin (238). Equal molar 
z~ 
amounts of Mg ' and ATP were found to inhibit this contrac-
tion. Therefore a decrease in the cellular (nuclear) amount 
of ATP as a result of the addition of KCN might result in a 
relative increase of the free Mg 2+ concentration. The sub-
sequent change in conformation of the chromatin might make 
the steroid receptor acceptor sites less susceptible for 
enzymes involved in the release of receptor molecules. 
Retention of nuclear receptor sites in testis and uterus 
The exact nature of the interaction of oestradiol-
receptor complexes with the chromatin and the mechanism of 
release with KCl is still unclear. Therefore one can only 
speculate about the factors which determine the observed 
differences in the retention of nuclear receptor sites, 
shown in appendix paper III. One possible explanation might 
be found in differences in the affinity of the oestradiol-
receptor complexes for acceptor sites on the chromatin. 
This could be due to variations in the nonhistone chromatin 
protein fraction among various tissues, because this group 
of proteins is thought to contain the so-called acceptor 
protein (121,124). 
For uterine and prostatic tissue it has been suggested 
that the retention of steroids by nuclear residual receptor 
sites (probably receptor sites with a very high affinity for 
the chromatin) are obligatory for hormone effects (140). 
This type of nuclear retention was shown to be absent in 
testicular tissue during longer incubation periods and may 
be due to the presence of acceptor sites with a relatively 
low affinity for the steroid-receptor complexes. This makes 
it very unlikely that an oestradiol effect in the testicular 
Leydig cell, if present, is mediated by an interaction of 
oestradiol-receptor complexes with acceptor sites in the 
non-KCl extractable nuclear fraction. 
6. 3 Su bnuclear distribution of oestradiol-receptor complexes in uterus 
From the results obtained in appendix paper III it was 
concluded that due to the lack of prolonged retention of 
oestradiol-receptor complexes in the non-KCl extractable 
fraction of testicular nuclei, the uptake and the subsequent 
binding of receptor complexes in testis and uterus might 
follow different pathways. One way to obtain further infor-
mation about the mechanism of action of steroid hormones via 
their receptors in any cell type is to unravel the molecular 
mechanisms inside the nucleus 1 which are involved in the 
expression of known steroid effects. Therefore one has to 
characterize and localize the locus on the chromatin which 
interacts with receptor molecules. A possible correlation 
of the binding of receptor complexes with this locus and a 
specific hormone effect inside the nucleus 1 i.e. RNA-poly-
merase activity increase or synthesis of specific mRNA 
species, might provide the evidence necessary for the elu-
cidation of the mechanism of action of steroid hormones. 
Preliminary results concerning the interaction of oestradiol-
receptor complexes with subnuclear fractions isolated from 
uterine tissue are presented in chapter 5. 
It became apparent that the subnuclear fractionation 
method by Tata and Baker (208) as such could not be applied· 
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to uterine tissue in order to obtain information about the 
subnuclear distribution of oestradiol receptor sites. It was 
also found that a classical method for the analysis of 
nuclear receptor sites i.e. sucrose density gradient centri-
fugation in high salt, was not suitable for the demonstration 
of receptor sites in the different subnuclear fractions. To 
circumvent these difficulties we made appropriate changes in 
the fractionation buffer (citrate was replaced by chloride) 
and decided to use hydroxylapatite column chromatography in 
0.4M KCl as a method for separation of nuclear receptor 
sites. This method has the advantage that tt is suitable for 
the separation of KCl extractable and non-KCl extractable 
receptor sites as was previously demonstrated by Gschwendt 
for the oestradiol receptor in rat liver nuclei (183). 
Application of the described method to nuclei obtained 
after in vitro incubation of uterus with oestradiol gave 
indications for the presence of steroid receptor molecules 
in both the euchromatin and heterochromatin fraction. The 
relatively small amount (in the order of 10%) of receptor 
sites which could be demonstrated in the nucleoplasm is 
probably released from nuclei during mild sonication and 
might represent a fraction of steroid-hormone complexes 
present in the nucleoplasm in vivo. 
From the data presented in chapter 5 it is evident that 
the method used for the subcellular fractionation of uterine 
nuclei in order to correlate uterine oestradiol effects 
within the nucleus with the presence of oestradiol-receptor 
complexes, still requires improvement. It may be worthwhile 
to compare the different techniques which are available for 
the fractionation of intact nuclei in order to obtain an 
unambigous characterization of the isolated fractions. 
Furthermore the use of more sensitive methods for the detec-
tion of steroid-hormone complexes, like the antibody assay 
technique developed by Castaneda and Liao (239) or a tech-
nique which uses fluorescence labelled receptors, might im-
prove our knowledge about the role of receptors in the mecha-
nism of action of steroid hormones. 
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Summary 
Effects of steroid hormones in target cells are thought 
to be mediated via the interaction of steroids with specific 
receptor molecules. The complex formed between the receptor 
and the steroid is translocated into the nucleus and ini-
tiates a cascade of events, which ultimately results in the 
response ascribed to a specific hormone. 
In chapter 2 the successive steps between the initial 
interaction of the steroid with its receptor and the final 
tissue response are discussed. 
In chapter 3 a summary of methods used for the determina-
tion of specific steroid binding sites is given. 
In order to obtain information about a possible function 
of the oestradiol receptor in the testicular Leydig cell we 
have compared several characteristics obtained for the tes-
ticular and uterine oestradiol ~eceptor. In chapter 4 and 
appendix papers I and II the experiments on the regulation 
of the number of cytoplasmic and nuclear receptors are in-
troduced and discussed. 
It was found that after administration of oestradiol to 
intact mature and immature rats a decrease in the testicular 
concentration of cytoplasmic receptor sites was observed 
within 1 h. The binding capacity was replenished starting 
about 3 h after oestradiol administration and after 5 h the 
receptor levels were completely restored (appendix paper I). 
In mature animals which were hypophysectomized for 
periods up to 10 days a constant level of cytoplasmic recep-
tor sites was measured in total testicular tissue and dis-
sected interstitial tissue (appendix paper I). From these 
results it is concluded that neither gonadotrophins nor 
steroid hormones are necessary for maintaining constant 
oestradiol receptor levels in the cytoplasm. 
The testicular receptor for oestradiol was demonstrated 
in its nuclear form in rats from 4 days of age onwards. No 
accurate figures could be obtained for the number of receptor 
sites during the development of the rat (appendix paper I). 
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By means of an exchange method, in which receptor bound 
oestradiol is substituted for 3H-oestradiol, it was demon-
strated that testicular tissue of intact immature rats 
(25 days old) contained a considerable amount of nuclear 
receptors, occupied with endogenous oestradiol (20%) 
(appendix paper II) . This amount was considerably increased 
in rats which had been treated with human choriogonadotropin 
for five successive days. Concomitant with this shift in 
favour of the nuclear fraction it was observed that the 
total amount of receptor sites per testis, was increased 
threefold. In contrast, after hypophysectomy the total 
amount of receptor sites per testis was only 50% of the 
amount measured in intact rats. In these animals no nuclear 
receptor sites occupied with endogenous oestradiol could be 
observed (appendix paper II) . These observations suggest 
that gonadotrophins and oestradiol may be important in the 
in vivo regulation of the amount and the subcellular distri-
bution of receptor sites in immature rat testicular tissue. 
In chapter 4 and appendix paper III the results obtained 
in a comparative study with the uterus are described. It was 
observed that inside rat testicular nuclei oestradiol is 
specifically bound by two different classes of receptor 
sites, which differ in extractability with KCl. The amount 
of 'extractable' nuclear binding sites could be increased by 
~ild trypsin treatment. The receptor sites, after being 
released with trypsin, showed a sedimentation value of 4S on 
sucrose density gradients, in contrast to the value of SS 
which was observed for KCl extracted receptors. 
The number of non-KCl extractable receptor sites in both 
testis and uterus was increased significantly after incuba-
tion of the tissues in the presence of KCN. This observation 
suggests that energy might be involved in either the binding 
or the subsequent release of nuclear oestradiol-receptor 
complexes. 
In vitro incubation of- testicular and uterine tissue was 
used as a technique for studying the rate of translocation 
and retention of nuclear oestradiol-receptor complexes in 
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both tissues (appendix paper III). The number of KCl 
extractable receptor sites in testis remained constant 
after 30 min of incubation; the number of non-KCl extract-
able receptor sites decreased continuously after incubation 
periods longer than 30 min. In contrast the number of both 
types of binding sites in the uterine nuclei after an 
initial increase, decreased to 50% of the maximum value 
between 30 and 60 min of incubation. On basis of these 
results it seems very likely that oestradiol-receptor com-
plexes in testis and uterus interact with different acceptor 
sites on the chromatin. 
In chapter 5 the experiments on the subnuclear distribu-
tion of oestradiol-receptor complexes in uterine tissue are 
presented. It was observed that oestradiol-receptor com-
plexes were localized in a transcriptionally active chroma-
tin fraction (euchromatin) and a chromatin which is repressed 
in transcription (heterochromatin). Also in the nucleoplasmic 
fraction oestradiol-receptor complexes could be demonstrated. 
In chapter 6 of this thesis, the resultS obtained in the 
appendix papers and in chapter 5 are discussed in more detail 
and are compared with results presented in the literature. 
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Samenvatting 
De interaktie van steroidhormonen met specifieke recep-
tor eiwitten speelt waarschijnlijk een rol in het tot stand 
komen van steroidhorrnoon effekten. Het steroid-receptor-
komplex dat gevorrnd wordt in het cytoplasma van een eel, 
verhuist naar de kern en heeft een reeks van gebeurtenissen 
tot gevolg, die resulteren in de veranderingen, die toege-
schreven worden aan een bepaald horrnoon. 
In hoofdstuk 2 is een overzicht gegeven van de gebeurte-
nissen die plaats vinden tussen de interaktie van het 
steroid met de receptor en de uiteindelijke veranderingen 
in de eel. 
In hoofdstuk 3 worden de methoden beschreven, die voor 
de bepaling van steroidreceptoren gebruikt zijn. 
De Leydig eel in de testis van de rat bevat een receptor 
eiwit, dat specifiek oestradiol bindt. Om voor dit eiwit 
een mogelijke funktie op te sporen zijn in dit proefschrift 
enkele eigenschappen van deze receptor vergeleken met die 
van de oestradiol receptor in uterus weefsel. In hoofdstuk 4 
worden de experimenten beschreven die de regulatie van cyto-
plasmatische receptoren en kernreceptoren bestuderen. Na 
toediening van oestradiol aan intakte volwassen of jonge 
ratten neemt de hoeveelheid cytoplasmatische receptor in de 
testis binnen 1 uur af. Reeds na 3 uur neemt de hoeveelheid 
receptor weer toe en na 5 uur worden weer kontrole waarden 
gemeten (appendix publikatie I). 
Na hypofysektomie van volwassen ratten blijft de hoeveel-
heid receptor gedurende 10 dagen konstant zowel in totaal 
testisweefsel als in interstitieel weefsel {appendix publi-
katie I). Op grond van deze resultaten is het onwaarschijn-
lijk dat gonadotrofines en steroidhormonen nodig zijn voor 
de handhaving van receptor gehaltes in het cytoplasma. 
De oestradiol receptor kon al aangetoond worden in kern-
frakties gelsoleerd uit de testis van 4 dagen oude ratten. 
Het was niet mogelijk kwantitatieve gegevens te verkrijgen 
voor de hoeveelheid receptor gedurende de ontwikkeling van 
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de rat (appendix publikatie I). 
In appendix publikatie II wordt een methode beschreven, 
waarmee een hoeveelheid kernreceptor gemeten kan worden in 
aanwezigheid van grate hoeveelheden niet-radioaktief oestra-
diol. Met behulp van deze methode, waarbij niet-radioaktief 
steroid uitgewisseld wordt tegen radioaktief steroid, is 
aangetoond, dat in de testis van 25 dagen oude ratten 20% 
van de totale hoeveelheid receptor zich in de kernfraktie 
bevindt (appendix publikatie II). Na toediening van HCG nam 
zowel de totale hoeveelheid receptor als het percentage re-
ceptor dat zich in de kern bevindt aanzienlijk toe. Door 
hypofysektomie verminderde de totale hoeveelheid receptor 
rnolekulen per testis tot 50% van de kontrole waarde. Deze 
receptoren werden alleen in het cytoplasrna en niet in de 
kern aangetroffen (appendix publikatie II). Op grand van 
deze resultaten is het waarschijnlijk dat gonadotrofines en 
oestradiol een rol spelen in de regulering van de hoeveel-
heid en de subcellulaire verdeling van de receptoren tussen 
cytoplasrna en kern van de testis van jonge ratten. 
In hoofdstuk 4 en appendix publikatie III zijn de eigen-
schappen van de oestradiol receptor in testis en uterus met 
elkaar vergeleken. In de kernfraktie van de testis bindt 
oestradiol zich aan twee verschillende receptor eiwitten. 
Deze eiwitten onderscheiden zich van elkaar op grand van hun 
extraheerbaarheid met KCl. Trypsine behandeling van kernen 
heeft een toename van de hoeveelheid KCl extraheerbare recep-
tor tot gevolg. Op sucrose dichtheidsgradienten vertonen de 
oestradiol-receptor komplexen na trypsine behandeling een 
sedimentatiewaarde van 4S. Dit in tegenstelling met de SS 
waarde, die gemeten wordt voor de trypsine behandeling. 
Wanneer testis- en uterusweefsel met oestradiol gelnku-
beerd werden in aanwezigheid van KCN resulteerde dit in een 
toename van de hoeveelheid kernreceptoren, die bestand zijn 
tegen KCl extraktie. Deze waarneming rnaakt het waarschijnlijk 
dat energie een rol speelt in de binding van receptoren in de 
kern of de daaropvolgende verwijdering van receptoren uit de 
kern. 
100 
De snelheid van verplaatsing naar en de verblijftijd van 
receptoren in de kernfraktie van testis en uterus zijn be-
studeerd met behulp van weefselinkubatie (appendix publika-
tie III). De hoeveelheid KCl extraheerbare receptor nam toe 
tot een maximum na 30 min., waarna deze waarde konstant 
bleef. De hoeveelheid receptor die niet met KCl geextraheerd 
wordt bereikte eveneens na 30 min. een maximum, maar nam bij 
langere inkubatieduur sterk af. Tijdens inkubatie van de 
uterus werd voor peide typen kernreceptoren na 30 min. een 
maximumhoeveelheid receptor gemeten. In dit geval had een 
langere inkubatieduur een afname tot 50% van de maximale 
waarden tot gevolg. De verschillen in kinetiek van de kern-
binding rnaken het aannernelijk dat oestradiol-receptor-
komplexen in de kernfrakties van testis en uterus op ver-
schillende wijze worden gebonden. 
In hoofdstuk 5 wordt de verdeling van oestradiol-receptor 
komplexen in verschillende kernfrakties van de uterus be-
schreven. De komplexen werden zowel aangetoond in een chro-
matine fraktie die aktief is in transkriptie (euchromatine) 
als in een fraktie, welke inaktief is (heterochromatine). 
In het nucleoplasma werden eveneens oestradiol-receptor-
komplexen aangetoond. 
In hoofdstuk 6 van dit proefschrift zijn de verkregen 
resultaten besproken in het kader van in de literatuur ver-
schenen waarnemingen. 
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Abbreviations 
ATP 
CBG 
DBG 
DNA 
DNAse 
dpm 
EBG 
ECHTAM 
- adenosine 5'-triphosphate 
- corticoid-binding globulin 
- dihydrotestosterone-binding globulin 
- deoxyribonucleic acid 
- deoxyribonuclease 
- disintegrations per minute 
- estrogen-binding globulin 
- epichlorohydrin-tris(hydroxymethyl)-
aminornethane 
E.coli - Escherichia coli 
E260 - absorbance at 260 nrn; 1 ern light-path 
FSH - follicle stimulating hormone 
g - relative centrifugal force 
h - hour 
HCG - human choriogonadotropin 
Hn-RNA - heterogeneous nuclear RNA 
IP - induced protein 
Ka - association constant 
KRBG - Krebs Ringer bicarbonate glucose 
lac-operon - lactose operon 
LH - luteinizing hormone 
M-l - litres per mole 
(m)M - (rnilli)rnoles per litre 
rnA - milliampere 
mRNA - messenger RNA 
PEG - progesterone-binding globulin 
poly-A - polyadenylic acid 
RNA - ribonucleic acid 
RNAse - ribonuclease 
RNP-particles - ribonucleoprotein particles 
rRNA - ribosomal RNA 
S - Svedberg unit 
SBG - sex steroid-binding globulin 
sec - seconds 
sp.act. - specific activity 
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tl; 
Tris 
tRNA 
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- hc3.lf life time 
- Tris(hydroxymethyl)aminomethane 
- transfer RNA 
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SUMMARY 
After administration of oestradiol-!? j3 to intact mature and immature rats, a decrease in the 
testicular concentration of specific oestradiol-binding sites was observed within 1 h. The 
binding capacity was replenished starting about 3 h after oestradiol administration and after 
5 h the oestrogen receptor level had returned to control values. Exposure of intact animals 
to oestradiol-17 j3 for longer periods (up to 24 h) did not result in an increase of receptor 
levels in testicular cytosol. 
Mature animals which were hypophysectomized for periods of up to 10 days did not show 
a significant change in the number of specific oestradiol-binding sites in either total testicular 
tissue or dissected interstitial tissue. At 15 days or longer periods after hypophysectomy, an 
apparent increase in receptor concentrations in total testicular cytosol was observed due to a 
relative increase in the amount of interstitial tissue. 
A specific oestradiol-binding protein is present in plasma of immature male rats aged less 
than 30 days. This plasma protein could also be demonstrated in the cytosol of testes of 
immature rats. In contrast to the cytosol receptor, which shows a moderate affinity for 
diethylstilboestrol (DES), the plasma protein did not bind DES. The sedimentation values 
of the plasma protein and the oestradiol receptor were 4 Sand 8 S respectively. These differ-
ences in characteristics made it possible to demonstrate the presence of the oestradiol recep-
tor in addition to the binding protein in testicular cytosol of rats from 14 days of age 
onwards. The nuclear receptor for oestradiol-17 j3 could be demonstrated after incubation of 
testicular tissue of rats from 4 days of age onwards. 
INTRODUCTION 
In the course of a study on steroid hormone receptors in testicular tissue we have previously 
demonstrated the presence of a specific oestradiol receptor in the cytosol and nuclear frac-
tions of rat testicular interstitial tissue (Brinkmann, Mulder, Lamers-Stahlhofen, Mechiel-
sen & van der Molen, 1972; Mulder, Brinkmann, Lamers-Stahlhofen & van der Molen, 
1973). This receptor is specific for oestradiol (Ka = 1010 1/mol) and has a negligible affinity 
for androgens (van Beurden-Lamers, Brinkmann, Mulder & van der Molen, 1974). The 
possible physiological meaning of the specific binding of oestradiol by interstitial cells is not 
clear. Studies by de Jong, Hey & van der Molen (1973, 1974) have shown that endogenous 
oestradiol can be demonstrated in testicular (l0- 10 mol /I) and interstitial (0·5-1 x IQ- 9 mol/!) 
tissue. Actions of exogenous oestradiol on testicular DNA, RNA and protein synthesis have 
been reported for Balb/c mice (Samuels, Uchikawa & Huseby, 1967). An effect of oestradiol 
on testosterone concentrations in the circulation of male rats without a concomitant change 
397 
398 
W. DE BOER, E. MULDER AND H. J. VAN DER MOLEN 
in luteinizing hormone (LH) levels, which might imply a direct effect of oestradiol on 
steroidogenesis in testicular tissue, has been observed. (Danutra, Harper, Boyns, Cole, 
Brownsey & Griffiths, 1973; Danutra, Harper & Griffiths, 1973; Chowdhury, Tcholakian 
& Steinberger, 1974; Tcholakian, Chowdhury & Steinberger, 1974). 
It is now widely accepted that steroid hormones exert their effects through an interaction 
with subcellular receptors. After binding of the hormone to cytoplasmic receptors the 
receptor~hormone complex is translocated into the nuclear fraction and becomes bound to 
the chromatin. This interaction between the receptor-hormone complex and the chromatin 
might further regulate gene expression. Thus the hormonal control of target cells could 
depend both on variations in hormone concentrations and on changes in the amount of 
receptor proteins. 
The purpose of the present study was to investigate the testicular concentration of recep-
tor sites for oestradiol-I7;J under various conditions. This included the influence of oestra-
diol-17 ;J administration on the concentration of cytoplasmic receptor sites, the effect of 
gonadotrophins in the regulation of receptor concentrations and the ontogeny of the testi-
cular oestradiol receptor in immature rats. 
MATERIALS AND METHODS 
Materials 
[2, 4, 6, 7- 3H)Oestradiol-l7;J (sp.act. 105 Ci/mmol) was obtained from the Radiochemical 
Centre, Amersham. The radiochemical purity was verified by)hin-layer chromatography. 
Diethy!stilboestrol and oestradiol-17;1 were obtained from Steraloids Inc, Pawling, N.Y., 
U.S.A. 
Preparation of subcellular fractions and incubation procedures 
Mature (3 months old) and immature rats of the R-Amsterdam strain were used. The animals 
were injected with 500 ng (mature animals) or 100 ng (immature animals) oestradiol-17;J 
dissolved in 0·15 M-saline containing 2% ethanol where indicated. For studies in vitro decap-
sulated testicular tissue of immature rats was incubated in 2·0 ml Krebs-Ringer-bicarbonate 
buffer (pH 7·4), containing 0·2% glucose and 2x J0-8 M-(3H]oestradiol-17;J. Incubations 
were carried out at 3ZO C for 60 min in an atmosphere of 95% 0 2 :5% CO~. Inter-
stitial tissue was obtained by wet dissection of decapsulated whole testicular tissue at 0 oc 
.(Christensen & Mason, 1965). The isolated tissue was homogenized in 10 mM-Tris-HCI 
buffer (pH 7·4), (I ml/g tissue) containing 1·5 mM~EDTA and 0·02% NaN3, with three 
strokes of a Potter-Elvehjem homogenizer at 1100 rev./min. The: homogenate was centri-
fuged at 105000 g for 60 min at 0 "C. The 105000 g supernatant (cytosol) was incubated 
with steroids for 16-24 hat 0 °C to reach saturation. For the preparation of nuclei, total 
testicular tissue was homogenized in ice-cold Tris~HCl buffer (pH 7·4), containing 1·5 m\f-
EDTA and 0·02% NaN3 with six strokes of a Potter-Elvehjem homogenizer at 1100 rev./ 
min. The homogenate was centrifuged at 500 g for 10 min at 0 cc. The 500 g pellet was 
washed once with homogenization buffer containing 0·2% Triton X-100 and twice with 
homogenization buffer. A nuclear extract was prepared by extraction of the nuclear fraction 
with 0·4 M-KCl in 10 MM Tris-HCl (pH 8·5), containing 1·5 mM-EDTA and 0·02% NaN3, 
for 60 min at 0 oc, followed by centrifugation at 105000 g for 30 min at 0 "C. 
Measurement of steroid binding 
When cytosol was incubated with oestradiol-17;1 the steroid was bound to specific and non-
specific binding sites. In preliminary experiments it was shown that 2 x 10-8 M-oestradio! 
saturates all specific binding sites. The cytosol was incubated with either [3H]oestradiol-17;J 
Oestradiol receptor in rat testicular tissue 
to determine total binding or [3H]oestradiol-17 jJ plus a 200-fold excess of unlabelled oestra-
diol-17/J to determine non-specific binding (Williams & Gorski, 1973). The amount of 
specifically bound steroid was calculated by subtracting the value for (SH]oestradiol-17/J 
bound in the presence of unlabelled oestradiol-17ft (non-specifically bound oestradiol-17/J) 
from the value for total [3H]oestradiol-17jJ binding. 
The bound and unbound steroid fractions after incubation of cytosol with steroids were 
separated by one of the following techniques. 
Sephadex chromatography 
Sephadex chromatography was performed as described by Williams & Gorski (1973). A 
50 ,ul portion of incubated cytosol was layered on a wlumn (8 x 0·5 em) of Sephadex 
G-25 Superfine grade. The column was eluted with homogenization buffer and the excluded 
volume (bound radioactivity) was collected in a vial and the radioactivity was measured. 
Gradient centrifugation 
After incubation of the cytosol with steroid, 200 ,ul were layered on 5 ml of a 5-20 %sucrose 
density gradient prepared in homogenization buffer. After centrifugation in a Beckman 
L2-65B centrifuge at 0 "C for 16 hat 150000 g,v in a SW65 rotor, the bottom of the tube 
was pierced and 30 fractions were collected. Radioactivity was measured in each fraction. 
Nuclear extracts were layered on 5 ml of a 5-20% sucrose density gradient prepared in 
extraction buffer and run for 18 hat 260000 gav· Bovine serum albumin (BSA) and alcohol 
dehydrogenase (ADH) were used as markers with sedimentation values of 4·3 S and 7·6 S 
respectively. 
Agar-gel electrophoresis 
Agar-gel electrophoresis was performed essentially as described by Wagner (1972). A 50 ttl 
portion of incubated cytosol was applied on an agar plate (100 x 85 x 5 mm thick) kept at 
0 oc (agar Noble; Difco, Detroit, Michigan, U.S.A.). After electrophoresis for 90 min at 
130 rnA per plate (200-250 V) at 0 oc, the plate was cut into ten strips, each containing one 
sample, and each strip was divided into 20 fractions of 4 mm. To count the radioactivity, 
steroid from the individual agar fractions was dissolved by shaking for 12 hat room tem-
perature in 10 ml Triton/scintillation fluid mixture. 
Pretreatment with charcoal 
Excess unbound steroid was in some experiments removed by adding 0·5 mg dextran-coated 
charcoal to 200 pl incubated cytosol. After mixing, the suspensions were incubated for 15 
min at 0 oc and charcoal was removed by centrifugation for 10 min at 1200 g. 
Protein determination 
The protein content of the isolated cytosols was determined by the method of Lowry, 
Rosebrough, Farr & Randall (1951) with bovine serum albumin as standard. Generally 
the cytosol of mature rat testis contained 20-25 mg/ml and immature rat testicular cytosol 
contained 5-15 mg/mL 
Estimation of oestradio!-17 P 
Oestradio\-17 jJ was measured by a radioimmunoassay technique as described by de Jong 
eta/. (1974). 
Measurement of radioactivity 
Radioactivity was measured in a Packard model3375 liquid scintillation spectrometer. The 
scintillation fluid consisted of a mixture of Triton X-100 (Rohm and Haas, Philadelphia, 
U.S.A.) and toluene (1 :2, v/v) containing 0·1 g POPOP (1,4-bis-(5-phenyloxazo\-2-y\) 
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benzene)/! and 4·8 g PPO (2,5~diphenyloxazole)/l (Packard Instrument S.A. Benelux, 
Brussels, Belgium). 
RESULTS 
Effects of exogenous oestradiol~ 17 fJ on cytoplasmic receptor levels 
Receptor concentrations were estimated by Sephadex chromatography and sucrose gradient 
centrifugation. With both these techniques specific steroid binding is estimated by subtract~ 
ing the radioactivity bound in the presence of the competing non~radioactive oestradiol from 
the radioactivity retained in the absence of the competing steroid. It has previously been 
shown that these two methods give similar results (van Beurden-Lamers eta/. 1974) which 
are also in good agreement with the results estimated using a Scatchard-type plot obtained 
by charcoal assay (Brinkmann eta!. 1972). 
Mature rats received a single injection of 500 ng oestradiol-17,8. One and 3 h after injec-
tion, the values obtained were significantly lower than the control levels, but levels 5 and 24 h 
after injection of oestradiol- I? ft were similar to those of the control (Fig. 1 a). 
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Fig. 1. Effect of oestradiol-17# on cytoplasmic receptor concentration. Rats were exposed to a 
single dose of oestradiol-17/l for various periods. Testicular cytosol was incubated for 24 hat 0 °C 
with 2 x IO-' M-["H]oestradiol-17(1 or with 2 x IQ-• M-["H]oestradiol-17(1 in the presence of 4 x IQ-1 
M·oestradiol-17(1. After incubation, binding was determined by Sephadex G-25 chromatcgraphy and 
sucrose density gradient centrifugation. Specific binding is expressed as a percentage of control 
values ±s.n. for rats not injected with oestradiol-17(1 (n = 4). (a) Injection of mature rats with 500 
ng oestradiol-17(1. (b) Injection of immature rats with 100 ng oestradiol·17(l. 
Immature rats (23 days) were injected with 100 ng oestradiol-17fi'. Within 1 h after oestra-
diol administration, receptor levels decreased significantly; levels similar to those of the 
control were observed again at 5 and 24 h after hormone injection (Fig. I b). 
Binding of [3H]oestradiol to cytoplasmic receptor molecules was measured after incuba-
tion at 0 oc. At this temperature only free receptor sites are estimated. Receptor sites which 
were already occupied by unlabelled oestradiol remain unaffected due to the slow dissocia-
tion of the receptor-hormone complex at 0 °C. From other data (van Beurden·Lamers eta!. 
Oestradiol receptor in rat testicular tissue 
1974; de Jong eta/. 1974) it has been calculated that in the order of 10% of the available 
receptor sites in testicular cytosol of untreated rats are maximally occupied by endogenous 
oestradiol. To measure the total amount of cytoplasmic receptor sites at various times after 
hormone injection mature and immature animals were injected with 500 and 100 ng [3H] 
oestradiol respectively. The specific activity of the injected steroid (105 Ci/mmol) is not 
influenced by the endogenous amount of oestradiol present in rat testicular tissue, because 
this amount is negligible compared with the amount of injected steroid. Testicular cytosols 
were isolated and incubated with [3H]oestradiol of the same specific activity as that used for 
injection. During this incubation process only free receptor sites are labelled, any receptor 
sites already labelled in vil•o and still present in the isolated cytosol would remain occupied. 
The amount of specifically bound hormone in the cytosol estimated after incubation in vitro 
was similar after injection of unlabelled oestradiol or after injection of [3H]oestradiol. This 
may reflect the fact that the receptor sites which are present in the cytoplasm at any time 
after oestradiol injection are all available for the binding of [3H]oestradiol in the subsequent 
incubation procedure. In previous studies the presence of specific nuclear receptors for 
oestradiol was demonstrated in interstitial tissue (Mulder eta!. 1973). Therefore it seems 
very likely that the observed decrease in cytosol receptor concentrations is a result of the 
translocation of receptor~hormone complexes into the nuclei. 
At various times after injection of 500 ng oestradiol-17,8 into mature rats, oestradiol-17,8 
concentrations in plasma were measured (Fig. 2). One hour after injecting the oestradiol-17,8 
the concentration was raised while 3, 5 and 24 h after administration plasma concentrations 
of oestradiol-17,8 did not differ significantly from the control values measured before ad-
ministration. 
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Fig. 2. Concentration of oestradiol-17P in rat plasma at various times after s.c. injection of 500 ng 
oestradiol-17P. After collection of plasma the concentration of oestradiol·17P was estimated. 
Results are means±s.o. (n = 3). 
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Effect of hypophysectomy on cytoplasmic receptor levels 
At various times after hypophysectomy receptor concentrations in total testicular tissue and 
interstitial tissue were determined. Up to 15 days after hypophysectomy no change could be 
observed in oestradiol receptor concentration in total testicular tissue (Fig. 3). Similar 
results were obtained for cytosol receptor concentrations in dissected interstitial tissue 
isolated from rats l-10 days after hypophysectomy. For periods longer than 15 days after 
hypophysectomy an increase in receptor concentrations in total testicular tissue was ob~ 
served (Fig. 3.). 
40 
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Fig. 3. Effect of duration of hypophysectomy on oestradiol-binding capacity in rat testicular cyto~ 
sol. Testicular cytosol was incubated for 16 h at 0 °C with either 2 x 10-• M-(lH]oestradiol-17,8 or 
2 X IQ-• M-[ 3H]oestradiol-17,8 in the presence of 4 X lQ-7 M-oestradiol-17,8. After incubation binding 
was determined by Sephadex G-25 chromatography. Each point represents the mean ( ± s.o.) of four 
different animals. Value at day 38 is the mean of two estimations. 
Oestradiol binding sites in plasma and testicular cytosol of immature rats 
Plasma of immature rats 4--35 days old was incubated with either pH]oestradiol-17,8 or 
PH]oestradiol-17,8 in the presence of a 200-fold excess of non-radioactive oestradiol-17,8. 
Specific binding was determined using agar-gel electrophoresis (Table I) or sucrose density 
gradient centrifugation (Fig. 4a). High levels of a specific oestradiol-binding protein with a 
sedimentation value of 4S were demonstrated immediately after birth while decreasing levels 
were measured during the onset of pubescence. No specific binding could be demonstrated 
in plasma of 30-day-old rats. 
When testicular cytoplasm of 20-day-old rats was incubated with [3H)oestradiol-17 fJ and 
analysed for binding using sucrose density gradients at low ionic strength two binding pro-
teins with different sedimentation values of 8 and 4S respectively could be demonstrated 
(Fig. 4b). Binding of [3H]oestradiol-17 ,8 to the 8 S component was blocked by DES and by 
oestradiol-17,8 whereas DES did not affect the 4S binding (Fig. 4b). Thus it is possible to 
distinguish between the cytoplasmic oestradiol receptor and the plasma binding protein 
using the differences in sedimentation value and in binding affinity for DES. After incubation 
Oestradiol receptor in rat testicular tissue 
Table I. Effect of age on the presence of oestradiol-17jl-binding sites in testicular cytosol and 
plasma of immature rats 
(Testicular cytosol and I :50 diluted plasma were incubated for 24 hat 0 °C either with 2x IQ- 9 
M-["H]oestradiol-17,8 or with 2 x 10-• M-['H]oestradiol-17,8 in the presence of 4 x IO-' M-diethyl-
stilboestrol. After incubation, cytosol samples were applied to sucrose density gradients and run for 
16 hat 150000 g.v in a SW 65 rotor. Specific binding in plasma samples was determined using 
agar-gel electrophoresis. In column II binding in plasma is given. In column Ill the range of the 
measured values in the cytosol is given, n.d. means that 8 S binding macromolecules were not detec-
table. For comparison the total amount of oestradiol-17,8-binding protein in cytosol is given in 
column IV. The results represent the mean of 2 to 3 experiments.) 
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Fig. 4. Oestradiol-binding proteins in plasma and testicular cytosol of 20-day-old rats. Testicular 
cytosol and l :50 diluted plasma were incubated with 2x to-• M-PH]oestradiol-17,8 (solid line), 
with 2 x 10-• M-["H]oestradiol-l7ji plus 4 x 10-' M-diethylstilboestrol (broken line), or with ["H]-
oestradiol-17;3 plus 4 x JO·' M-oestradiol-17,8 (dotted line). After incubation at 0 °C for 24 h and 
removal of unbound steroids with charcoal, samples were applied 10 sucrose density gradients. 
Plasma samples (Fig. 4a) were run for 18 hat 260000 g,.,.; cytosol samples {Fig. 4b) for 16 hat 
150000 g",. in a SW65 rotor. Fractions were collected from the bottom of the tube. The arrows 
indicate the positions of bovine serum albumin (BSA) (4·3 S) and alcohol dehydrogenase (ADH) 
(7·6 S). 
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of testicular cytosol from immature rats with (3H]oestradiol-17P in the presence of a 200-
fold excess of DES the 8 S receptor for oestradiol-17 P could be demonstrated for rats from 
the age of 14 days onwards (Table I). The last column of Table l represents the specific 
binding of f3H]oestradiol-17 P to both the cytoplasmic receptor and the 4S binding protein 
in the testicular cytosol of immature rats as determined by agar-gel electrophoresis. 
To investigate the presence of testicular oestradiol receptors in rats younger than 14 days, 
total testicular tissue was incubated with (3H]oestradiol-17P or (3HJoestradiol-17;J' in the 
presence of a 200-fold excess DES. In the nuclear extract prepared from testicular tissue of 
rats from 4 days of age onwards a specific binding peak for [3H]oestradiol-17 P was found 
(Fig. 5). 
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Fig. 5. Nuclear oestradiol-binding proteins from testicular tissue of immature rats. Total testis 
tissue was incubated for 60 min with either 2 x 10-~ M-["H]oestradioi-17/J or with 2x 10-s M[~H]­
oestradiol-17/1 plus 4 x w-• M-diethylstilboestrol. Nuclei and nuclear extract were prepared as des-
cribed in Materials and Methods. Nuclear elttracts (200;d) were applied to sucrose density gradients 
containing0·4 M-KCl and run for 18 hat 260000gav in a SW65 rotor. Values are corrected for non-
specific binding. The protein concentrations of the nuclear extracts were 2·7, 2·0 and 3·2 mg/ml for 
4 (solid line), 7 (broken line) and 10 (dotted line) day-old-rats respectively. The arrow indicates 
the position of bovine serum albumin (BSA) (4·3 S). 
DISCUSSION 
There is no general concept about the regulation of steroid hormone receptor concentrations. 
For rat prostate it has been shown that after castration the amount of cytoplasmic receptor 
for dihydrotestosterone decreased to undetectable levels (Jung & Baulieu, 1971; Mainwaring 
& Mangan, 1973; Sullivan & Strott, 1973; Bruchov'sky & Craven, 1975), but after longer 
periods of castration almost complete restoration of receptor levels was observed (Sulliv<in 
& Strott, 1973). In guinea-pig uterus, administration of oestradiol-17;1 results in an enhance-
ment of cytoplasmic receptor levels for progesterone while administration of progesterone 
itself causes a decrease of receptor levels (Milgram, Thi, Atger & Baulieu, 1973; Freifeld, 
Feil & Bardin, 1974). Treatment of immature rats with oestradiol-17 p results in an increase 
Oestradiol receptor in rat testicular tissue 
in the level of uterine receptors for oestradiol-17jJ (Sarff & Gorski, 1971). The present data 
indicate that administration of lOO and 500 ng unlabelled oestradiol-l7jJ to immature and 
mature rats respectively caused a rapid decrease of oestradiol-17jJ receptor sites available in 
testicular cytoplasm (Fig. 1). The time-course of the disappearance and reappearance of 
cytoplasmic receptor sites after oestradiol-l7jJ administration closely parallels the entry of 
oestradiol into and its removal from the blood circulation. Injection of [3H]oestradiol-17jJ 
and the subsequent incubation of cytosol with [3H]oestradiol-17jJ at ooc resulted in a 
similar decrease of receptor levels as measured after injection of unlabelled oestradiol-17jJ. 
Therefore the observed decrease in the amount of specifically bound radioactivity must be 
the result of the disappearance of receptor molecules from the cytoplasm. Previously the 
existence of a nuclear form of oestradiol-17 jJ receptor in interstitial tissue has been demon-
strated (Mulder et a!. 1973). For uterine tissue Williams & Gorski (1972) observed an 
equilibrium between the concentration of receptor-bound steroid in the cytosol and recep-
tor-bound steroid in the nuclei. Therefore the observed changes in testicular receptor con-
centration after hormone injection may also reflect the translocation process of hormone 
molecules into the nuclei. A comparison of the processes of nuclear translocation and 
cytoplasmic restoration of receptor molecules between testicular tissue and other oestrogen-
sensitive tissues shows several differences. In uterine tissue of immature rats the lowest 
cytoplasmic receptor levels have been measured 3~6 h after administration of I OOng oestradiol-
17jJ (Sarff & Gorski, 1971; Cidlowski & Muldoon, 1974). Control levels were reached only 
after 12 h (Sarff & Gorski, 1971). Administration of I pg oestradiol-17jJ to adult female 
rats resulted in a maximal depletion of cytoplasmic receptor molecules in pituitary, hypotha· 
lam us and uterus within 1 h. The reappearance of receptor molecules in uterine tissue and 
pituitary occurred at 15 h after injection reaching levels slightly below those of the control. 
In the hypothalamus, however, a plateau (60% of the control value) was reached 5 h after 
injection. In addition an enhancement of cytoplasmic receptor concentrations, as observed 
in uterine tissue 24 h after oestradiol administration, was not observed in testicular tissue. 
Thus testicular tissue belongs to the group of tissues which in response to oestradiol adminis-
tration shows a depletion and subsequent reappearance of cytosol receptor molecules. The 
magnitude and the rate of both processes seems to vary among various tissues. 
Six to 12 days after hypophysectomy in rats, plasma levels of gonadotrophins and testi-
cular levels of oestradiol-17 jJ and testosterone are decreased (Gay & Sheth, 1972; de Jong, 
1974). In the present experiments cytoplasmic levels of oestradiol-17jJ receptor were not 
affected after hypophysectomy. The initial decrease in oestradiol concentration in testicular 
tissue after hypophysectomy might have resulted in a proportional increase in unoccupied 
and therefore measurable receptor sites. A constant amount of measurable receptor sites 
might therefore accompany a decrease in the total receptor concentration (unoccupied and 
occupied sites) during the first days after hypophysectomy. It has been calculated, however, 
that only in the order of 10% of the total receptor sites in testicular cytosol of intact rats 
can be maximally occupied by endogenous oestradiol-l7jJ (van Beurden-Lamers et a!. 
1974; de Jong eta!. 1974). Therefore it appears very unlikely that gonadotrophins, oestra-
diol-17 jJ and testosterone are important for the maintenance of the concentration of oestra-
diol-17.8 receptors in testicular cytoplasm. The increase in receptor sites which is found at 
15 days or longer periods after hypophysectomy is an apparent increase, reflecting the 
relative increase in the amount of interstitial tissue. 
Testicular cytosol of immature rats older than 14 days contained two binding proteins for 
oestradiol-17jJ with sedimentation values of 4S and 8S respectively (Fig. 4). This is similar 
to the observations for oestradiol-17jJ binding by uterine cytosols of immature rats (Michel, 
Jung & Baulieu, 1974; Somjen, Kaye & Lindner, 1974). The binding capacity of plasma of 
immature male rats for oestradiol-17jJ showed a decrease of more than two orders of 
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magnitude between birth and puberty, which paralleled the decrease in 4 S oestradiol~l7 ;J~ 
binding protein in testicular cytoplasm. It is therefore very likely that the oestradiol-17 jJ-
binding plasma protein is_responsible for (part of) the 4 S oestradiol-17;1 binding found in 
the testicular cytoplasm of immature rats. This suggestion is supported by the similar 
behaviour of both the plasma component and the 4 S testicular cytosol component towards 
diethylstilboestrol. 
The very large concentration of 4 S oestradiol-17 ;J binding protein in testicular tissue 
made the quantitative measurement of receptor concentrations less accurate. Therefore small 
amounts of oestradiol-17 ;J receptor molecules, even if present in the testicular cytosol of rats 
younger than 14 days, might have escaped detection. However, the nuclear form of the 
testicular oestradiol-! 7fl receptor could be demonstrated in rats from 4 days of age onwards. 
Similar observations have been made for other receptors both for gonadal and adrenal 
steroids. The hepatic receptor for glucocorticoids could be demonstrated in liver cytosol of 
foetuses and immature rats (Feldman, 1974). The epididymal androgen receptor has been 
detected in 20-day-old rats (Calandra, Podesta, Rivarola & Blaquier, 1974) and the pres-
ence of oestradiol-17 fl-binding proteins with a sedimentation value of 8 S has been demon-
strated in uteri of 5-day-old rats (Michel eta!. 1974). 
The physiological meaning of the testicular oestradiol-17 fl receptor is not yet clear. It has 
been reported that administration of oestradiol benzoate (50 f.l8) to adult male rats results in 
a rapid decrease in testicular testosterone levels within 2 h without changes in LH levels in 
the circulation (Tcholakian eta!. 1974). The present results showed that injection of oestra-
diol-17ft into mature and immature rats caused a rapid decrease in testicular receptor levels 
in the cytoplasm. Therefore a possible direct inhibiting effect of oestradiol-17 ,8 on testoster-
one synthesis could be mediated by the binding of oestradiol-17 ;J to the cytoplasmic receptor 
and the subsequent binding of the receptor-hormone complex to the chromatin. Whether 
the endogenous concentration of oestradiol-17fl in mature rats is high enough to exert the 
same regulatory effect on testosterone synthesis is unknown. The presence of very large 
amounts of oestradiol-17 fl-binding protein in immature rat plasma which decreased during 
the onset of pubescence might be sufficiently high to trap all the endogenous oestrogen. This 
would indicate that the suggested regulatory role of oestrogens on steroid biosynthesis in 
testicular tissue can only be important if the oestradiol-17ft binding in testicular cytosol 
exceeds the binding in plasma. 
This work was supported (in part) by the Foundation for Medical Research FUNGO, 
which is subsidized by the Netherlands Organization for the Advancement of Pure Research 
(Z.W.O.). 
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1. An [3H]oestradiol-exchange method was developed for the determination of oestradiol-
receptor complexes in the nuclear fraction of immature rat testicular tissue. This method 
permits the determination of nuclear oestradiol-receptor sites in the presence of a 
relatively large amount of non-specific oestradiol binding present in testicular nuclei. 
After incubation of nuclei for 60min at 20°C in the presence of [3H]oestradiol with or 
without a 1000-fold excess of non-radioactive diethylstilboestrol, specific binding can be 
determined quantitatively in the KCl-extractable fraction, which contains 40% of the 
total receptor population. 2. The amount of receptor-bound steroid present in the 
0.4M-KCI extract of testicular nuclei remained constant during incubation at 20"C. For 
uterine nuclei incubated with [3H]oestradiol at 37°C a shift of specifically bound 
[3H]oestradiol occurred from the KCI-soluble fraction to the KCI-insoluble fraction. 
3. In intact rat testis, about 20% of the total receptor concentration was present in its 
nuclear form. Hypophysectomy 5 days before measurement resulted in a twofold decrease 
in the amount of receptor, which was present mainly in the cytosol. After injection of 
choriogonadotropin to intact animals, the total receptor concentration increased 
threefold. 4. This nuclear exchange method might be useful for determination of occupied 
specific receptor sites in tissues with relatively low contents of specific receptors. 
Investigations of a biochemicai explanation for 
the mechanism of action cfsteroids have revealed the 
presence of specific n:ceptors for steroid hormones in 
target tissues. For uterine tissue it is well documented 
that oestradiol-receptor complexes migrate into the 
nucleus, bind to receptor sites on the chromatin and 
initiate a sequence of events which result in the hor-
mone effect (Clark et al., 1973; O'Malley & Means, 
1975). The in~erstitial tissue of the testis from rats of 
4 days of age onwards contains a specific receptor for 
oestradiol (Brinkmann et al., 1972; Mulder et at., 
1973; de Boer eta!., 1976). Oestradiol is endogenously 
produced in the testis and it appears that oestradiol 
concentrations in rat testis interstitial tissue (0.5-
1 nM) are higher than those in seminiferous tubules 
(de Jong eta!., 1974), but it is still uncertain whether 
oestradiol has a physiological function in testicular 
tissue. The well-known decrease in testicular testo-
sterone production after administration of oestradiol 
could be fully explained by a negative feedback of 
oestrogens on Jutropin (luteinizing hormone) secre-
tion (W. M. 0. van Beurden-Lamers, unpub!ished 
work), although it has been suggested that oestradiol 
might have a local intratesticulareffect on testosterone 
production. 
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Possible direct effects of oestradiol mediated by the 
oestradiol receptor on Leydig-cell functions have 
not been studied in detail. On the assumption that an 
effect of steroid hormones is preceded by binding of 
the steroid-receptor complex in the nucleus, it was 
the purpose of the present study to investigate a pos-
sible translocation of the oestradiol receptor into the 
nucleus of testicular tissue of intact animals. In addi-
tion, the effects of oestradiol and administration of 
choriogonadotropin on the concentration and 
localization of the receptor were studied. 
For a quantitative determination of nuclear 
receptor sites in intact animals it is necessary to use a 
method that can distinguish between the total avail-
able amount of receptor sites and the number of 
receptor sites that is occupied by endogenous oestra-
diol. Anderson et at. (1972) have developed an [3H]-
oestradiol-exchange method for determination of the 
number of nuclear oestradi0J-receptor sites in the 
331 
presence of endogenous oestradiol. Because a 
considerable amount of non-specific oestradiol-bind-
ing sites was observed in testicular tissue, it was 
necessary to modify this nuclear exchange method. 
We have therefore compared this modified hormone-
exchange assay for determination of nuclear oestra-
diol receptors in testicular tissue with the assay 
described by Anderson eta!. (1972) for uterine tissue. 
Materials and Methods 
Preparations of animals and materials 
Immature male and female rats (21~3S-days-old) of 
the R-Amsterdam strain were used in this study. In 
some experiments animals were hypophysectomized 
S days before the experiments. Male rats were injected 
subcutaneously with a solution of either SOOng of 
oestradiol-17ft or SOOng of [3H]oestradiol-17P in 
0.2ml ofO.lSM-NaCl containing 2.S% (v/v) ethanol. 
The rats were decapitated lh after the injection. In 
experiments designed to examine the effect of human 
choriogonadotropin, a daily dose of SOi.u. of the 
hormone (WHO, 197S), dissolved in 0.1 m! of 
O.lSM-NaCI, was subcutaneously injected for 5 
successive days. Testicular tissue was removed after 
decapitation of the animals and placed on a Petri 
dish on ice before incubation or isolation of nuclei. 
[2,4,6,7-3HJ0estradiol-17 P (sp. radioactivity 85Ci/ 
mmol) was obtained from The Radiochemical Centre, 
Amersham, Bucks., U.K., and was examined for 
purity by t.l.c. Diethylstilboestrol and oestradiol-17 P 
were obtained from Steraloids Inc., Pawling, NY, 
U.S.A. 
Incubation of whole tissues in vitro 
One decapsulated testis or one uterus, stripped of 
adhering fat and mesentery, from immature rats was 
incubated with lOnM-oestradiol in 2.0ml of Krebs~ 
Ringer bicarbonate buffer, pH7.4, containing 0.2% 
glucose (Umbreit et al., 1964). Incubations were 
carried out in an atmosphere of Ol+C02 (95:5) for 
60min at 32"C for testicular tissue and at 37"C for 
uterine tissue. In control studies tissues were incu-
bated with either t0nM-(3H]oestradiol or 10nM-
[3H]oestradiol plus lO.uM-diethylstilboestrol. 
Uterine and testicular tissue of immature rats con~ 
tains, in addition to the receptor, a plasma binding 
protein (oc-fetoprotein), which has a rather high affin-
ity for oestrogens (Raynaud et a!., 1971; Aussel 
eta!., 1974; de Boer eta!., 1976). However, oestradiol 
bound to the plasma protein cannot be displaced by 
an excess of diethylstilboestrol. Therefore excess of 
diethylstilboestrol rather than oestradiol was used in 
incubations where the non-specific binding was 
estimated. The specific oestradiol binding to receptor 
molecules was then defined as the difference between 
the total binding and the non-specific binding and is 
expressed as fmol/mg of protein or as fmol/two testes 
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or fmol/uterus. Previously it has been shown that the 
affinity of diethylstilboestrol for the testicular 
oestradiol receptor is one-quarter of the affinity of 
oestradiol (van Beurden-Lamers et a!., 1974). The 
amount of non-specific binding, obtained after incu-
bation of mature rat testis and uterus in vitro, tissues 
that do not contain a-fetoprotein or other specific 
oestradiol-binding plasma proteins, did not differ if 
a 100-foldexcess of oestradiol or a 1000-foldexcess of 
diethylstilboestrol was used. 
Preparations of nuclei 
After isolation and incubation the testicular tissue 
was homogenized in 10 vo!. of 10 mM-Tris/HCl buffer, 
pH7.4, containing 1.5mM-EDTA and 0.02% NaN3 
(TEN buffer) with six strokes of a Porter~Eivehjem 
homogenizer at 1 JOOrev.jmin. The homogenate was 
rehomogenized in an all-glass Potter~Elvehjem homo-
genizer and centrifuged at 500g for IOmin at O"C. 
The 500g pellet was washed once with 3 ml ofTEN 
buffer, twice with 3ml of TEN buffer containing 
0.2% Triton X-100 and another time with 3m! of 
TEN buffer. Uterine tissue after incubation was 
suspended in 3m! ofTEN buffer and homogenized by 
hand with two strokes in an all-glass Kontes homo-
genizer. The homogenate was centrifuged at 800g 
for lOmin at 0°C and the pellet was washed three 
times with 3m! of TEN buffer. The resulting nuclear 
pellets were used either for the hormone-exchange 
assay of the nuclear oestradiol-binding sites or for 
immediate extraction with 0.4M-KCL 
Hormone-binding assay 
(a) Determination of nuclear binding, after incuba-
tion or injection with [3H]oestradiol. Isolated nuclei 
were extracted with 0.4M-KCl in TEN buffer, pH 8.5, 
during 60min at O?C. The extract was centrifuged at 
O"C for lOmin at 1500g, and a KC!-extractab!e and a 
residual nuclear fraction were obtained as the super-
natant and pellet fractions. The bound radioactivity 
in the KCJ-extractable fraction was measured by 
sucrose-density-gradient centrifugation. The residual 
nuclear fraction was dissolved in 1 ml of I M-NaOH, 
and 100 .ul was counted for radioactivity after addition 
of 50.ul of 3 M-HCIO~. 
(b) Hormone-exchange assay followed by KC! ex-
traction of nuclei. Isolated nuclei were incubated in 
TEN buffer containing25% (v/v) glycerol for periods 
up to 120min at different temperatures with either 
I0nM-[3Hjoestradiol or 10nM-[3H]oestradiol plus 
lO.uM-diethylstilbo{-strol. After the incubation, nuclei 
were extracted as described under (a). To remove the 
excess of unbound steroid, the nuclear suspension in 
0.4M-KC! was treated for lOmin with dextran-coated 
charcoal (final concentrations: 0.5% charcoal and 
0.05% dextran T 300) at ooc and was subsequently 
centrifuged for 30minat l05000g,v. in a SW 65 rotor 
to remove the charcoaL Specific binding in the super~ 
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natant fraction was measured by using sucrose-
density-gradient centrifugation. In this assay system 
the radioactivity in the residual nuclear fraction could 
not be measured, owing to the sedimentation of 
charcoal in this fraction. 
(c) Hormone-exchange assay technique (Anderson 
et af., 1972). Isolated nuclei were incubated as 
described under (h). After the incubation, nuclei were 
washed twice with TEN buffer and were immediately 
extracted with 3m! of ethanol. The ethanol extract 
was removed for assay of the amount of radio-
activity. 
Sucrose-density-gradient centrifugation 
A 200~300 .ul portion of the KCl-extractable nuclear 
fraction was layered on top of a linear 5-20% (w/v) 
sucrose gradient prepared in TEN buffer, pH8.5, 
containing 0.4M-KCI. The gradients were centri-
fuged at 260000g~v. for ISh at 0°C in a Beckman 
SW 65 rotor. On separate gradients bovine serum 
albumin (200,ug) was run as a sedimentation marker 
(4.6S). After centrifugation, each gradient was frac-
tionated into 27 fractions of0.2ml, and each fraction 
was assayed for radioactivity. The amount of 
specifically bound [3H]oestradiol was determined as 
the difference between the amount of radioactivity 
sedimenting in the 5S region of the incubations with 
10n~-[3H]oestradiol and with 10nM-[3H]oestradiol 
plus lOpM-diethylstilboestrol respectively as de-
scribed for whole tissue (see also Fig. 1). 
General procedures 
Protein was determined by the procedure of Lowry 
eta!. (1951), with bovineserumalbuminasastandard. 
Radioactivity was measured in a Packard model3375 
liquid-scintillation spectrometer. The scintillation 
fluid consisted of a mixture of Triton X-100 (Rohm 
and Haas, Philadelphia, PA, U.S.A.) and toluene 
(l :2, v/v) containing 0.1 g of PO POP [1 ,4-bis-
(5-phenyloxazol-2-ylbenzene] and 4.Sg of PPO 
(2,5-diphenyloxazole )/litre (Packard Instrument S.A., 
Benelux, Brussels, Belgium). 
Results 
Exchange assay of nuclear binding sites for oestradiol 
li1 testiwlar and uterine tissue by using ethanol extrac· 
lion 
Initially we attempted to measure nuclear binding 
of oestradiol in testicular and uterine tissue using the 
method of Anderson et al. (1972) as described in the 
Materials and Methods section. Table 1 shows that 
for uterine tissue 74% of the total amount of steroid 
in the nuclear sample was due to specifically bound 
steroid. This amount is in close agreement with the 
amount of specifically bound steroid observed in 
experiments where the specifically bound steroid was 
measured after incubation of uterine tissue with 
radioactive steroid and immediate extraction of iso-
+&ed nuclei. 
In testicular tissue after exchange at 20°C, as well 
as at 32°C, only a small percentage of the steroid 
appeared to be specifically bound. Consequently 
unreliable data with a large s.D. were obtained for the 
amount of specific binding sites in testicular tissue. In 
control nuclei obtained from testicular tissue, 
directly labelled in vitro with radioactive oestradiol 
without nuclear exchange, the non-specifically bound 
oestradiol represents only 30% of the total amount of 
bound oestradiol. In this case an accurate estimate of 
specific binding by ethanol extraction is possible. 
Determination of specific oestradiol binding in KCl 
extracts of nuclei after nuclear exchange 
The relative amount of non-specifically adsorbed 
steroid on testicular nuclei could be lowered by extrac-
tion of nuclei with 0.4M-KCI and removal of excess of 
free steroid by charcoal adsorption as described in 
the Materials and Methods section. Specific binding 
in the KCI extract was measured by sucrose-gradient 
Table 1. Exr:hange assay of nuclear binding sites/or oes/radiol in testicular and uterine tissue 
Uterine tissue was incubated for 60min at 3TC with 20nM-oestradiol. Isolated nuclei were incubated for 60minat3TC 
with either lOnM·['H]ocstradiol or 10nM-[3H]oestradiol plus 10ttM-diethylstilboestrol. Testicular tissue was incubated 
for 60min at 32"C with JOnM-oestradiol.lsolated nuclei were incubated for 60min at 20"C or 32oC with either J0m1-
[3H]oestradiol or 10n"1-[3 H]oestradiol plus 10tt).1·diethylstilboestrol. Incubated uterine and testicular nuclei were 
washed twice with TEN buffer and extracted with 3 ml of ethanol. Uterine and testicular nuclei, obtained after incubation 
of tissues with either [3H]oestradiol or [3H]oestradiol plus diethylstilboestrol, were extracted immediately after isolation 
and were used as a control. Results are given in fmol of [3 H]oestradiol bound per uterus or per two testes±s.o. for the 
nl1mbers of experiments shown in parentheses. 
Assay conditions Total binding Non-specific binding Specific binding 
Uterus Exchange at 37'C 1011 ± 323 (5) 263±59 (5) 748±267 (5) 
Control 1089±200(3) 68± 6 (3) 1021±195{3) 
Testis Exchange at 20"C 2011± 98 (5) 1932± 64 (5) 79± 36 {5) 
Exchange at 32"C 1891± 50(4) 1763±80(4) 126± 82 (4) 
Control 92± 11 (3) 30± 5(3) 62± 6 (3) 
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Fig. l. Binding of [3 H]oestradiol in rhe KC!-exrractab{e 
fraction of testicular nuclei 
Testicular tissue was incubated for 60min at 32'C 
with either lOnM-eHJoestradiol (0) or lOnM-[31-J]-
oestradiol plus lOpM-diethylstilboestrol (o). Nuclei 
were isolated and extracted as described in the 
Materials and Methods section. A 200111 portion of 
the nuclear extracts was centrifuged on sucrose 
gradients for ISh at 260000g,,._. Specific binding of 
oestradiol in the KCI extract was estimated by calcu-
lating the difference in radioactive steroid sedimcnting 
in the 55 region of the gradient in the presence and in 
the absence of the excess of competing steroid. The 
arrow indicates the position of bovine serum albumin 
(4.65) run in a separate gradient. 
centrifugation (Fig. 1). The amount of specifically 
bouod steroid recovered in the KCI-extractable frJ.c-
tion represents 39±9% (s.D.) (11 =G) from the total 
amount of specific nuclear binding as determined by 
ethanol extraction (Table 1, line 5). To determine the 
amount of binding sites in the KCl extract, an almost 
complete exchange should be obtained at a tempera-
ture where no appreciable decomposition of binding 
sites occurs. The effect of different incubation 
temperatures on the stability of nuclear oestmdiol 
binding is shown in Fig. 2. In the absence of excess of 
[~H]oestradiol in the incubation medium, specific 
binding in both the KC1-extractable and residual 
nuclear fraction decreases considerably during 1 h 
of incubation (Fig. 2a). In the presence of oestradiol, 
dissociation of binding sites in the KCI-extractable 
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fraction at 20°C was less than 5% (Fig. 2b). Dissocia-
tion of the binding sites in the residual nuclear frac-
tion in the presence of added 3H-labelled steroid 
could not be measured, owing to the large amount 
of free and non-specifically bound oestradiol present 
in this fraction. For uterine tissue both the KCI-
extractable and the non-KCJ-extractable nuclear 
receptors (pellet) could be measured, because in con-
trast with testicular nuclei, it was possible to remove 
excess of unbound steroid by washing the uterine 
nuclei. In the presence of added [3H]oestradiol, a 
loss of binding sites in the KCI-extractable fraction 
was accompanied by an increase in the amount of 
non-KCI-extractable binding sites (Fig. 3b). As a 
consequence the total binding of oestradiol remained 
nearly constant. In the absence of [3 H]oestradiol the 
amount of both KCI-extractable and non-KCl-
extractable binding sites in uterine nuclei were con· 
siderably decreased (Fig. 3a). 
The time-course of the p H]oestradiol exchange by 
KCJ-extractable nuclear receptor sites in testicular 
tissue was studied after labelling of the tissue in vivo 
by injection of oestradiol. Fig. 4 shows that the hor-
mone exchange in the KCI-extractable fraction is 
completed within I5min. The amount of specific 
binding measured after the exchange procedure 
[21.9fmol±2.7 (s.D.), n=I3] did not differ signifi· 
cantly from control values [22.4fmol±2.5 (S.D.), 
11 = 3], which were obtained after injection of 
(3HJoestradiol in vivo. Therefore the hormone-
exchange procedure in ~;itra during 60min of incuba-
tion of nuclei with [.JH]oestradiol at 20"C gives reli-
able results for oestradiol-receptor concentrations. 
Determination of occupied nuclear oestradiol receptors 
in testicular tissue of intact immature rats and the 
effects of hypophysectomy on the amount of n11clear 
receptor sires 
Fig. S(a) shows that the KCI-extractable fraction 
of testicular nuclei isolated from intact immature 
rats and subjected to the hormone-exchange pro-
cedure contains oestradiol-binding sites in the 5S 
region of the gradient. In contrast, in testicular tissue 
of 5-day hypophysectomized rats little or no specifi-
cally bound oestradiol could be demonstrated in the 
5S region or sucrose gradients after application of the 
cxch:mge technique (Fig. 5b). Ta.ble 2 shows the num-
ber of nuclear receptor sites per two testes of intact 
and hypophysectomized animals and the total avail-
able amounts of nuclear rcceptot· sites measured 
after injection of rats with 500ng of non-radioactive 
oestradiol. As a result of hypophysectomy the total 
available number of receptor sites is decreased by a 
factor of two. 
Effect of choriogonadotropill lreatmc'll/ on the mnotmt 
of specific nuclear receptor silt•s 
Administration of 50i.u. of choriogonadotropin/ 
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Fig. 2. Effect of temperature on the stability of testicular nuclear oestradiol receptors 
Testicular tissue was incubated for 60min at 32"C with either lOnM-PH]ocstradiol or lOnM-r'H]oestradiol plus 
lOpM-diethylstilboestrol. Nuclei were isolated and nuclear suspensions were kept for 60min at different temperatures 
either without [3H]oestradioi (a) or with !Om.1-(3H]oestradiol (b) in the incubation medium. Thereafter nuclei were 
washed twice with TEN buffer and extracted with 0.4M-KC1 as described in the Materials and Methods section. In (a) 
specific binding in the KCl-extractab!e (A) and residual nuclear fraction (e) was calculated as a percentage oft he total 
nuclear binding (o) obtained after incubation of nuclei at ooc [61.3 ±4.9(4)fmolftwo testes]. In (b) specific binding in 
the KCl-extractable fraction is given as the percentage of the specific binding obtained after incubation of nuclei at 0°C 
[23.0±3.4(3)fmoljtwo testes]. Each value is the mean±s.n. of two to four determinations. 
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Fig. 3. E.f{ec/ of/emperature on the stabifity ofuterine nuclear oestradiol receptors 
Uterine tissue was incubated for 60min at 37"C with either 20nM-[3H]oestradiol or 20nM-["H]oestradiol plus 4pM-
diethylstilbocstrol. Nuclei were isolated and nuclear suspensions were kept for 60rnin at different temperatures either 
withOIJt ['H]oestradiol (a) or with lOnM-['H]oestradiol (b) in the incubation medium. Thereafter nuclei were washed 
twice with TEN buffer and extracted \\·ith 0.4M-KC1 as described in the Materials ;1nd Methods section. Specific binding 
in the KC!-extractablc (.A) and re~idual nuclear fraction ( •) was c:llculatcd as the percentage of the Iota] nuclear binding 
(0) obtained after incubation of nuclei at O"C [985±231 (5)fmoljuterus]. Each value is the mean±s.D. of two to five 
detern1inations. 
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Fig. 4. Time-course of oestradiol exchange with the nuclear 
receptor at 20aC after injection of rats with oestradiol in vivo 
Immature rats were subcutaneously injected with 
500ng of oestradiol, and 1 hlater testicular nuclei were 
prepared and incubated for different time-periods at 
20°C with either 10IL\.f-[3H]oestradiol or lOnM-
PH]oestradiol plus IOp:.l-diethylstilboestrol. After 
incubation the nuclei were extracted with 0.4M-KCI 
and specific binding in the KCl-extractable fraction 
was estimated by sucrose-density-gradient centrifu-
gation as described in the Materials and Methods 
section. The number of specific oestradiol-binding 
sites in the KCJ-extractable nuclear fraction obtained 
after injection ofanimals with 500 ng of [3H]oestradiol 
in vivo was used as a control. Results are expressed in 
fmol per two testes and represent the mean±s.o. 
obtained from three to four experiments. 
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day for 5 successive days resulted, 20h after the last 
injection, in an increased number of KCI-extractable 
nuclear binding sites as measured by the hormone-
Table 2. Determination of occupied KCI-extractable nuclear 
bindb1g sites for oestradiol in testicular tissue of intact rats, 
hypophysectomized rats and choriogonadotropin-treated 
rats 
Nuclei were isolated from testicular tissue from intact 
rats, from rats that had been hypophysectomized 
5 days before or from rats that had been treated with 
50i.u. of choriogonadotropin for 5 successive days. 
For determination of the total amount of nuclear 
binding sites all groups of animals were injected with 
SOOng of non-radioactive oestradiol 60min before the 
animals were killed. Nuclei were incubated for 60min 
at 20°C with either 10nM-[3HJoestradiol or lOOM:· 
[3H]oestradiol plus lOpM-diethylstilboestrol. Incu-
bated nuclei were washed with TEN buffer and ex-
tracted with 0.4M-KCJ. The specific oestradiol bind-
ing in the KCl-extractable fraction was measured by 
sucrose-gradient centrifugation as described in the 
Materials and Methods section. Results are expressed 
in fmol per two testes and represent the mean±s.D. 
for the numbers of experiments shown in paren~ 
theses. 
Intact 
Intact+oestradiol 
Hypophysectomized 
Hypophysectomized+oestradiol 
Choriogonadotropin 
Choriogonadotropin+oestradiol 
200 
Occupied nuclear 
binding sites 
(fmol/two testes) 
4.7± 1.5(6) 
21.8± 2.7 (8) 
0.5 ± 0.6 (4) 
12.4± 0.8 (3) 
47.5± 1.7 (3) 
65.0± 10.4 (4) 
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Fig. 5. Presence of occupied nuclear receptors for oestradiol in testicular tissue of intact and hypophysectomized rats 
Testicular nuclei were isolated from intact rats (a) or from rats that had been hypophysectomized 5 days before the 
experiments (b). Nuclei were incubated for60min at 20oC with either IOn).f-PH]oestradiol ($)or 10nM-[3HJoestradiol 
plus lOJtM~diethylstilboestrol (0). Incubated nuclei were extracted with 0.4M-KCI and the specific binding in the 
KCI-extractable fraction was estimated by sucrose-density~gradient centrifugation as described in .the Materials and 
Methods section. The arrows indicate the position of bovine serum albumin (4.6S) run in a separate gradient. 
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exchange assay (Table 2). To measure the total num-
ber of receptor sites, testicular nuclei, isolated from 
choriogonadotropin-treated animals injected with 
SOOng of oestradiol 60min before death, were sub-
jected to the exchange procedure. In choriogonado-
tropin-treated rats the testicular receptor concen-
tration was three times that in intact animals (see 
Table 2). 
Discussion 
The accumulation of specific receptor-steroid 
complexes in target-cell nuclei appears to precede 
the observed effects of steroids on synthesis of new 
RNA and protein (van der Berget al., 1974; Lazier, 
1975; Tsai eta/., 1975; Janne eta!., 1976; Hardin 
eta!., 1976). This has stimulated the interest in quan-
titative evaluations of nuclear steroid receptors as a 
possible indicator of physiological actions of steroids, 
even if in some cases the actual physiological import-
ance of a steroid is not yet known. Such a situation 
exists for oestradiol in the rat testis. Oestradiol is 
produced and present in the testis, and there is now 
ample proof of the occurrence of specific cytoplasmic 
and nuclear receptors in rat testis interstitial tissue 
(Brinkmann eta!., 1972; Mulder et al., 1973; de Boer 
et al., 1976). However, there is no certainty about the 
possible action of oestradiol or the significance of the 
oestradiol receptors in testicular tissue. Therefore 
in the present study we attempted to investigate the 
biochemical behaviour of oestradiol in nuclei of 
testis interstitial tissue as a possible indicator of a 
physiological effect. 
For our studies we required a reliable method for 
the quantitative determination of nuclear receptor-
oestradiol complexes. In order to obtain information 
about the amount of receptor that was already occu-
pied by endogenous unlabelled steroid, we were 
interested in a method that could distinguish between 
the total amount (occupied and unoccupied) of 
oestradiol receptor and the amount occupied. 
Methods that have been used for labelling receptors 
in vitro with negligible amounts of radioactive ligand 
(followed by separation of unbound and receptor-
bound radioactive ligand) only give an indication of 
the number of unoccupied receptor sites. 
Anderson eta!. (1972) were the first to introduce 
the so-called nuclear exchange method, which uses 
the exchange of 3H-labelled steroid with the endo-
genous receptor-bound steroid in the nuclear fraction 
for quantitative determination of the number of 
occupied nuclear receptor sites. In this method 3 H-
Jabelled steroid, accumulated in the nucleus after 
the exchange procedure, is extracted with ethanol 
(total radioactivity T).~ In control experiments ex-
change is performed in the presence of 3H-labelled 
steroid and an excess of non-radioactive steroid. It is 
assumed that in this case the amount of 3 H-labelled 
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steroid extracted with ethanol represents the non-
specifically bound steroid (N). Specific binding of 
[3 H]oestradiol to nuclear receptor molecules is defined 
as the difference between total and non-specific 
binding (T-N). The practicability and reliability of 
this approach for measuring nuclear steroid-hormone 
receptors in several tissues has been reported (Ander-
son eta!., 1973; Hsueh et al., 1974; Sanborn et al., 
1975; Teng & Teng, 1976). An indication of the total 
amount of receptor present should be obtained if, 
before the exchange labelling, tissues and animals are 
treated with excess of unlabelled steroid, so that all 
cytoplasmic receptor molecules are transferred to 
the nuclear fraction (Anderson eta!., 1972). 
In initial experiments with testicular tissue, when 
we tried to use the conditions described by Anderson 
et al. (1972) for uterine tissue, it became evident that 
in testis nuclei, almost ali [3H]oestradiol (96%) was 
retained by non-specific binding sites (Table 1). 
Therefore measurements of occupied nuclear receptor 
sites in testicular tissue became inaccurate. For uterine 
tissue, which was used for comparison, 26% of the 
total amount of radioactive oestradiol in nuclei was 
retained by non-specific binding sites (Table 1). The 
amount of non-specifically bound steroid in the 
nuclear extract could be decreased if, after the ex-
change procedure, both the amount of non-specific 
binding sites and the amount of free steroid were 
decreased. This could be achieved if, after incubation 
with steroids, nuclei were extracted with 0.4M-KCI 
and subsequently treated with charcoal to remove 
excess of free steroid. Others have observed that the 
number of cytoplasmic oestradiol-binding sites 
measured by a charcoal-adsorption method in the 
presence of 0.4M-KCl was underestimated as a 
result of a partial dissociation of the hormone from 
the oestradiol-receptor complex (Peck & Clark, 
1974). In our studies we measured the number of 
receptor sites in nuclei obtained after injection of 
animals with ['H]oestradiol. Under these conditions 
the measured number of receptor sites did not differ 
significantly from the number of sites obtained after 
injection of animals with non-radioactive oestradiol 
and by the exchange procedure (Fig. 4). Therefore 
it seems unlikely that, in the exchange procedure 
using charcoal adsorption, a considerable under-
estimation of the number of oestradiol-binding sites 
occurs. The modified method did result in much lower 
numbers of non-specific binding sites (1 0-20% of the 
total binding). This procedure has, however, the dis-
advantage that only in the KCI-extractable nuclear 
fraction can specific binding be measured. Because 
free steroid cannot be removed from the residual 
nuclear fraction, the difference between the total 
binding and the non-specific binding is too small to 
obtain reliable steroid-receptor measurements. 
Of the total amount of receptor present, about 
40% could be extracted from testicular nuclei with 
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0.4M-KC1; 60% was recovered in the residual nuclear 
fraction. Comparable results have been obtained 
after extraction of nuclei from kidney and hen oviduct 
(Best-Belpomme eta!., 1975; Janne et al., 1976), but 
the extraction efficiencies for chick liver nuclei and 
immature rat uterine nuclei were sUghtly lower 
(Lebeau et al., 1974; Mester & Baulieu, 1975). Even 
if only part of the total nuclear receptor population 
can be measured quantitatively in this way, informa-
tion indicating the number of occupied receptor sites 
present in testicular nuclei of immature rats under 
different physiological conditions might be obtained. 
The KCl solution appears to extract a nuclear non-
histone fraction (Kostraba et al., 1975), and the KCl-
extractable radioactivity may reflect the steroid-
receptor complexes associated with non-histone 
proteins. 
For testicular nuclei it was necessary to use an 
exchange temperature of 20°C. It was shown that the 
exchange of [3H]oestradio1 at this temperature was 
completed within 5min (Fig. 4). At higher tempera-
tures a considerable Joss ofKCl-extractable receptor 
sites was observed during incubations of intact nuclei 
(Fig. 2). Also for other steroid-hom10ne receptors, 
degradation has been observed during the honnone-
exchangeassay(Hsuehetal., 1974; Mester &Baulieu, 
1975). A good correlation was observed, however, 
between the depletion of cytoplasmic receptor sites 
and the increase in nuclear receptor sites measured by 
hormone exchange in Miillerian-duct cells after 
oestradiol administration (Teng & Teng, 1976). A 
possible difference in proteolytic enzyme activity in 
the isolated nuclei might offer an explanation for 
these contrasting findings. 
In the present study, occupied oestradiol receptors 
could be demonstrated in the KCJ-extractable frac-
tion from nuclei of 25-day-old rats (4.7fmol/two 
testes). After administration of oestradiol the 
amount of receptor in the KCI extract increased to 
21.8fmol/two testes (fable 2). As a consequence 
endogenous oestradiol in testicular tissue of intact 
immature rats could translocate 22% of the total 
receptor population into the nuclear fraction. For 
uterine tissue of intact immature rats, about 16% of 
the total oestradiol-receptor concentration was pre-
sent in the nuclear fraction (Anderson et al., 1972). 
In our studies, hypophysectomy of inunature rats 
resulted, after 5 days, in a decrease in the number of 
KCl-extractable binding sites occupied with endo-
genous oestradiol (0.5 fmol/two testes). The total 
amount of KCl-extractable binding sites in hypo-
physectomized animals measured after oestradiol 
administration also decreased (12.4fmoljtwo testes). 
Therefore the receptor population in hypophysectom-
ized rats is decreased to about 50% of the value in 
intact rats. The small amount of receptor sites occu-
pied by endogenous oestradiol does reflect the fall of 
the testicular oestradiol concentration after hypo-
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physectomy. The decrease in testicular oestradiol-
receptor content after hypophysectomy might be 
explained by a degeneration of Leydig cells or by a 
decrease in the number of these ~lis due to the 
disappearance oflutropin (Woods & Simpson, 1961; 
Gay &Sheth, 1972; Odell &Swerdloff, 1975). Similar 
observations have been made after hypophysectomy 
of mature female rats, which also results in a dramatic 
decrease in the number of available cytoplasmic 
receptor sites for oestradiol in the liver (Chamness 
ct al., 1975). The effect of choriogonadotropin was 
studied in order to investigate a possible role of gona-
dotropins on the number of oestradiol-receptor sites 
in testicular tissue. In intact immature rats, chorio-
gonadotropin caused an increase in both the number 
of occupied receptor sites (47.5fmoljtwo testes) and 
the total amount of receptor sites (65.0fmol(two 
testes) in the KCl-extractable fraction. From these 
values it can be concluded that 73% of the total 
receptor population is present in the nuclear fraction 
and that choriogonadotropin administration results 
in a threefold increase in the receptor-site population 
per testis if compared with that in intact rats. The 
increase correlates very well with the observed 
increase in the number of Leydig cells in 21-day-old 
rats after choriogonadotropin treatment (15i.u.(day 
for 5 successive days) owing to mitosis and cellular 
differentiation (Chemes et al., 1976). It appears likely 
therefore that the number of oestradiol-receptor sites 
per Leydig cell does not change after choriogonado-
tropin treatment. 
It is concluded that the number of total available 
and occupied oestradiol-receptor sites in the KCI-
extractable fraction of testicular nuclei is under the 
potential control of the hormonal environment. 
Whether the observed changes in the number of 
receptor sites are correlated with similar changes in 
the activities of the RNA and protein-synthesizing 
processes still requires investigation. 
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Summary 
1. Oestradiol in rat testicular and uterine tissue is spe-
cifically bound to nuclear receptor sites, which can be 
separated in KCl-extractable nuclear and nuclear residual 
(a nuclear fraction which resists KCl extraction) recep-
tor sites. 
2. The amount of 'extractable' nuclear binding sites for 
oestradiol in testis could be increased by mild trypsin 
treatment. Treatment of testicular nuclei with deoxycho-
late or DNAse resulted in a decrease of residual receptor 
sites and a concomitant increase of unbound oestradiol in 
the •extractable• nuclear fraction. 
3. The presence of KCN in vitro resulted in a relative in-
crease in the number of oestradiol binding sites in the 
nuclear residual fraction in both uterine and testicular 
tissue; the number of binding sites in the KCl-extractable 
fraction was not affected by KCN. 
4. During in vitro incubations of testicular tissue the num-
ber of oestradiol binding sites in the KCl-extractable 
nuclear fraction reached a maximum and remained constant 
after 30 min of incubation; the number of binding sites 
in the nuclear residual fraction decreased after incuba-
tion periods longer than 30 min. 
5. During in vitro incubations of uterine tissue the number 
of oestradiol binding sites in the KCl-extractable nu-
clear fraction and the nuclear residual fraction after an 
initial increase decreased to 50% of the maximal value 
between 30 and 60 min of incubation. 
6. It is concluded, that the testicular oestradiol receptor 
shows certain characteristics comparable with those of 
the uterine receptor. However, regarding the differences 
in retention time of steroids in the nucleus, it seems 
very unlikely that the oestradiol effect in uterus and 
the oestradiol effect in testis, if present are mediated 
by identical receptor mechanisms. 
Introduction 
It is now well accepted that the cytoplasm of target 
cells for steroid hormones contains a specific binding pro-
tein called a receptor. The complete sequence of events in 
the response of a tissue to a steroid hormone is still un-
known, but a postulated primary step is the interaction of 
the steroid with its receptor in the cytoplasm of the tar-
get tissue. The formed steroid-receptor complex migrates 
into the nucleus and binds to acceptor sites on the chroma-
tin which ultimately results in a response of the tissue to 
the steroid via changes in RNA and protein synthesis 
[1' 2' 3' .u . 
The rat testicular Leydig cell contains a cytoplasm re-
ceptor for oestradiol which can be transported into the .nu-
cleus and which binds to the chromatin under the influence 
of endogenously produced oestradiol [5,6,7,~. Whether the 
2 
binding of oestradiol-receptor complexes to nuclear acceptor 
sites results in a physiological effect in the Leydig cell 
is still unclear [9]. 
In order to gain further insight in a possible function 
of oestradiol receptors in the Leydig cell the processes of 
translocation and nuclear binding of receptor-oestradiol 
complexes in vitro in testicular tissue with similar pro-
cesses in uterine tissue, a tissue which responds well to 
oestrogen administration, were compared [10,1~. 
In the present study we have also investigated the ef-
fects of trypsin, deoxycholate and DNAse treatment on the 
nature of nuclear oestradiol binding sites in testicular 
tissue. For uterine tissue it has been postulated that the 
number of nuclear residual oestradiol receptor sites (the 
fraction which resists KCl-extraction) determines the tissue 
response to oestradiol [12]. Therefore the distribution of 
KCl-extractable and nuclear residual binding sites was in-
vestigated after incubation of uterine and testicular tissue 
with oestradiol. 
It has been reported that energy might be required for 
the action of glucocorticoids and progesterone [13,14,15-, 
16]. In this respect we have also studied the effect of 
energy deprivation on the distribution of oestradiol binding 
sites in KCl-extractable and nuclear residual fractions of 
uterine and testicular tissue. 
Experimental 
Materials. Unlabelled oestradiol and diethylstilboestrol 
(DES) were purchased from Steraloids Inc. Pawling, New York, 
U.S.A. 3H-oestradiol (sp.act. 96 Ci/mmol) was purchased 
from Radiochemical· Centre, Aroersham, U.K. The purity of the 
steroids was determined by thin-layer chromatography. Tryp-
sine (analytical grade) was obtained from Boehringer 
Mannheim, West Germany, sodium deoxycholate from Merck, 
Darmstadt, West Germany and DNAse from Sigma, St. Louis, 
U.S.A. 
3 
Source of tissues and treatments. Immature (25-30 day 
old) and mature (3 months old) rats of the R-Arnsterdam strain 
were used in this study. Interstitial tissue of mature rat 
testis was obtained by wet dissection after incubation in 
vitro [17]. One decapsulated testis or one uterus stripped 
of adhering fat and mesentery, from immature rats, was in-
cubated in 2.0 ml Krebs Ringer bicarbonate buffer, pH 7.4, 
containing 0.2% glucose. For mature rat testis 4.0 ml of 
incubation medium was used per testis. Incubations were car-
ried out for different time periods in an atmosphere of 95% 
o2 : 5% co2 . In studies where the effect of KCN was inves-
tigated tissues were incubated in Krebs Ringer bicarbonate 
buffer, pH 7.4, containing 5 x 10- 4M KCN. Testicular tissue 
was incubated at 32°C; uterine tissue at 37°c. 
Tissues were incubated either with 2 x 10-SM 3H-oestra-
diol (total binding) or with 2 x 10-SM 3H-oestradiol in the 
presence of 4 x 10- 6M DES (non-specific binding). Specific 
binding of 3H-oestradiol is defined as the difference be-
tween the total binding and the non-specific binding. 
Preparation of subcellular fractions. After incubation 
total testicular tissue and interstitial tissue were homo-
genized in 10 vol 10 mM Tris-HCl buffer, pH 7.4, containing 
1.5 mM EDTA and 0.02% NaN 3 (TEN-buffer) with 6 strokes of 
Potter-Elvehjem homogenizer at 1100 rev./min. The homoge-
nate was rehomogenized in an all-glass Potter-Elvehjem ho-
mogenizer and was subsequently centrifuged at 500 g for 
10 min at 0°C. The 500 g pellet was washed once with TEN-
buffer, twice with TEN-buffer containing 0.2% Triton X-100 
and another time with TEN-buffer. Uterine tissue of imma-
ture rats was homogenized in an Ultraturrax homogenizer for 
10 sec, rehomogenized in a Potter-Elvehjem homogenizer and 
centrifuged at 800 g for 10 min at 0°C. The 800 g pellet 
was further washed and centrifuged at 800 g as described 
for testicular tissue. The nuclear preparations thus obtai-
ned appeared pure by phase contrast microscopy and had a 
protein/DNA ratio in the range of 1.7-1.9. The isolated 
4 
pellets were used immediately after isolation for estimation 
of nuclear binding. Where indicated the 500 g and 800 g su-
pernatants of the testicular and uterine tissue respectively 
were centrifuged at 105,000 g for 60 min to obtain the cyto-
sol fraction. 
Incubation of nuclei. In experiments concerning the na-
ture of the oestradiol binding sites in testicular nuclei 
the following procedure was used. After incubation of testis 
tissue from mature rats in the presence of steroids for 
60 min at 32°C interstitial tissue nuclei were isolated. 
Nuclei obtained from the interstitial tissue of one testis 
were suspended in 10 mM Tris buffer, pH 7.4 and incubated 
with DNAse (150 "g/ml; 30 min at 20°C), trypsin (150 "g/ml; 
30 min at 10°C} or deoxycholate (1% DOC, 30 min at 0°C) in 
a volume of 1.0 ml. After incubation the nuclear suspensions 
were centrifuged for 30 min at 105,000 g and specific bin-
ding of 3H-oestradiol was measured in the supernatant 
('soluble') and pellet ('nuclear residual') fraction as des-
cribed below. A KCl-extractable nuclear fraction and a nu-
clear residual fraction obtained after extraction of untrea-
ted nuclei with 0.4M KCl served as a control. 
Estimation of specific 3H-oestradiol binding. It was at-
tempted to extract the 3H-oestradiol in the nuclear pellet 
with 0.4M KCl in TEN-buffer, pH 8.5. The nuclear pellet was 
mixed with an equal volume of 0.8M KCl in TEN-buffer, pH 8.5. 
The final volume of the extraction buffer was adjusted to 
800 ~1 with 0.4M KCl in TEN-buffer, pH 8.5. After incubation 
for 60 min at 0°C the extract was centrifuged for 30 min at 
105,000 g and an aliquot of the supernatant fraction was 
analyzed on sucrose density gradients as described below 
(KCl-extractable nuclear binding). The residual nuclear pel-
let, from which no further 3H-oestradiol could be extracted 
with KCl-TEN-buffer, was solubilized in 1 N NaOH and an ali-
quot was counted for radioactivity after addition of an 
equal volume of 3 N perchloric acid (residual nuclear bin-
5 
ding). Specific binding in both fractions was estimated by 
substracting the non-specific binding from the total binding 
of 3H-oestradiol and was expressed as fmol/mg protein, pre-
sent in each fraction. In the 105,000 g supernatants speci-
fic cytosol binding was estimated by sucrose density gradient 
centrifugation as described below. 
Sucrose gradient centrifugation. A 200 ~l portion of the 
KCl-extractable nuclear fraction was layered on top of a 
linear 5-20% (w/v) sucrose density gradient prepared in TEN-
buffer, pH 8.5, containing 0.4M KCl. Gradients were centri-
fuged at 260,000 g for 18 h at 0°C in a Beckman SW65 rotor. 
av 
Cytosol fractions (200-400 ~1) were layered on top of linear 
5-20% (w/v) sucrose gradients prepared in TEN-buffer and gra-
dients were centrifuged at 150,000 g for 16 h at 0°c. On 
av 
separate gradients 200 ~g of bovine serum albumin (BSA) or 
alcohol dehydrogenase (ADH) were run as sedimentation mar-
kers (4.6S and 7.6S respectively). After centrifugation each 
gradient was fractionated in 27 fractions of 0,2 ml each and 
each fraction was assayed for radioactivity. 
General procedures. Protein was determined by the proce-
dure of Lowry et al. [1~ with bovine serum albumin as a 
standard. Radioactivity was measured in a Packard model 3375 
liquid scintillation spectrometer. The scintillation fluid 
consisted of a mixture of Triton X-100 (Rohm and Haas, 
Philadelphia, U.S.A.) and toluene (1:2 v/v) containing 
0.1 g POPOP (1,4-bis-(5-pheny1oxazo1-2-yl) benzene)/1 and 
4.8 g PPO (2,5-diphenyloxazol)/1 (Packard Instrument S.A., 
Benelux, Brussels, Belgium). 
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Results 
Determination of two different types of specific oestra-
diol binding sites in testicular nuclei. Immature rat tes-
ticular tissue was incubated either with 10-SM 3H-oestradiol 
or with 10-8M 3H-oestradiol in the presence of increasing 
amounts non-radioactive DES (Fig. 1). Nuclei were isolated, 
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Figure Determination of two different nuclear binding 
sites for oestradiol. 
Testicular tissue from immature rats was incubated for 
60 min at 32°C either with 10-SM 3H-oestradiol or with 10-SM 
3 . . . . H-oestrad~ol ~n the presence of LncreasLng amounts of non-
radioactive diethylstilboestrol. Nuclei were isolated and 
extracted with 0.4M KCl. Binding of oestradiol in the KCl-
extractable fraction and the nuclear residual fraction was 
estimated as described in the methods section. The binding 
obtained in these two nuclear fractions in the absence of 
non-radioactive competitor is defined as the 100% value. 
• - e nuclear extract; x --- x residual nuclear fraction. 
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extracted with 0.4M KCl and oestradiol binding sites present 
in the KCl-extractable fraction and the nuclear residual 
fraction (the fraction which resists extraction) was esti-
mated. 
In Fig. 1 it is shown that increasing amounts of non-
radioactive DES decreased the binding of 3H-oestradiol in 
both the KCl-extractable and the nuclear residual fraction. 
A two and three fold excess non-radioactive DES reduced the 
initial amount of binding by a factor two in the KCl-
extractable fraction and nuclear residual fraction respec-
tively. 
In the order of 40% of the specifically bound steroid in 
testicular nuclei was generally recovered in the KC1 
extractable fraction; 60% resisted KCl extraction. The dis-
tribution of specific binding sites in the two nuclear frac-
tions did not change if nuclei were extracted several times 
with 0.4M KCl. At O.SM and higher salt concentrations the 
nuclear material became quite viscous and could not be se-
dimented by centrifugation. 
Nature of the oestradiol binding sites in testicular 
nuclei. In order to investigate the nature of the oestradiol 
binding sites in testicular nuclei, testes from mature rats 
were incubated with oestradiol and the obtained nuclear sus-
pension from interstitial tissue nuclei was incubated, 
either with trypsin, DNAse or deoxycholate. 
The results in Fig. 2 show that treatment of nuclei with 
trypsin resulted in an increased amount of specifically 
bound 3H-oestradiol in the soluble fraction. Further analy-
sis of this soluble fraction on sucrose density gradients 
revealed that 3H-oestradiol was specifically bound to a 4S 
sedimenting macromolecule. If nuclei were treated with DNAse 
or deoxycholate an oestradiol binding macromolecules with a 
sedimentation value of SS was observed in sucrose density 
gradients. This value is similar to the value obtained after 
extraction of nuclei with 0.4M KCl. Treatment of nuclei with 
either DNAse or deoxycholate did not result in a further 
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Figure 2 Effect of different treatments on the binding of 
oestradiol in testicular nuclei. 
Testicular tissue from mature rats was incubated for 
60 min at 32°C in the presence of steroids and after dis-
section of the interstitial tissue, nuclei were isolated. 
Aliquots of the nuclear suspension in 10 nM Tris-buffer, 
pH 7.4, were treated either with trypsin (150 ~g/ml; 30 min 
at !0°C), with deoxycholate ( 1% DOC; 30 min at 0°C) or with 
DNAse (!50 1-1g/ml; 30 min at 20°C). After incubation the 
suspensions were centrifuged at 105,000 g for 30 min and 
specific binding in the supernatant ('nuclear extractable') 
and pellet fraction ('residual nuclear fraction') were 
measured as described in Materials and Methods. Nuclei ex-
tracted with 0.4M KCl were used as a control. Radioactive 
steroid in the nuclei is subdivided in radioactivity bound 
by the nuclear extractable fraction (sedimentation value 
of 55 or 4S), free radioactive oestradiol in the extrac-
table fraction and specifically bound residual nuclear 
radioactivity (R). 
9 
Uterus. Uterine tissue was incubated at 37°C for diffe-
rent time periods after an initial incubation of 60 min at 
0°C in the presence of steroids. Nuclei were isolated and 
extracted with 0.4M KCl in order to obtain a KCl-extrac-
table and nuclear residual fraction. Specifically bound 
oestradiol in both nuclear fractions increased during the 
time of incubation reaching a maximum after 30 min (Fig. 4). 
After continued incubation the specific binding of oestra-
diol in the KCl-extractable and nuclear residual fraction 
declined reaching a plateau after 60 min. During the first 
period of incubation the initial increase in nuclear oes-
tradiol binding was accompanied by a decrease in the amount 
of specifically bound oestradiol in the cytosol fraction. 
After 60 min specific binding sites for oestradiol in the 
cytosol fraction became undetectable. 
Effect of energy deprivation on the distribution of spe-
cifically bound 3H-oestradiol in testicular and uterine nu-
clei. To determine the effect of energy deprivation on the 
distribution of oestradiol binding sites, testicular and 
uterine tissue were incubated in the presence of steroid 
and 5xl0- 4M KCN. Tissues incubated in the presence of ste-
roids but with the omission of KCN from the incubation me-
dium served as control tissues. One hour after the addition 
of KCN the number of specific oestradiol binding sites in 
the nuclear residual fractions of both testicular (Fig. SA) 
and uterine (Fig. SB) tissue were enhanced significantly 
compared to controls. For testicular tissue a twofold in-
crease was measured, for uterine tissue the increase was 
slightly lower (1.6 fold). The addition of KCN had no spe-
cific effect on the specific binding of oestradiol in the 
KCl-extractable nuclear fraction of both tissues. 
12 
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Figure 4 Time course of oestradiol binding in subcellular 
fractions after incubation of uterine tissue in vitro. 
Uteri from immature rats were preincubated at 0°C for 
60 min either with 2xl0-SM 3H-oestradiol or with 2xl0- 8M 
3H-oestradiol plus 4xl0- 6M DES. After this incubation period 
the temperature was elevated to 37°C and incubation was con-
tinued for different time periods. Uteri were rinsed with 
buffer, homogenized and nuclei were isolated. After extrac-
tion of nuclei with 0.4M KCl specific oestradiol binding was 
estimated in the KCl-extractable fraction and the nuclear 
residual fraction. Specific binding in the cytosol fraction, 
obtained as described in the method section, was also esti-
mated. Each point reflects an individual estimation. 
• - • nuclear extract; o --- o nuclear residual fraction; 
~ --- ~ cytosol fraction. 
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Figure 5 In vitro effect of KCN on the nuclear binding of 
oestradiol in testicular and uterine tissue. 
Tissues were pre-incubated in KRBG-buffer at 32°C or 37°C 
for 60 min either with 2xl0-SM 3H-oestradiol or with 
-8 3 -6 Zx!O M H-oestradiol plus 4xl0 M DES. After this period 
the tissues were washed with KRB-buffer and further incu-
bated in KRB-buffer for a period of 60 min at 32°C oi 37°C 
in the presence of both steroids and 5x!0- 4M KCN. Nuclei 
were isolated and specific oestradiol binding in the KCl-
extractable and nuclear residual fractions was estimated. 
The specific binding obtained after incubation of testis 
and uterus in KRBG for a period of 120 min in the presence 
of steroids is defined as the iOO% value. Results are ex-
pressed as the mean of 3 experiments ~ S.E.M. 
C = control incubation. K = incubation in the presence of 
KCN. 
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Discussion 
The testicular Leydig cell contains a receptor protein 
which is specific for oestradiol [7,19]. This oestradiol 
receptor has also been demonstrated in total testicular 
tissue from immature rats [20] and in dissected interstitial 
tissue of mature rats [5,20]. From the present results it 
appears that two different fractions of specifically bound 
oestradiol can be demonstrated iri testicular nuclei: one 
fraction (40%) is extractable with 0.4M KCl, the other 
fraction resists KCl-extraction. The number of specific 
binding sites in the KCl-extractable fraction did not show 
any increase if nuclei were extracted repeatedly or if nu-
clei were extracted with concentrations of KCl above 0.4M. 
The present observations are compatible with those for 
steroid-hormone receptors in other tissues where nuclear 
binding could also be distinguished in a KCl-extractable 
and a nuclear residual form [12,13,21,22,24 1 25,26]. 
The role of different types of nuclear binding sites for 
steroid hormones is not yet clear. Evidence has been pre-
sented, however, that the residual nuclear binding proteins 
for oestradiol and testosterone might be important in the 
mechanism of action of steroid hormones [12,27 1 28]. The de-
monstration of two different nuclear binding sites for oes-
tradiol in Leydig cells raises the possibility that actions 
of oestradiol in these cells can also be mediated via a si-
milar receptor mechanism. 
The in vitro incubations of testicular tissue with 3H-
oestradiol showed that both types of nuclear oestradiol bin-
ding were similarly affected by increasing amounts of non-
radioactive DES (Fig. 1). The addition of a 2-3 fold excess 
3 
of non-radioactive DES caused a 50% reduction of the H-
oestradiol binding in both nuclear fractions. This observa-
tion is in good agreement with those obtained with the cy-
toplasmic oestradiol receptor [ 19]. 
Different approaches were used to characterize the nature 
of the nuclear oestradiol binding sites in testicular tis-
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sue. Mild trypsin treatment of nuclei, which contained oes-
tradiol-receptor complexes, caused a release of binding si-
tes for oestradiol with a sedimentation value of 4S. This 
value is different from the sedimentation value of SS which 
is normally observed for KCl-extractable nuclear oestradiol 
receptors. Receptor complexes with a sedimentation value of 
4S were also solubilized after treatment of liver and ute-
rine nuclei with trypsin [22-,23]. 
It has been reported previously that trypsin treatment 
of the oestradiol receptor from cytosols of calve uteri 
resulted in a loss of binding affinity of the receptor for 
DNA and it has been suggested [29] that trypsin treatment 
releases part of the receptor molecule, which contains the 
chromatin-binding unit, whereas the oestrogen binding unit 
remains unaffected and shows a sedimentation value of 4S on 
sucrose density gradients. 
Extraction of isolated liver nuclei with NaCl solutions 
in a concentration range of 0.14M to 2M causes removal of 
DNA-histones and associated proteins; the residual protein 
fraction contains acidic proteins[3o]. For other tissues it 
has been reported that nuclear steroid hormone receptors 
are associated with acidic nuclear proteins [27, 31] . It has 
been reported by Wang [3o], that deoxycholate (DOC) could 
solubilize 95% of the nuclear residual proteins from rat 
liver, including the acidic protein fraction. In the pre-
sent experiments deoxycholate treatment of testicular nuclei, 
containing oestradiol-receptor complexes, caused the release 
of a considerable amount of total nuclear radioactive oes-
tradiol, but only a minor fraction was bound to macromole-
cules with a sedimentation value of SS. Addition of DOC to 
cytoplasmic oestradiol-receptor complexes did not result in 
a dissociation of the hormone from the receptor molecule. 
Therefore the observed release of unbound radioactivity from 
deoxycholate-treated nuclei might reflect a lowered affinity 
of the nuclear receptor molecule for the hormone subsequent 
to its binding by the chromatin. 
DNAse was used in another attempt to characterize the na-
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ture of the nuclear steroid binding. After treatment with 
DNAse of testicular nuclei, containing accumulated oestra-
diol-receptor complexes, a considerable increase of radio-
active oestradiol in the soluble nuclear fraction was ob-
tained, but again only a small part of the released oestra-
diol was bound to macromolecules. 
From the observed effects of DNAse in the present expe-
riments as well as in previous experiments by others [13, 
32 1 33 1 34 1 35,36,37,38,39] it is no·t possible to derive un-
ambiguous information about the nature of the nuclear accep-
tor sites which bind hormone-receptor complexes. From the 
available evidence [4,27,31,40,41,42] it appears most likely 
that the nuclear acceptor sites are composed of both DNA and 
nonhistone proteins. 
The observed increase in the amount of nuclear binding 
sites in the KCl-extractable and nuclear residual fraction 
of testicular tissue during the first 30 min of incubation 
(Fig. 3) might reflect translocation of cytoplasmic receptor 
molecules. 
Whereas the level of nuclear binding sites in the KCl-
extractable fraction remained rather constant, the number of 
oestradiol binding sites in the nuclear residual fraction 
decreased, which might reflect either an inactivation of 
binding sites in this fraction or a redistribution of bin-
ding sites over nuclear and cytosol fractions. A possible 
return of nuclear binding sites into the cytoplasmic frac-
tion could not be measured due to very high levels of non-
specific binding sites in this fraction. 
Different results were obtained for uterine tissue 
(Fig. 4). After an initial increase, the specific binding 
to KCl-extractable and residual nuclear fractions declined 
to levels about 50% of the maximum value, which was observed 
at 30 min after the start of the incubation. This pattern is 
in close agreement with observations of Mester et al. for 
uterine tissue after in vivo injection of immature rats with 
oestradiol [24]. The measured amoUnt of specific oestradiol 
binding sites in the nuclear residual fraction 60 min after 
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incubation (160 £mol/uterus) is comparable with the amount 
estimated by Clark et al. 1 and 6 h after in vivo injection 
of oestradiol [12]. These authors suggested that this rather 
constant amount of accumulated nuclear residual binding 
sites might be the important fraction for the response of 
the uterus to oeStradiol [10,1~. In testicular tissue the 
amount of nuclear residual binding sites, after a maximum 
at t = 30 min, dropped gradually, without reaching a pla-
teau. 
From the results presented in Fig. 3 and Fig. 4 it can be 
concluded that the in vitro translocation of oestradiol-
receptor complexes into the nuclear fractions of uterus and 
testis follow similar time courses. However, differences 
were observed for the retention times of the oestradiol-
receptor complexes in the nuclear fractions of both tissues. 
The incubation temperatures used in the experiments were 
37°C and 32°C for uterus and testis respectively. Therefore 
it cannot be excluded that the observed differences in the 
nuclear retention reflect a difference in the stability of 
the binding of hormone-receptor complexes to uterine and 
testicular chromatin under physiological conditions. 
If hormone effects in cells are mediated via a receptor 
mechanism in the nuclear fraction, then the short retention 
time of tightly bound nuclear oestradiol receptor molecules 
(the binding sites in the residual nuclear fraction) could 
offer an explanation for the difficulties in the search for 
an oestrogen effect in the testis. In the literature some 
evidence is available that cellular ATP is involved in the 
mechanism of action of steroid hormones. It has been obser-
ved that the progesterone receptor in oviduct binds ATP 
[16] and that KCN could inhibit the glucocorticoid receptor 
release from fibroblast nuclei [13]. In our studies the pre-
sence of KCN increased the amounts of oestradiol binding in 
the residual nuclear fraction in testicular (2-fold in-
crease) and uterine (1.6 fold) tissue, while the oestradiol 
binding in the KCl-extractable fraction remained unaffected. 
The increased residual nuclear binding in the presence of 
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KCN might indicate that a continuous production of ATP is 
necessary for the release of receptor molecules, possibly 
in an inactive form [43], into the cytosol. Further inves-
tigations are needed to elucidate the energy requirements 
in the mechanism of action of steroid hormones. 
From the present results it can be concluded that the 
testicular Leydig cell shares the large group of cells that 
contain receptors for steroid hormones. Under the influence 
of added oestradiol the cytoplasmic receptor was transloca-
ted into the nuclei where it could be recovered from two 
different nuclear binding sites which differed in extracti-
bility with KCl. The retention times of bound oestradiol in 
the nuclear fraction which resisted KCl extraction were 
different for uterine and testicular tissue. Therefore it 
seems very unlikely that the oestradiol effect in uterine 
tissue and in testicular tissue, if present, are mediated 
by identical nuclear receptor mechanisms. 
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